Cover
Cover | 6 Months Ended |
Jun. 30, 2021 | |
Cover [Abstract] | |
Document Type | 6-K |
Entity Registrant Name | Barclays Bank PLC |
Amendment Flag | false |
Document Fiscal Year Focus | 2021 |
Document Fiscal Period Focus | Q2 |
Document Period End Date | Jun. 30, 2021 |
Entity Central Index Key | 0000312070 |
Current Fiscal Year End Date | --12-31 |
Condensed consolidated Income S
Condensed consolidated Income Statement (unaudited) - GBP (£) £ in Millions | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | ||
Profit or loss [abstract] | |||
Interest and similar income | £ 2,444 | £ 3,173 | |
Interest and similar expense | (921) | (1,502) | |
Net interest income | 1,523 | 1,671 | |
Fee and commission income | 4,070 | 3,818 | |
Fee and commission expense | (870) | (939) | |
Net fee and commission income | 3,200 | 2,879 | |
Net trading income | 3,467 | 4,225 | |
Net investment expense | (36) | (146) | |
Other income | 35 | 8 | |
Total income | 8,189 | 8,637 | |
Credit impairment releases/(charges) | 288 | (2,674) | |
Net operating income | 8,477 | 5,963 | |
Staff costs | (2,385) | (2,191) | |
Infrastructure, administration and general expenses | (2,674) | (2,357) | |
Litigation and conduct | (87) | (19) | |
Operating expenses | (5,146) | (4,567) | |
Share of post-tax results of associates and joint ventures | 3 | 1 | |
Profit on disposal of subsidiaries, associates and joint ventures | 0 | 126 | |
Profit before tax | 3,334 | 1,523 | [1] |
Tax charge | (611) | (230) | |
Profit after tax | 2,723 | 1,293 | |
Attributable to: | |||
Equity holders of the parent | 2,420 | 960 | |
Other equity instrument holders | 303 | 333 | |
Profit after tax | £ 2,723 | £ 1,293 | |
[1] | H120 comparative figures have been restated to make the condensed cash flow statement more relevant following a review of the disclosure and the accounting policies applied that was undertaken in H220. Amendments, which were first applied in the Barclays Bank PLC Annual Report 2020, have been made to the classification of cash collateral reported within cash and cash equivalents and to the presentation of items within net cash flows from operating and investing activities. Footnotes 2 and 3 below quantify the impact of the changes to the respective cash flow categories in H120 and provide further detail. |
Condensed consolidated statemen
Condensed consolidated statement of comprehensive income (unaudited) - GBP (£) £ in Millions | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | ||
Statement of comprehensive income [abstract] | |||
Profit after tax | £ 2,723 | £ 1,293 | |
Other comprehensive (loss)/income that may be recycled to profit or loss: | |||
Currency translation reserve | [1] | (552) | 1,386 |
Fair value through other comprehensive income reserve | [1] | (312) | 137 |
Cash flow hedging reserve | [1] | (823) | 1,065 |
Other | [1] | 0 | (6) |
Other comprehensive (loss)/income that may be recycled to profit or loss | [1] | (1,687) | 2,582 |
Other comprehensive (loss)/income not recycled to profit or loss | |||
Retirement benefit remeasurements | 103 | 645 | |
Own credit | (47) | 496 | |
Other comprehensive income not recycled to profit or loss | 56 | 1,141 | |
Other comprehensive (loss)/income for the period | (1,631) | 3,723 | |
Total comprehensive income for the period | £ 1,092 | £ 5,016 | |
[1] | Reported net of tax. |
Condensed consolidated balance
Condensed consolidated balance sheet (unaudited) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2019 |
Assets | ||||
Cash and balances at central banks | £ 163,804 | £ 155,902 | ||
Cash collateral and settlement balances | 108,536 | 97,616 | ||
Loans and advances at amortised cost | 133,815 | 134,267 | ||
Reverse repurchase agreements and other similar secured lending | 3,048 | 8,981 | ||
Trading portfolio assets | 147,144 | 127,664 | ||
Financial assets at fair value through the income statement | 191,128 | 171,761 | ||
Derivative financial instruments | 256,129 | 302,693 | ||
Financial assets at fair value through other comprehensive income | 50,184 | 51,902 | ||
Investments in associates and joint ventures | 22 | 24 | ||
Goodwill and intangible assets | 1,453 | 1,154 | ||
Property, plant and equipment | 1,193 | 1,537 | ||
Current tax assets | 500 | 424 | ||
Deferred tax assets | 2,362 | 2,552 | ||
Retirement benefit assets | 2,701 | 1,814 | ||
Other assets | 2,318 | 1,440 | ||
Total assets | 1,064,337 | 1,059,731 | ||
Liabilities | ||||
Deposits at amortised cost | 249,732 | 244,696 | ||
Cash collateral and settlement balances | 100,957 | 85,549 | ||
Repurchase agreements and other similar secured borrowing | 11,067 | 10,443 | ||
Debt securities in issue | 42,931 | 29,423 | ||
Subordinated liabilities | 29,045 | 32,005 | £ 33,425 | |
Trading portfolio liabilities | 56,137 | 46,139 | ||
Financial liabilities designated at fair value | 263,920 | 249,626 | ||
Derivative financial instruments | 246,983 | 300,580 | ||
Current tax liabilities | 586 | 644 | ||
Deferred tax liabilities | 29 | 225 | ||
Retirement benefit liabilities | 275 | 232 | ||
Other liabilities | 8,028 | 5,251 | ||
Provisions | 951 | 1,208 | ||
Total liabilities | 1,010,641 | 1,006,021 | ||
Equity | ||||
Called up share capital and share premium | 2,348 | 2,348 | ||
Other equity instruments | 8,621 | 8,621 | ||
Other reserves | 1,449 | 3,183 | ||
Retained earnings | 41,278 | 39,558 | ||
Total equity | 53,696 | 53,710 | £ 56,694 | £ 50,615 |
Total liabilities and equity | £ 1,064,337 | £ 1,059,731 |
Condensed consolidated statem_2
Condensed consolidated statement of changes in equity (unaudited) - GBP (£) £ in Millions | Total | Called up share capital and share premium | Other equity instruments | Other reserves | Retained earnings | |||||
Beginning Balance, equity at Dec. 31, 2019 | £ 50,615 | £ 2,348 | £ 8,323 | £ 3,235 | £ 36,709 | |||||
Profit after tax | 1,293 | 333 | 960 | |||||||
Currency translation movements | 1,386 | [1] | 1,386 | |||||||
Fair value through other comprehensive income reserve | 137 | 137 | ||||||||
Cash flow hedges | 1,065 | [1] | 1,065 | |||||||
Retirement benefit remeasurements | 645 | 645 | ||||||||
Own credit | 496 | 496 | ||||||||
Other | (6) | [1] | (6) | |||||||
Total comprehensive income for the period | 5,016 | 333 | 3,084 | 1,599 | ||||||
Other equity instruments coupons paid | (333) | (333) | ||||||||
Equity settled share schemes | 475 | 475 | ||||||||
Vesting of Barclays PLC shares under equity settled share schemes | (289) | (289) | ||||||||
Dividends paid- ordinary shares | (263) | (263) | ||||||||
Dividends paid - preference shares | (28) | (28) | ||||||||
Increase through other contributions by owners, equity | 1,500 | 1,500 | ||||||||
Other movements | 1 | 1 | ||||||||
Ending Balance, equity at Jun. 30, 2020 | 56,694 | 2,348 | [2] | 8,323 | [2] | 6,319 | [2] | 39,704 | ||
Beginning Balance, equity at Dec. 31, 2020 | 53,710 | 2,348 | [2] | 8,621 | [2] | 3,183 | [2] | 39,558 | ||
Profit after tax | 2,723 | 303 | [2] | 2,420 | ||||||
Currency translation movements | (552) | [1] | (552) | [2] | ||||||
Fair value through other comprehensive income reserve | (312) | (312) | [2] | |||||||
Cash flow hedges | (823) | [1] | (823) | [2] | ||||||
Retirement benefit remeasurements | 103 | 103 | ||||||||
Own credit | (47) | (47) | [2] | |||||||
Other | [1] | 0 | ||||||||
Total comprehensive income for the period | 1,092 | 303 | [2] | (1,734) | [2] | 2,523 | ||||
Other equity instruments coupons paid | (303) | (303) | [2] | |||||||
Equity settled share schemes | 255 | 255 | ||||||||
Vesting of Barclays PLC shares under equity settled share schemes | (349) | (349) | ||||||||
Dividends paid- ordinary shares | (694) | (694) | ||||||||
Dividends paid - preference shares | (13) | (13) | ||||||||
Other movements | (2) | (2) | ||||||||
Ending Balance, equity at Jun. 30, 2021 | £ 53,696 | £ 2,348 | [2] | £ 8,621 | [2] | £ 1,449 | [2] | £ 41,278 | ||
[1] | Reported net of tax. | |||||||||
[2] | Details of share capital, other equity instruments and other reserves are shown on pages 40 to 41. |
Condensed consolidated cash flo
Condensed consolidated cash flow statement (unaudited) - GBP (£) £ in Millions | 6 Months Ended | |||
Jun. 30, 2021 | Jun. 30, 2020 | [1] | ||
Statement of cash flows [abstract] | ||||
Profit before tax | £ 3,334 | £ 1,523 | ||
Adjustment for non-cash items | [2] | 5,001 | (35) | |
Net decrease/(increase) in loans and advances at amortised cost | [2] | 2,932 | (6,581) | |
Net increase in deposits at amortised cost | 5,036 | 32,357 | ||
Net increase in debt securities in issue | 13,508 | 16,960 | ||
Changes in other operating assets and liabilities | [3] | (8,814) | (6,447) | |
Corporate income tax paid | (617) | (270) | ||
Net cash from operating activities | 20,380 | 37,507 | ||
Net cash from investing activities | [2] | (3,112) | (11,201) | |
Net cash from financing activities | (2,883) | 653 | ||
Effect of exchange rates on cash and cash equivalents | (5,534) | 7,813 | ||
Net increase in cash and cash equivalents | 8,851 | 34,772 | ||
Cash and cash equivalents at beginning of the period | [3] | 173,125 | 139,314 | |
Cash and cash equivalents at end of the period | [3] | £ 181,976 | £ 174,086 | |
[1] | H120 comparative figures have been restated to make the condensed cash flow statement more relevant following a review of the disclosure and the accounting policies applied that was undertaken in H220. Amendments, which were first applied in the Barclays Bank PLC Annual Report 2020, have been made to the classification of cash collateral reported within cash and cash equivalents and to the presentation of items within net cash flows from operating and investing activities. Footnotes 2 and 3 below quantify the impact of the changes to the respective cash flow categories in H120 and provide further detail. | |||
[2] | Movements in cash and cash equivalents relating to debt securities at amortised cost were previously shown within loans and advances at amortised cost in operating activities. These debt securities holdings are now considered to be part of the investing activity performed by the Barclays Bank Group following a change in accounting policy and have been presented within investing activities in H121. Comparatives have been restated. The effect of this change was to reclassify £4,179m of net cash outflows from operating activities to investing activities in H120. | |||
[3] | Cash and cash equivalents have been restated to exclude cash collateral and settlement balances, with the exception of balances that the Barclays Bank Group holds at central banks related to payment schemes. The effect of this change decreased cash and cash equivalents by £27,974m as at 30 June 2020 and £16,702m as at 31 December 2019. As a result, net cash from operating activities decreased by £11,272m in H120, representing the net increase in the cash collateral and settlement balances line item in this period. |
Condensed consolidated cash f_2
Condensed consolidated cash flow statement (unaudited) (Parenthetical) - GBP (£) £ in Millions | 6 Months Ended | 12 Months Ended | |
Jun. 30, 2020 | Dec. 31, 2019 | ||
Condensed Cash Flow Statements, Captions [Line Items] | |||
Amounts reclassified to investing activities | [1],[2] | £ (11,201) | |
Amounts reclassified/decreased from/in operating activities | [1] | (37,507) | |
Decrease in cash and cash equivalents | [1] | (34,772) | |
Increase (decrease) due to changes in accounting policy | |||
Condensed Cash Flow Statements, Captions [Line Items] | |||
Amounts reclassified to investing activities | 4,179 | ||
Amounts reclassified/decreased from/in operating activities | 4,179 | ||
Increase (decrease) due to corrections of prior period errors | |||
Condensed Cash Flow Statements, Captions [Line Items] | |||
Amounts reclassified/decreased from/in operating activities | 11,272 | ||
Decrease in cash and cash equivalents | £ 27,974 | £ 16,702 | |
[1] | H120 comparative figures have been restated to make the condensed cash flow statement more relevant following a review of the disclosure and the accounting policies applied that was undertaken in H220. Amendments, which were first applied in the Barclays Bank PLC Annual Report 2020, have been made to the classification of cash collateral reported within cash and cash equivalents and to the presentation of items within net cash flows from operating and investing activities. Footnotes 2 and 3 below quantify the impact of the changes to the respective cash flow categories in H120 and provide further detail. | ||
[2] | Movements in cash and cash equivalents relating to debt securities at amortised cost were previously shown within loans and advances at amortised cost in operating activities. These debt securities holdings are now considered to be part of the investing activity performed by the Barclays Bank Group following a change in accounting policy and have been presented within investing activities in H121. Comparatives have been restated. The effect of this change was to reclassify £4,179m of net cash outflows from operating activities to investing activities in H120. |
Basis of preparation
Basis of preparation | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of initial application of standards or interpretations [abstract] | |
Basis of preparation | Basis of preparation These condensed consolidated interim financial statements for the six months ended 30 June 2021 have been prepared in accordance with the Disclosure and Transparency Rules (DTR) of the UK’s Financial Conduct Authority (FCA) and IAS 34, Interim Financial Reporting, as published by the International Accounting Standards Board (IASB) and adopted by the UK. The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2020. The annual financial statements for the year ended 31 December 2020 were prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and in accordance with International Financial Reporting Standards (IFRS) and interpretations (IFRICs) as issued by the IASB and adopted pursuant to Regulation (EC) No 1606/2002 as it applies in the European Union as well as adopted by the UK. UK adopted IFRS and EU adopted IFRS are currently the same and were the same as at 31 December 2020. The accounting policies and methods of computation used in these condensed consolidated interim financial statements are the same as those used in the Barclays Bank PLC Annual Report 2020. 1. Going concern The financial statements are prepared on a going concern basis, as the Directors are satisfied that the Barclays Bank Group and parent company have the resources to continue in business for a period of at least 12 months from approval of the interim financial statements. In making this assessment, the Directors have considered a wide range of information relating to present and future conditions which includes a review of a working capital report (WCR). The WCR is used by the Directors to assess the future performance of the Barclays Bank Group and that is has the resources in place that are required to meet its ongoing regulatory requirements. The WCR includes an assessment of the impact of internally generated stress testing scenarios on the liquidity and capital requirements forecasts. The stress tests used were based upon an assessment of reasonably possible downside economic scenarios that the Barclays Bank Group could experience. The WCR indicated that the Barclays Bank Group had sufficient capital in place to support its future business requirements and remained above its regulatory minimum requirements in the internal stress scenarios. 2. Other disclosures The Credit risk disclosures on pages 9 to 19 form part of these interim financial statements. |
Segmental reporting
Segmental reporting | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of operating segments [abstract] | |
Segmental reporting | Segmental reporting Analysis of results by business Corporate and Investment Bank Consumer, Cards and Payments Head Office Barclays Bank Group Half year ended 30.06.21 £m £m £m £m Total income 6,632 1,649 (92) 8,189 Credit impairment releases 260 22 6 288 Net operating income/(expenses) 6,892 1,671 (86) 8,477 Operating expenses (3,617) (1,126) (316) (5,059) Litigation and conduct (2) (82) (3) (87) Total operating expenses (3,619) (1,208) (319) (5,146) Other net income 1 3 — — 3 Profit/(loss) before tax 3,276 463 (405) 3,334 As at 30.06.21 £bn £bn £bn £bn Total assets 991.3 62.7 10.3 1,064.3 Corporate and Investment Bank Consumer, Cards and Payments Head Office Barclays Bank Group Half year ended 30.06.20 £m £m £m £m Total income 6,973 1,742 (78) 8,637 Credit impairment charges (1,320) (1,299) (55) (2,674) Net operating income/(expenses) 5,653 443 (133) 5,963 Operating expenses (3,458) (1,053) (37) (4,548) Litigation and conduct (4) (8) (7) (19) Total operating expenses (3,462) (1,061) (44) (4,567) Other net income 1 12 115 — 127 Profit/(loss) before tax 2,203 (503) (177) 1,523 As at 31.12.20 £bn £bn £bn £bn Total assets 990.9 57.8 11.0 1,059.7 1 Other net income represents the share of post-tax results of associates and joint ventures and profit (or loss) on disposal of subsidiaries, associates and joint ventures. Split of income by geographic region 1 Half year ended 30.06.21 Half year ended 30.06.20 £m £m United Kingdom 2,698 2,835 Europe 1,213 1,240 Americas 3,676 3,872 Africa and Middle East 20 23 Asia 582 667 Total 8,189 8,637 1 The geographical analysis is based on the location of the office where the transactions are recorded. |
Net fee and commission income
Net fee and commission income | 6 Months Ended |
Jun. 30, 2021 | |
Fee and commission income (expense) [abstract] | |
Net fee and commission income | Net fee and commission incomeFee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from Contracts with Customers: Corporate and Investment Bank Consumer, Cards and Payments Head Office Total Half year ended 30.06.21 £m £m £m £m Fee type Transactional 184 984 — 1,168 Advisory 399 61 — 460 Brokerage and execution 527 26 — 553 Underwriting and syndication 1,715 — — 1,715 Other 25 76 11 112 Total revenue from contracts with customers 2,850 1,147 11 4,008 Other non-contract fee income 59 3 — 62 Fee and commission income 2,909 1,150 11 4,070 Fee and commission expense (369) (496) (5) (870) Net fee and commission income 2,540 654 6 3,200 Corporate and Investment Bank Consumer, Cards and Payments Head Office Total Half year ended 30.06.20 £m £m £m £m Fee type Transactional 177 968 — 1,145 Advisory 260 46 — 306 Brokerage and execution 654 31 — 685 Underwriting and syndication 1,468 — — 1,468 Other 35 100 19 154 Total revenue from contracts with customers 2,594 1,145 19 3,758 Other non-contract fee income 57 3 — 60 Fee and commission income 2,651 1,148 19 3,818 Fee and commission expense (441) (497) (1) (939) Net fee and commission income 2,210 651 18 2,879 Transactional fees are service charges on deposit accounts, cash management services and transactional processing fees. These include interchange and merchant fee income generated from credit and bank card usage. Advisory fees are generated from wealth management services and investment banking advisory services related to mergers, acquisitions and financial restructurings. Brokerage and execution fees are earned for executing client transactions with various exchanges and over-the-counter markets and assisting clients in clearing transactions. Underwriting and syndication fees are earned for the distribution of client equity or debt securities, and the arrangement and administration of a loan syndication. These include commitment fees to provide loan financing. |
Tax
Tax | 6 Months Ended |
Jun. 30, 2021 | |
Major components of tax expense (income) [abstract] | |
Tax | The tax charge for H121 was £611m (H120: £230m), representing an effective tax rate of 18.3% (H120: 15.1%). The effective tax rate for H121 includes a benefit recognised as a result of the increase in the UK corporation tax rate and absent this benefit the tax charge would have been £748m and the effective tax rate would have been 22.4%. The H120 effective tax rate included a benefit recognised for re-measurement of the Barclays Bank Group’s UK deferred tax assets as a result of UK corporation tax previously being maintained at a rate of 19%. In its Budget held in March 2021, the UK Government announced that the UK rate of corporation tax will increase from 19% to 25% from 1 April 2023. This legislative change has been enacted, resulting in the Barclays Bank Group’s UK deferred tax liabilities increasing by £28m with a tax benefit in the income statement of £137m and a tax charge within other comprehensive income of £165m. The UK Government also announced that it will undertake a review of the additional 8% banking surcharge during 2021. The Budget Report issued on 3 March 2021 outlines that “the government will set out how it intends to ensure that the combined rate of tax on banks’ profits does not increase substantially from its current level”. Any subsequent reduction in the banking surcharge arising from the Government’s review would result in the Barclays Bank Group’s UK deferred tax liabilities again being re-measured, the timing of which is uncertain but is expected to occur in H122. In the USA, the Biden administration published in April 2021 The Made In America Tax Plan, which proposes an increase in the US federal corporate income tax rate. This would result in a re-measurement to increase the Barclays Bank Group’s US deferred tax assets upon enactment, the timing of which is uncertain. In addition, revisions to international elements of the US tax regime are being considered that could affect the Barclays Bank Group’s US tax position in future. The G7 finance ministers published a communiqué on 5 June 2021which sets out high level political agreement on global tax reform, including the implementation of a global minimum tax rate. The Barclays Bank Group will continue to monitor developments and assess the potential impact of associated future legislative changes. As at 30.06.21 As at 31.12.20 Deferred tax assets and liabilities £m £m USA 1,908 2,049 Other territories 454 503 Deferred tax assets 2,362 2,552 Deferred tax liabilities – UK (29) (225) Analysis of deferred tax assets Temporary differences 1,591 1,841 Tax losses 771 711 Deferred tax assets 2,362 2,552 |
Dividends on ordinary shares
Dividends on ordinary shares | 6 Months Ended |
Jun. 30, 2021 | |
Dividends on ordinary shares [Abstract] | |
Dividends on ordinary shares | Dividends on ordinary shares Half year ended 30.06.21 Half year ended 30.06.20 Dividends paid during the period £m £m Ordinary shares 694 263 Preference shares 13 28 Total 707 291 An interim dividend in respect of the year ended 31 December 2021 of £100m will be paid on 2 August 2021. |
Fair value of financial instrum
Fair value of financial instruments | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of fair value measurement of assets [abstract] | |
Fair value of financial instruments | Fair value of financial instruments This section should be read in conjunction with Note 16, Fair value of financial instruments of the Barclays Bank PLC Annual Report 2020, which provides more detail about accounting policies adopted, valuation methodologies used in calculating fair value and the valuation control framework which governs oversight of valuations. There have been no changes in the accounting policies adopted or the valuation methodologies used. Valuation The following table shows the Barclays Bank Group’s assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification: Valuation technique using Quoted market prices Observable inputs Significant unobservable inputs (Level 1) (Level 2) (Level 3) Total As at 30.06.21 £m £m £m £m Trading portfolio assets 73,307 71,285 2,552 147,144 Financial assets at fair value through the income statement 1,089 186,032 4,007 191,128 Derivative financial instruments 11,643 240,830 3,656 256,129 Financial assets at fair value through other comprehensive income 14,495 35,646 43 50,184 Investment property — — 8 8 Total assets 100,534 533,793 10,266 644,593 Trading portfolio liabilities (30,063) (26,057) (17) (56,137) Financial liabilities designated at fair value (142) (263,482) (296) (263,920) Derivative financial instruments (11,227) (230,157) (5,599) (246,983) Total liabilities (41,432) (519,696) (5,912) (567,040) As at 31.12.20 Trading portfolio assets 60,619 65,182 1,863 127,664 Financial assets at fair value through the income statement 4,439 162,930 4,392 171,761 Derivative financial instruments 9,154 289,071 4,468 302,693 Financial assets at fair value through other comprehensive income 12,150 39,599 153 51,902 Investment property — — 10 10 Total assets 86,362 556,782 10,886 654,030 Trading portfolio liabilities (23,331) (22,780) (28) (46,139) Financial liabilities designated at fair value (159) (249,126) (341) (249,626) Derivative financial instruments (8,762) (285,579) (6,239) (300,580) Total liabilities (32,252) (557,485) (6,608) (596,345) The following table shows the Barclays Bank Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type: As at 30.06.21 As at 31.12.20 Assets Liabilities Assets Liabilities £m £m £m £m Interest rate derivatives 916 (1,269) 1,613 (1,615) Foreign exchange derivatives 151 (129) 144 (143) Credit derivatives 100 (364) 196 (351) Equity derivatives 2,489 (3,837) 2,497 (4,112) Commodity derivatives — — 18 (18) Corporate debt 981 (38) 698 (3) Reverse repurchase and repurchase agreements — (161) — (174) Non-asset backed loans 3,467 — 3,093 — Asset backed securities 562 — 767 (24) Equity cash products 401 — 542 — Private equity investments 98 — 84 — Other 1 1,101 (114) 1,234 (168) Total 10,266 (5,912) 10,886 (6,608) 1 Other includes commercial real estate loans, fund and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property. Assets and liabilities reclassified between Level 1 and Level 2 During the period there were no material transfers between Level 1 and Level 2 (period ended December 2020: no material transfers between Level 1 and Level 2). Level 3 movement analysis The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The table shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the period. Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as Level 3 if an unobservable input is deemed significant. Level 3 movement analysis Purchases Sales Issues Settle- ments Total gains and losses in the period recognised in the income statement Total gains or losses recognised in OCI Transfers As at 30.06.21 As at 01.01.21 Trading income Other income In Out £m £m £m £m £m £m £m £m £m £m £m Corporate debt 151 305 (87) — — 25 — — 40 (11) 423 Non-asset backed loans 709 620 (131) — (84) 13 — — 124 (106) 1,145 Asset backed securities 686 112 (294) — — (10) — — 43 (48) 489 Equity cash products 214 13 (17) — — 32 — — 29 (9) 262 Other 103 21 — — (51) (1) — — 162 (1) 233 Trading portfolio assets 1,863 1,071 (529) — (135) 59 — — 398 (175) 2,552 Non-asset backed loans 2,280 696 (299) — (388) 10 — — 69 (47) 2,321 Equity cash products 320 166 (194) — — (171) 18 — — — 139 Private equity investments 88 22 (7) — (7) (1) 3 — — — 98 Other 1,704 2,296 (2,389) — (160) (19) 1 — 16 — 1,449 Financial assets at fair value through the income statement 4,392 3,180 (2,889) — (555) (181) 22 — 85 (47) 4,007 Non-asset backed loans 106 — — — — — — — — (106) — Asset backed securities 47 — — — (5) — — 1 — — 43 Financial assets at fair value through other comprehensive income 153 — — — (5) — — 1 — (106) 43 Investment property 10 — (2) — — — — — — — 8 Trading portfolio liabilities (28) (3) 14 — — (7) — — — 7 (17) Financial liabilities (341) — — — 98 7 — — (78) 18 (296) Interest rate derivatives (2) 9 — — 33 (121) 4 — 21 (296) (352) Foreign exchange derivatives 1 — — — 58 (6) — — 3 (34) 22 Credit derivatives (155) (118) 2 — (5) 12 (1) — 1 (1) (265) Equity derivatives (1,615) (315) (1) — (32) (221) — — 28 808 (1,348) Net derivative financial instruments 1 (1,771) (424) 1 — 54 (336) 3 — 53 477 (1,943) Total 4,278 3,824 (3,405) — (543) (458) 25 1 458 174 4,354 1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,656m and derivative financial liabilities were £5,599m. Level 3 movement analysis Total gains and losses in the period recognised in the income statement Total gains or losses recognised in OCI Transfers As at 30.06.20 As at 01.01.20 Purchases Sales Issues Settle-ments Trading income Other income In Out £m £m £m £m £m £m £m £m £m £m Corporate debt 120 25 — — — (26) — — 4 (17) 106 Non-asset backed loans 974 1,927 (740) — (4) (111) — — 97 (320) 1,823 Asset backed securities 656 249 (224) — (76) (12) — — 41 (11) 623 Equity cash products 392 2 (4) — — (67) — — 28 (4) 347 Other 122 47 — — — 2 — — 8 — 179 Trading portfolio assets 2,264 2,250 (968) — (80) (214) — — 178 (352) 3,078 Non-asset backed loans 1,964 1,050 (270) — (112) 110 — — — — 2,742 Equity cash products 835 14 — — — (22) (29) — — — 798 Private equity investments 113 1 (2) — — 2 4 — 20 (12) 126 Other 1,250 1,865 (2,017) — (13) (8) 55 — 24 — 1,156 Financial assets at fair value through the income statement 4,162 2,930 (2,289) — (125) 82 30 — 44 (12) 4,822 Non-asset backed loans 343 79 — — (157) — — (3) — — 262 Asset backed securities 86 — (1) — — 1 — (1) — — 85 Financial assets at fair value through other comprehensive income 429 79 (1) — (157) 1 — (4) — — 347 Investment property 13 — (1) — — — (2) — 2 (2) 10 Trading portfolio liabilities — — — — — — — — — — — Financial liabilities designated at fair value (343) — — (3) — (12) (1) — (22) 26 (355) Interest rate derivatives (206) 17 — — 10 268 1 — 300 (10) 380 Foreign exchange derivatives (7) — — — (12) 89 — — 5 (8) 67 Credit derivatives 198 (258) 11 — (376) 151 1 — 2 8 (263) Equity derivatives (820) (447) (1) — 17 (90) — — (5) (23) (1,369) Net derivative financial instruments 1 (835) (688) 10 — (361) 418 2 — 302 (33) (1,185) Total 5,690 4,571 (3,249) (3) (723) 275 29 (4) 504 (373) 6,717 1 Derivative financial instruments are presented on a net basis. On a gross basis, derivative financial assets were £7,747m and derivative financial liabilities were £8,932m. Unrealised gains and losses on Level 3 financial assets and liabilities The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets and liabilities held at the period end. Half year ended 30.06.21 Half year ended 30.06.20 Income statement Other compre-hensive income Total Income statement Other compre-hensive income Total Trading income Other income Trading income Other income £m £m £m £m £m £m £m £m Trading portfolio assets 35 — — 35 (177) — — (177) Financial assets at fair value through the income statement (67) 35 — (32) 126 (24) — 102 Financial assets at fair value through other comprehensive income — — — — — — (2) (2) Investment properties — — — — — (2) — (2) Trading portfolio liabilities (6) — — (6) — — — — Financial liabilities designated at fair value 7 — — 7 (16) (1) — (17) Net derivative financial instruments (367) — — (367) 248 — — 248 Total (398) 35 — (363) 181 (27) (2) 152 Valuation techniques and sensitivity analysis Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative models. Sensitivity analysis of valuations using unobservable inputs As at 30.06.21 As at 31.12.20 Favourable changes Unfavourable changes Favourable changes Unfavourable changes Income statement Equity Income Statement Equity Income statement Equity Income Statement Equity £m £m £m £m £m £m £m £m Interest rate derivatives 52 — (83) — 82 — (123) — Foreign exchange derivatives 6 — (10) — 6 — (11) — Credit derivatives 53 — (44) — 55 — (44) — Equity derivatives 185 — (193) — 174 — (179) — Commodity derivatives 2 — (2) — 2 — (2) — Corporate debt 22 — (16) — 16 — (14) — Non-asset backed loans 129 — (172) — 104 3 (190) (3) Equity cash products 122 — (111) — 158 — (141) — Private equity investments 17 — (18) — 15 — (15) — Other 1 18 — (18) — 21 — (21) — Total 606 — (667) — 633 3 (740) (3) 1 Other includes commercial real estate loans, fund and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property. The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the impact of using alternative models, would be to increase fair values by up to £606m (December 2020: £636m) or to decrease fair values by up to £667m (December 2020: £743m) with substantially all the potential effect impacting profit and loss rather than reserves. Significant unobservable inputs The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified as Level 3 are consistent with those described within Note 16, Fair value of financial instruments in the Barclays Bank PLC Annual Report 2020. Fair value adjustments Key balance sheet valuation adjustments are quantified below: As at 30.06.21 As at 31.12.20 £m £m Exit price adjustments derived from market bid-offer spreads (492) (483) Uncollateralised derivative funding (80) (115) Derivative credit valuation adjustments (210) (268) Derivative debit valuation adjustments 91 113 • Exit price adjustments derived from market bid-offer spreads increased by £9m to £492m. • Uncollateralised derivative funding decreased by £35m to £80m as a result of tightening input funding spreads. • Derivative credit valuation adjustments decreased by £58m to £210m as a result of tightening input counterparty credit spreads. • Derivative debit valuation adjustments decreased by £22m to £91m as a result of tightening input Barclays Bank PLC credit spreads. Portfolio exemption The Barclays Bank Group uses the portfolio exemption in IFRS 13, Fair Value Measurement to measure the fair value of groups of financial assets and liabilities. Instruments are measured using the price that would be received to sell a net long position (i.e. an asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an orderly transaction between market participants at the balance sheet date under current market conditions. Accordingly, the Barclays Bank Group measures the fair value of the group of financial assets and liabilities consistently with how market participants would price the net risk exposure at the measurement date. Unrecognised gains as a result of the use of valuation models using unobservable inputs The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on initial recognition, less amounts subsequently recognised, is £114m (December 2020: £103m) for financial instruments measured at fair value and £29m (December 2020: £30m) for financial instruments carried at amortised cost. There are additions of £32m (December 2020: £26m) and amortisation and releases of £21m (December 2020: £23m) for financial instruments measured at fair value and amortisation and releases of £1m (December 2020: £2m) offset by additions of £nil (December 2020: £1m) for financial instruments carried at amortised cost. Third party credit enhancements Structured and brokered certificates of deposit issued by the Barclays Bank Group are insured up to $250,000 per depositor by the Federal Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that the Barclays Bank Group and other banks pay for deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the IFRS 9 fair value option includes this third party credit enhancement. The on-balance sheet value of these brokered certificates of deposit amounted to £1,241m (December 2020: £1,494m). Comparison of carrying amounts and fair values for assets and liabilities not held at fair value Valuation methodologies employed in calculating the fair value of financial assets and liabilities measured at amortised cost are consistent with those described within Note 16, Fair value of financial instruments in the Barclays Bank PLC Annual Report 2020. The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Barclays Bank Group’s balance sheet: As at 30.06.21 As at 31.12.20 Carrying amount Fair value Carrying amount Fair value Financial assets £m £m £m £m Loans and advances at amortised cost 133,815 134,228 134,267 134,537 Reverse repurchase agreements and other similar secured lending 3,048 3,048 8,981 8,981 Financial liabilities Deposits at amortised cost (249,732) (249,757) (244,696) (244,738) Repurchase agreements and other similar secured borrowing (11,067) (11,067) (10,443) (10,443) Debt securities in issue (42,931) (42,925) (29,423) (29,486) Subordinated liabilities (29,045) (30,515) (32,005) (33,356) |
Subordinated liabilities
Subordinated liabilities | 6 Months Ended |
Jun. 30, 2021 | |
Subordinated liabilities [abstract] | |
Subordinated liabilities | Subordinated liabilities Half year ended 30.06.21 Year ended 31.12.20 £m £m Opening balance 32,005 33,425 Issuances 5,075 3,856 Redemptions (6,599) (5,954) Other (1,436) 678 Closing balance 29,045 32,005 Issuances of £5,075m comprise £4,920m of intra-group loans from Barclays PLC and £82m ZAR Floating Rate Notes and £73m USD Floating Rate Notes issued externally by Barclays Bank PLC subsidiaries. Redemptions of £6,599m comprise £2,065m of intra-group loans from Barclays PLC and £4,534m of externally issued notes comprising £1,961m GBP 10% Fixed Rate Subordinated Notes, £1,339m EUR 6% Fixed Rate Subordinated Notes, £1,075m USD 10.179% Fixed Rate Subordinated Notes and £86m EUR Subordinated Floating Rate Notes issued by Barclays Bank PLC and £73m USD Floating Rate Notes issued by a Barclays Bank PLC subsidiary. Other movements predominantly comprise foreign exchange movements and fair value hedge adjustments. |
Provisions
Provisions | 6 Months Ended |
Jun. 30, 2021 | |
Provisions [abstract] | |
Provisions | Provisions As at 30.06.21 As at 31.12.20 £m £m Customer redress 51 44 Legal, competition and regulatory matters 207 222 Redundancy and restructuring 22 44 Undrawn contractually committed facilities and guarantees 572 769 Onerous contracts 4 6 Sundry provisions 95 123 Total 951 1,208 |
Retirement benefits
Retirement benefits | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of defined benefit plans [abstract] | |
Retirement benefits | Retirement benefits As at 30 June 2021, the Barclays Bank Group’s IAS 19 pension surplus across all schemes was £2.4bn (December 2020: £1.6bn). The UK Retirement Fund (UKRF), which is the Group’s main scheme, had an IAS 19 pension surplus of £2.6bn (December 2020: £1.8bn). The movement in the surplus for the UKRF was driven by payment of deficit reduction contributions, and an increase in the discount rate, partially offset by higher than expected long-term price inflation. UKRF funding valuations |
Called up share capital
Called up share capital | 6 Months Ended |
Jun. 30, 2021 | |
Equity [abstract] | |
Called up share capital | Called up share capitalOrdinary shares As at 30 June 2021 the issued ordinary share capital of Barclays Bank PLC comprised 2,342m (December 2020: 2,342m) ordinary shares of £1 each. Preference shares As at 30 June 2021 the issued preference share capital of Barclays Bank PLC of £6m (December 2020: £6m) comprised 1,000 Sterling Preference Shares of £1.00 each (December 2020: 1,000); 31,856 Euro Preference Shares of €100 each (December 2020: 31,856); and 58,133 US Dollar Preference shares of $100 each (December 2020: 58,133). There were no issuances or redemptions of ordinary or preference shares in the six months to 30 June 2021. |
Other equity instruments
Other equity instruments | 6 Months Ended |
Jun. 30, 2021 | |
Miscellaneous components of equity [abstract] | |
Other equity instruments | Other equity instruments Other equity instruments of £8,621m (December 2020: £8,621m) are AT1 securities issued to Barclays PLC. Barclays PLC uses funds from market issuances to purchase AT1 securities from Barclays Bank PLC. There have been no issuances or redemptions in the period. The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under prevailing capital rules applicable as at the relevant issue date. AT1 securities are undated and are redeemable, at the option of Barclays Bank PLC, in whole on (i) the initial call date, or on any fifth anniversary after the initial call date or (ii) any day falling in a named period ending on the initial reset date, or on any fifth anniversary after the initial reset date. In addition, the AT1 securities are redeemable, at the option of Barclays Bank PLC, in whole in the event of certain changes in the tax or regulatory treatment of the securities. Any redemptions require the prior consent of the PRA. |
Other reserves
Other reserves | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of reserves within equity [abstract] | |
Other reserves | Other reserves As at 30.06.21 As at 31.12.20 £m £m Currency translation reserve 2,184 2,736 Fair value through other comprehensive income reserve (68) 244 Cash flow hedging reserve 358 1,181 Own credit reserve (1,001) (954) Other reserves (24) (24) Total 1,449 3,183 Currency translation reserve The currency translation reserve represents the cumulative gains and losses on the retranslation of the Barclays Bank Group’s net investment in foreign operations, net of the effects of hedging. As at 30 June 2021, there was a credit balance of £2,184m (December 2020: £2,736m credit) in the currency translation reserve. The £552m debit movement principally reflects the strengthening of GBP against USD and EUR during the period. Fair value through other comprehensive income reserve The fair value through other comprehensive income reserve represents the unrealised change in the fair value through other comprehensive income investments since initial recognition. As at 30 June 2021, there was a debit balance of £68m (December 2020: £244m credit) in the fair value through other comprehensive income reserve. The loss of £312m is principally driven by a £303m loss from the decrease in fair value of bonds due to increasing bond yields and £151m of net gains transferred to the income statement along with impairment release of £5m, which was partially offset by a tax credit of £147m. Cash flow hedging reserve The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss. As at 30 June 2021, there was a credit balance of £358m (December 2020: £1,181m credit) in the cash flow hedging reserve. The decrease of £823m principally reflects a £931m decrease in the fair value of interest rate swaps held for hedging purpose as major interest rate forward curves increased and £143m of gains transferred to the income statement. This is partially offset by a tax credit of £256m. Own credit reserve The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the own credit reserve are not recycled to profit or loss in future periods. As at 30 June 2021, there was a debit balance of £1,001m (December 2020: £954m debit) in the own credit reserve. The movement of £47m principally reflects a £266m loss from the tightening of EF spreads. This is partially offset by other activity of £100m and a tax credit of £115m. Other reserves As at 30 June 2021, there was a debit balance of £24m (December 2020: £24m debit) in other reserves relating to redeemed ordinary and preference shares issued by Barclays Bank Group. |
Contingent liabilities and comm
Contingent liabilities and commitments | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of contingent liabilities [abstract] | |
Contingent liabilities and commitments | Contingent liabilities and commitments As at 30.06.21 As at 31.12.20 Contingent liabilities £m £m Guarantees and letters of credit pledged as collateral security 13,805 15,138 Performance guarantees, acceptances and endorsements 6,601 5,794 Total 20,406 20,932 Commitments Documentary credits and other short-term trade related transactions 1,017 1,086 Standby facilities, credit lines and other commitments 282,742 263,936 Total 283,759 265,022 In addition to the above, Note 14, Legal, competition and regulatory matters details out further contingent liabilities where it is not practicable to disclose an estimate of the potential financial effect on the Barclays Bank Group. |
Legal, competition and regulato
Legal, competition and regulatory matters | 6 Months Ended |
Jun. 30, 2021 | |
Legal, competition and regulatory matters | |
Legal, competition and regulatory matters | Legal, competition and regulatory matters The Barclays Bank Group faces legal, competition and regulatory challenges, many of which are beyond our control. The extent of the impact of these matters cannot always be predicted but may materially impact our operations, financial results, condition and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision, or both, depending on the relevant facts and circumstances. The recognition of provisions in relation to such matters involves critical accounting estimates and judgments in accordance with the relevant accounting policies applicable to Note 8, Provisions. We have not disclosed an estimate of the potential financial impact or effect on the Barclays Bank Group of contingent liabilities where it is not currently practicable to do so. Various matters detailed in this note seek damages of an unspecified amount. While certain matters specify the damages claimed, such claimed amounts do not necessarily reflect the Barclays Bank Group’s potential financial exposure in respect of those matters. Investigations into certain advisory services agreements and related civil action FCA proceedings In 2008, Barclays Bank PLC and Qatar Holdings LLC entered into two advisory service agreements (the Agreements). The Financial Conduct Authority (FCA) conducted an investigation into whether the Agreements may have related to Barclays PLC’s capital raisings in June and November 2008 (the Capital Raisings) and therefore should have been disclosed in the announcements or public documents relating to the Capital Raisings. In 2013, the FCA issued warning notices (the Notices) finding that Barclays PLC and Barclays Bank PLC acted recklessly and in breach of certain disclosure-related listing rules, and that Barclays PLC was also in breach of Listing Principle 3. The financial penalty provided in the Notices is £50m. Barclays PLC and Barclays Bank PLC continue to contest the findings. Following the conclusion of the Serious Fraud Office (SFO) proceedings against certain former Barclays executives resulting in their acquittals, the FCA proceedings, which were stayed, have resumed. Civil action In 2021, the High Court of Justice (High Court) dismissed a claim brought by PCP Capital Partners LLP and PCP International Finance Limited (PCP) against Barclays Bank PLC for fraudulent misrepresentation and deceit arising from certain statements made by Barclays Bank PLC to PCP relating to the November 2008 capital raising. PCP’s application to appeal the High Court’s decision has also been refused which concludes these proceedings. Investigations into LIBOR and other benchmarks and related civil actions Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have conducted investigations relating to Barclays Bank PLC’s involvement in allegedly manipulating certain financial benchmarks, such as LIBOR. The SFO closed its investigation with no action to be taken against the Barclays Group. Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Barclays Group and other banks in relation to the alleged manipulation of LIBOR and/or other benchmarks. USD LIBOR civil actions The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial purposes in the US District Court in the Southern District of New York (SDNY). The complaints are substantially similar and allege, among other things, that Barclays PLC, Barclays Bank PLC, Barclays Capital Inc. (BCI) and other financial institutions individually and collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US Commodity Exchange Act (CEA), the US Racketeer Influenced and Corrupt Organizations Act (RICO), the Securities Exchange Act of 1934 and various state laws by manipulating USD LIBOR rates. Putative class actions and individual actions seek unspecified damages with the exception of three lawsuits, in which the plaintiffs are seeking a combined total of approximately $100m in actual damages and additional punitive damages against all defendants, including Barclays Bank PLC. Some of the lawsuits also seek trebling of damages under the Antitrust Act and RICO. Barclays Bank PLC has previously settled certain claims. Two class action settlements where Barclays Bank PLC has respectively paid $7.1m and $20m have received final court approval. Barclays Bank PLC also settled a further matter for $7.5m, paid in June 2021. Sterling LIBOR civil actions In 2016, two putative class actions filed in the SDNY against Barclays Bank PLC, BCI and other Sterling LIBOR panel banks alleging, among other things, that the defendants manipulated the Sterling LIBOR rate in violation of the Antitrust Act, CEA and RICO, were consolidated. The defendants’ motion to dismiss the claims was granted in 2018. The plaintiffs have appealed the dismissal. Japanese Yen LIBOR civil actions In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel banks by a lead plaintiff involved in exchange-traded derivatives and members of the Japanese Bankers Association’s Euroyen Tokyo Interbank Offered Rate (Euroyen TIBOR) panel. The complaint alleges, among other things, manipulation of the Euroyen TIBOR and Yen LIBOR rates and breaches of the CEA and the Antitrust Act. In 2014, the court dismissed the plaintiff’s antitrust claims, and, in 2020, the court dismissed the plaintiff’s remaining CEA claims. The plaintiff has appealed the lower court’s dismissal of such claims. In 2015, a second putative class action, making similar allegations to the above class action, was filed in the SDNY against Barclays PLC, Barclays Bank PLC and BCI. The plaintiffs filed an amended complaint in 2020, and the defendants have filed a motion to dismiss. SIBOR/SOR civil action In 2016, a putative class action was filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants, alleging manipulation of the Singapore Interbank Offered Rate (SIBOR) and Singapore Swap Offer Rate (SOR). In 2018, the court dismissed all claims against Barclays PLC, Barclays Bank PLC and BCI. The plaintiffs’ appeal of the dismissal of their claims was granted in March 2021 and the matter has been remanded to the lower court for further proceedings. ICE LIBOR civil actions In 2019, several putative class actions were filed in the SDNY against a panel of banks, including Barclays PLC, Barclays Bank PLC, BCI, other financial institution defendants and Intercontinental Exchange Inc. and certain of its affiliates (ICE), asserting antitrust claims that defendants manipulated USD LIBOR through defendants’ submissions to ICE. These actions have been consolidated. The defendants’ motion to dismiss was granted in 2020. The plaintiffs have appealed the dismissal. In August 2020, an ICE LIBOR-related action was filed by a group of individual plaintiffs in the US District Court for the Northern District of California on behalf of individual borrowers and consumers of loans and credit cards with variable interest rates linked to USD ICE LIBOR. Plaintiffs have filed motions seeking, among other things, preliminary and permanent injunctions to enjoin the defendants from continuing to set LIBOR or enforce any financial instrument that relies in whole or in part on USD LIBOR. Non-US benchmarks civil actions Legal proceedings (which include the claims referred to below in ‘Local authority civil actions concerning LIBOR’) have been brought or threatened against Barclays Bank PLC (and, in certain cases, Barclays Bank UK PLC) in the UK in connection with alleged manipulation of LIBOR, EURIBOR and other benchmarks. Proceedings have also been brought in a number of other jurisdictions in Europe and Israel. Additional proceedings in other jurisdictions may be brought in the future. Credit Default Swap civil action In July 2021, the New Mexico Attorney General, on behalf of the New Mexico State Investment Council, filed an antitrust class action in the US District Court for the District of New Mexico against Barclays PLC, Barclays Bank PLC, BCI and other financial institutions. The plaintiff alleges that the defendants conspired to manipulate the benchmark price used to value Credit Default Swap (CDS) contracts at settlement (i.e. the CDS final auction price). The plaintiff alleges violations of the Antitrust Act and the CEA, and unjust enrichment under state law. Foreign Exchange investigations and related civil actions In 2015, the Barclays Group reached settlements totalling approximately $2.38bn with various US federal and state authorities and the FCA in relation to investigations into certain sales and trading practices in the Foreign Exchange market. The Barclays Group continues to provide relevant information to certain authorities. The European Commission is one of a number of authorities still conducting an investigation into certain trading practices in Foreign Exchange markets. The European Commission announced two settlements in May 2019 and the Barclays Group paid penalties totalling approximately €210m. In June 2019, the Swiss Competition Commission announced two settlements and the Barclays Group paid penalties totalling approximately CHF 27m. The financial impact of the ongoing matters is not expected to be material to the Barclays Bank Group’s operating results, cash flows or financial position. Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Barclays Group and other banks in relation to alleged manipulation of Foreign Exchange markets. FX opt out civil action In 2018, Barclays Bank PLC and BCI settled a consolidated action filed in the SDNY, alleging manipulation of Foreign Exchange markets (Consolidated FX Action), for a total amount of $384m. Also in 2018, a group of plaintiffs who opted out of the Consolidated FX Action filed a complaint in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants. Some of the plaintiff’s claims were dismissed in 2020. Retail basis civil action In 2015, a putative class action was filed against several international banks, including Barclays PLC and BCI, on behalf of a proposed class of individuals who exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The SDNY has ruled that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action. The Court subsequently dismissed all Retail Basis Claims against the Barclays Group and all other defendants. The plaintiffs have filed an amended complaint. Non-US FX civil actions Legal proceedings have been brought or are threatened against Barclays PLC, Barclays Bank PLC, BCI and Barclays Execution Services Limited (BX) in connection with alleged manipulation of Foreign Exchange in the UK, a number of other jurisdictions in Europe, Israel and Australia and additional proceedings may be brought in the future. These include two purported class actions filed against Barclays PLC, Barclays Bank PLC, BX, BCI and other financial institutions in the UK Competition Appeal Tribunal in 2019 following the settlements with the European Commission described above. Also in 2019, a separate claim was filed in the UK in the High Court by various banks and asset management firms against Barclays Bank PLC and other financial institutions alleging breaches of European and UK competition laws related to FX trading. Metals investigations and related civil actions Barclays Bank PLC previously provided information to the US Department of Justice (DoJ), the US Commodity Futures Trading Commission and other authorities in connection with investigations into metals and metals-based financial instruments. A number of US civil complaints, each on behalf of a proposed class of plaintiffs, have been consolidated and transferred to the SDNY. The complaints allege that Barclays Bank PLC and other members of The London Gold Market Fixing Ltd. manipulated the prices of gold and gold derivative contracts in violation of the Antitrust Act and other federal laws. This consolidated putative class action remains pending. A separate US civil complaint by a proposed class of plaintiffs against a number of banks, including Barclays Bank PLC, BCI and BX, alleging manipulation of the price of silver in violation of the CEA, the Antitrust Act and state antitrust and consumer protection laws, has been dismissed as against the Barclays entities. The plaintiffs have the option to seek the court’s permission to appeal. Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc. and BCI on behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices. US residential mortgage related civil actions There are various pending civil actions relating to US Residential Mortgage-Backed Securities (RMBS), including four actions arising from unresolved repurchase requests submitted by Trustees for certain RMBS, alleging breaches of various loan-level representations and warranties (R&Ws) made by Barclays Bank PLC and/or a subsidiary acquired in 2007. The unresolved repurchase requests had an original principal balance of approximately $2.1bn. The Trustees have also alleged that the relevant R&Ws may have been breached with respect to a greater (but unspecified) amount of loans than previously stated in the unresolved repurchase requests. These repurchase actions are ongoing. In one repurchase action, the New York Court of Appeals held that claims related to certain R&Ws are time-barred. Barclays Bank PLC has reached a settlement to resolve two of the repurchase actions, which is subject to final court approval. The financial impact of the settlement is not expected to be material to the Barclays Bank Group’s operating results, cash flows or financial position. The remaining two repurchase actions are pending. In 2020, a civil litigation claim was filed in the New Mexico First Judicial District Court by the State of New Mexico against six banks, including BCI, on behalf of two New Mexico state pension funds and the New Mexico State Investment Council relating to legacy RMBS purchases. As to BCI, the complaint alleges that the funds purchased approximately $22m in RMBS underwritten by BCI. The plaintiffs have asserted claims under New Mexico state law, which provides for the ability to claim treble damages and civil penalties. Government and agency securities civil actions and related matters Certain governmental authorities have conducted investigations into activities relating to the trading of certain government and agency securities in various markets. The Barclays Group provided information in cooperation with such investigations. Civil actions have also been filed on the basis of similar allegations, as described below. Treasury auction securities civil actions Consolidated putative class action complaints filed in US federal court against Barclays Bank PLC, BCI and other financial institutions under the Antitrust Act and state common law allege that the defendants (i) conspired to manipulate the US Treasury securities market and/or (ii) conspired to prevent the creation of certain platforms by boycotting or threatening to boycott such trading platforms. The court dismissed the consolidated action in March 2021. The plaintiffs have filed an amended complaint, which the defendants have moved to dismiss. In addition, certain plaintiffs have filed a related, direct action against BCI and certain other financial institutions, alleging that defendants conspired to fix and manipulate the US Treasury securities market in violation of the Antitrust Act, the CEA and state common law. Supranational, Sovereign and Agency bonds civil actions Civil antitrust actions have been filed in the SDNY and Federal Court of Canada in Toronto against Barclays Bank PLC, BCI, BX, Barclays Capital Securities Limited and, with respect to the civil action filed in Canada only, Barclays Capital Canada, Inc. and other financial institutions alleging that the defendants conspired to fix prices and restrain competition in the market for US dollar-denominated Supranational, Sovereign and Agency bonds. In one of the actions filed in the SDNY, the court granted the defendants’ motions to dismiss the plaintiffs’ complaint. The dismissal was affirmed on appeal. The plaintiffs have voluntarily dismissed the other SDNY action. In the Federal Court of Canada action, the plaintiffs reached settlements with a small number of banks in 2020 (not including Barclays Capital Canada, Inc.), but the plaintiffs have not commenced the class certification process and the action remains at an early stage. Variable Rate Demand Obligations civil actions Civil actions have been filed against Barclays Bank PLC and BCI and other financial institutions alleging the defendants conspired or colluded to artificially inflate interest rates set for Variable Rate Demand Obligations (VRDOs). VRDOs are municipal bonds with interest rates that reset on a periodic basis, most commonly weekly. Two actions in state court have been filed by private plaintiffs on behalf of the states of Illinois and California. Three putative class action complaints, two of which have been consolidated, have been filed in the SDNY (the third complaint was filed in June 2021). In the consolidated SDNY class action, certain of the plaintiff’s claims were dismissed in November 2020. In the California action, the plaintiffs’ claims were dismissed in June 2021. The plaintiffs may appeal. Government bond civil actions In a putative class action filed in the SDNY in 2019, plaintiffs alleged that BCI and certain other bond dealers conspired to fix the prices of US Government sponsored entity bonds in violation of US antitrust law. BCI agreed to a settlement of $87m, which received final court approval in 2020. Separately, various entities in Louisiana, including the Louisiana Attorney General and the City of Baton Rouge, have commenced litigation against Barclays Bank PLC and other financial institutions making similar allegations as the SDNY class action plaintiffs. The parties have reached a settlement to resolve these matters. The financial impact of the settlement is not expected to be material to the Barclays Bank Group’s operating results, cash flows or financial position. In 2018, a separate putative class action against various financial institutions including Barclays PLC, Barclays Bank PLC, BCI, Barclays Bank Mexico, S.A., and certain other subsidiaries of the Barclays Bank Group was consolidated in the SDNY. The plaintiffs asserted antitrust and state law claims arising out of an alleged conspiracy to fix the prices of Mexican Government bonds. Barclays PLC has settled the claim for $5.7m, which is subject to final court approval. Odd-lot corporate bonds antitrust class action In 2020, BCI, together with other financial institutions, were named as defendants in a putative class action. The complaint alleges a conspiracy to boycott developing electronic trading platforms for odd-lots and price fixing. Plaintiffs demand unspecified money damages. The defendants have filed a motion to dismiss. Interest rate swap and credit default swap US civil actions Barclays PLC, Barclays Bank PLC and BCI, together with other financial institutions that act as market makers for interest rate swaps (IRS) are named as defendants in several antitrust class actions which were consolidated in the SDNY in 2016. The complaints allege the defendants conspired to prevent the development of exchanges for IRS and demand unspecified money damages. In 2018, trueEX LLC filed an antitrust class action in the SDNY against a number of financial institutions including Barclays PLC, Barclays Bank PLC and BCI based on similar allegations with respect to trueEX LLC’s development of an IRS platform. In 2017, Tera Group Inc. filed a separate civil antitrust action in the SDNY claiming that certain conduct alleged in the IRS cases also caused the plaintiff to suffer harm with respect to the Credit Default Swaps market. In 2018 and 2019, respectively, the court dismissed certain claims in both cases for unjust enrichment and tortious interference but denied motions to dismiss the federal and state antitrust claims, which remain pending. BDC Finance L.L.C. In 2008, BDC Finance L.L.C. (BDC) filed a complaint in the Supreme Court of the State of New York (NY Supreme Court), demanding damages of $298m, alleging that Barclays Bank PLC had breached a contract in connection with a portfolio of total return swaps governed by an ISDA Master Agreement (the Agreement). Following a trial, the court ruled in 2018 that Barclays Bank PLC was not a defaulting party, which was affirmed on appeal. In April 2021, the trial court entered judgement in favour of Barclays Bank PLC for $3.3m and as yet to be determined legal fees and costs. BDC has appealed. In 2011, BDC’s investment advisor, BDCM Fund Adviser, L.L.C. and its parent company, Black Diamond Capital Holdings, L.L.C. also sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from Barclays Bank PLC’s conduct relating to the Agreement, asserting claims for violation of the Connecticut Unfair Trade Practices Act and tortious interference with business and prospective business relations. This case is currently stayed. Civil actions in respect of the US Anti-Terrorism Act There are a number of civil actions, on behalf of more than 4,000 plaintiffs, filed in US federal courts in the US District Court in the Eastern District of New York (EDNY) and SDNY against Barclays Bank PLC and a number of other banks. The complaints generally allege that Barclays Bank PLC and those banks engaged in a conspiracy to facilitate US dollar-denominated transactions for the Iranian Government and various Iranian banks, which in turn funded acts of terrorism that injured or killed plaintiffs or plaintiffs’ family members. The plaintiffs seek to recover damages for pain, suffering and mental anguish under the provisions of the US Anti-Terrorism Act, which allow for the trebling of any proven damages. The court granted the defendants’ motions to dismiss three out of the six actions in the EDNY. Plaintiffs have appealed in one action. The remaining actions are stayed pending decisions on the appeal. Out of the two actions in the SDNY, the court also granted the defendants’ motion to dismiss one action. The remaining action is stayed pending any appeal in the former case. Shareholder derivative action In November 2020, a purported Barclays shareholder filed a putative derivative action in New York state court against BCI and a number of current and former members of the Board of Directors of Barclays PLC and senior executives or employees of the Barclays Group. The shareholder filed the claim on behalf of nominal defendant Barclays PLC, alleging that the individual defendants harmed the company through breaches of their duties, including under the Companies Act 2006. The plaintiff seeks damages on behalf of Barclays PLC for the losses that Barclays PLC allegedly suffered as a result of these alleged breaches. An amended complaint was filed in April 2021, which BCI and certain other defendants have moved to dismiss. Derivative transactions civil action In July 2021, Vestia (a Dutch housing association) issued a claim against Barclays Bank PLC in the UK in the High Court in relation to a series of derivative transactions entered into with Barclays Bank PLC between 2008 and 2012. The claim has not been served on Barclays. Skilled person review and associated matters In August 2020, the FCA granted an application by Clydesdale Financial Services Limited (CFS), which trades as Barclays Partner Finance and houses Barclays’ point-of-sale finance business, for a validation order with respect to certain loans to customers brokered by Azure Services Limited (ASL), a timeshare operator, which did not, at the point of sale, hold the necessary broker licence. As a condition to the validation order, the FCA required CFS to undertake a skilled person review of the assessment of affordability processes for the loans brokered by ASL (ASL Loans) as well as CFS’ policies and procedures for assessing affordability and oversight of brokers more generally, and dictated a remediation methodology in the event that ASL Loans did not pass the affordability test. CFS has voluntarily agreed to remediate the ASL Loans, which is expected to amount to £37m, in accordance with the FCA’s methodology. The remaining scope of the skilled person review is ongoing and the skilled person is expected to report in the fourth quarter of 2021. It is not currently possible to predict the outcome of the skilled person review and/or whether remediation activity will be undertaken or required in relation to other parts of CFS’ loan portfolio and the scope of, and methodology for, any such remediation. Investigation into UK cards’ affordability The FCA is investigating certain aspects of the affordability assessment processes used by Barclays Bank UK PLC and Barclays Bank PLC for credit card applications made to Barclays’ UK credit card business. Barclays is providing information in cooperation with the investigation. HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax In 2018, HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the UK from Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices have retrospective effect and correspond to assessments of £181m (inclusive of interest), of which Barclays would expect to attribute an amount of approximately £128m to Barclays Bank UK PLC and £53m to Barclays Bank PLC. HMRC’s decision has been appealed to the First Tier Tribunal (Tax Chamber). Local authority civil actions concerning LIBOR Following settlement by Barclays Bank PLC of various governmental investigations concerning certain benchmark interest rate submissions referred to above in ‘Investigations into LIBOR and other benchmarks and related civil actions’, in the UK, certain local authorities have brought claims against Barclays Bank PLC and Barclays Bank UK PLC asserting that they entered into loans in reliance on misrepresentations made by Barclays Bank PLC in respect of its conduct in relation to LIBOR. Barclays Bank PLC and Barclays Bank UK PLC were successful in their applications to strike out the claims. One local authority has obtained permission to pursue an appeal against this decision, while the claims brought by the other local authorities have been settled on terms such that the parties have agreed not to pursue these claims and to bear their own costs. General The Barclays Bank Group is engaged in various other legal, competition and regulatory matters in the UK, the US and a number of other overseas jurisdictions. It is subject to legal proceedings brought by and against the Barclays Bank Group which arise in the ordinary course of business from time to time, including (but not limited to) disputes in relation to contracts, securities, debt collection, consumer credit, fraud, trusts, client assets, competition, data management and protection, intellectual property, money laundering, financial crime, employment, environmental and other statutory and common law issues. The Barclays Bank Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer protection measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and business activities in which the Barclays Bank Group is or has been engaged. The Barclays Bank Group is cooperating with the relevant authorities and keeping all relevant agencies briefed as appropriate in relation to these matters and others described in this note on an ongoing basis. At the present time, Barclays Bank PLC does not expect the ultimate resolution of any of these other matters to have a material adverse effect on its financial position. However, in light of the uncertainties involved in such matters and the matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters (including formerly active matters or those matters arising after the date of this note) will not be material to Barclays Bank PLC’s results, operations or cash flow for a particular period, depending on, among other things, the amount of the loss resulting from the matter(s) and the amount of profit otherwise reported for the reporting period. |
Related party transactions
Related party transactions | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of transactions between related parties [abstract] | |
Related party transactions | Related party transactions Related party transactions in the half year ended 30 June 2021 were similar in nature to those disclosed in the Barclays Bank PLC Annual Report 2020. Amounts included in the Barclays Bank Group’s financial statements with other Barclays Group companies are as follows: Half year ended 30.06.21 Half year ended 30.06.20 Parent Fellow subsidiaries Parent Fellow subsidiaries £m £m £m £m Total income (304) 10 (346) 31 Operating expenses (31) (1,560) (34) (1,443) As at 30.06.21 As at 31.12.20 Parent Fellow subsidiaries Parent Fellow subsidiaries £m £m £m £m Total assets 6,311 1,672 6,803 1,917 Total liabilities 28,201 3,779 25,819 3,954 Except for the above, no related party transactions that have taken place in the half year ended 30 June 2021 have materially affected the financial position or performance of the Barclays Bank Group during this period. |
Interest rate benchmark reform
Interest rate benchmark reform | 6 Months Ended |
Jun. 30, 2021 | |
Interest rate benchmark reform [Abstract] | |
Interest rate benchmark reform | Interest rate benchmark reform Following the financial crisis, the reform and replacement of benchmark interest rates such as LIBOR has become a priority for global regulators. The FCA and other global regulators have instructed market participants to prepare for the cessation of LIBOR after the end of 2021, and to adopt RFRs. While it is expected that most reforms affecting the Barclays Bank Group will be completed by the end of 2021, consultations and regulatory changes are in progress and as certain US Dollar tenors will continue to be published up to mid-2023, significant remediation efforts will continue beyond the end of 2021. How the Barclays Group is managing the transition to alternative benchmark rates Barclays has established a Group-wide LIBOR Transition Programme. Further detail on the transition programme is available in the Barclays Bank PLC Annual Report 2020 (page 261). In March 2021 the FCA announced the dates by which panel bank submissions for all LIBOR settings will cease, after which representative LIBOR rates will no longer be available. These dates are: immediately after 31 December 2021, in the case of all sterling, euro, Swiss franc and Japanese yen settings, and the 1-week and 2-month US dollar settings; and immediately after 30 June 2023, in the case of the remaining US dollar settings. Throughout 2021 the FCA will consult with market participants to require continued publication on a ‘synthetic’ basis for some sterling LIBOR settings and, for one additional year, some Japanese yen LIBOR settings. Approaches to transition exposure expiring post the expected end dates for LIBOR vary by product and nature of counterparty. The transition we are undertaking is at the request of the regulators, in line with their expectations and according to the regulatory endorsed timetable. The rates to which clients and customers are being transitioned are endorsed by the regulators. We are making disclosures as part of the transition to clarify the rate to be applied and the potential risks inherent in the transition. Barclays is actively engaging with counterparties to transition or include appropriate fallback provisions and transition mechanisms in its floating rate assets and liabilities with maturities after 2021, when most IBORs are expected to cease to be published, or will be published on a non-representative basis for a limited time. Barclays is working with central clearing counterparties where the transition of cleared derivative contracts will follow a market-wide, standardised approach to reform. Barclays is working to the UK Risk Free Rate Working Group (RFRWG) target of completion of active conversion of, and/or addition of robust fallbacks to legacy GBP LIBOR contracts where viable by the end of Q321. Additionally, plans are in place to address non-GBP and other official sector industry milestones and targets. Progress made during H121 Building on the progress made in 2020, the Barclays Bank Group has delivered further alternative RFR product capabilities and alternatives to LIBOR across loans, bonds and derivatives. Client outreach is progressing to plan and we have continued to engage actively with customers and counterparties to transition or include the appropriate fallback provisions. The Barclays Bank Group has in place detailed plans, processes and procedures to support the transition of the remainder during 2021. Barclays has adhered to the ISDA IBOR Fallbacks Protocol for its major derivative dealing entities and we continue to track progress and engage with clients on their own adherence. Following the progress made during 2020, the Barclays Bank Group continues to deliver technology and business process changes in preparation for LIBOR cessation and transitions to RFRs that will be necessary during 2021 and beyond in line with official sector expectations and milestones. The Barclays Bank Group met the Q121 UK RFRWG milestone to cease initiation of GBP LIBOR linked loans, securitisations or linear derivatives and the Q221 milestones to cease initiation of new non-linear derivatives, exchange traded futures and Bank Of Japan milestone to cease issuance of JPY LIBOR linked loans and bonds. The Barclays Bank Group has put in place controls so that any exceptions or exemptions are approved, and is taking a similar approach to forthcoming cessation milestones. |
Barclays Bank PLC parent conden
Barclays Bank PLC parent condensed balance sheet | 6 Months Ended |
Jun. 30, 2021 | |
Condensed Financial Information Disclosure [Abstract] | |
Barclays Bank PLC parent condensed balance sheet | Barclays Bank PLC parent condensed balance sheet As at 30.06.21 As at 31.12.20 Assets £m £m Cash and balances at central banks 139,089 133,386 Cash collateral and settlement balances 85,357 87,723 Loans and advances at amortised cost 191,048 191,538 Reverse repurchase agreements and other similar secured lending 5,745 11,535 Trading portfolio assets 95,985 84,089 Financial assets at fair value through the income statement 241,198 203,073 Derivative financial instruments 247,767 297,129 Financial assets at fair value through other comprehensive income 48,618 50,308 Investment in associates and joint ventures 12 13 Investment in subsidiaries 19,168 17,780 Goodwill and intangible assets 109 112 Property, plant and equipment 149 425 Current tax assets 566 545 Deferred tax assets 1,122 1,171 Retirement benefit assets 2,652 1,812 Other assets 1,652 913 Total assets 1,080,237 1,081,552 Liabilities Deposits at amortised cost 271,293 272,190 Cash collateral and settlement balances 69,758 68,862 Repurchase agreements and other similar secured borrowing 18,849 27,722 Debt securities in issue 30,404 17,221 Subordinated liabilities 28,813 31,852 Trading portfolio liabilities 54,033 48,093 Financial liabilities designated at fair value 310,115 267,137 Derivative financial instruments 238,875 292,538 Current tax liabilities 390 336 Deferred tax liabilities 29 225 Retirement benefit liabilities 113 104 Other liabilities 5,701 3,145 Provisions 776 984 Total liabilities 1,029,149 1,030,409 Equity Called up share capital and share premium 2,348 2,348 Other equity instruments 13,328 13,328 Other reserves (541) 776 Retained earnings 35,953 34,691 Total equity 51,088 51,143 Total liabilities and equity 1,080,237 1,081,552 Barclays Bank PLC considers the carrying value of its investment in subsidiaries to be fully recoverable. |
Credit Risk
Credit Risk | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of credit risk exposure [abstract] | |
Credit Risk | Loans and advances at amortised cost by product The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification. Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure, as expected credit loss (ECL) is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision. Stage 2 As at 30.06.21 Stage 1 Not past due <=30 days past due >30 days past due Total Stage 3 Total 1 Gross exposure £m £m £m £m £m £m £m Home loans 9,575 643 21 143 807 1,017 11,399 Credit cards, unsecured loans and other retail lending 21,196 2,541 177 132 2,850 1,617 25,663 Wholesale loans 86,087 12,454 524 373 13,351 1,340 100,778 Total 116,858 15,638 722 648 17,008 3,974 137,840 Impairment allowance Home loans 7 37 1 1 39 341 387 Credit cards, unsecured loans and other retail lending 609 677 38 66 781 1,057 2,447 Wholesale loans 193 316 5 10 331 667 1,191 Total 809 1,030 44 77 1,151 2,065 4,025 Net exposure Home loans 9,568 606 20 142 768 676 11,012 Credit cards, unsecured loans and other retail lending 20,587 1,864 139 66 2,069 560 23,216 Wholesale loans 85,894 12,138 519 363 13,020 673 99,587 Total 116,049 14,608 678 571 15,857 1,909 133,815 Coverage ratio % % % % % % % Home loans 0.1 5.8 4.8 0.7 4.8 33.5 3.4 Credit cards, unsecured loans and other retail lending 2.9 26.6 21.5 50.0 27.4 65.4 9.5 Wholesale loans 0.2 2.5 1.0 2.7 2.5 49.8 1.2 Total 0.7 6.6 6.1 11.9 6.8 52.0 2.9 As at 31.12.20 Gross exposure £m £m £m £m £m £m £m Home loans 9,627 761 53 87 901 1,099 11,627 Credit cards, unsecured loans and other retail lending 18,923 4,987 393 191 5,571 1,853 26,347 Wholesale loans 83,254 14,184 1,066 688 15,938 2,167 101,359 Total 111,804 19,932 1,512 966 22,410 5,119 139,333 Impairment allowance Home loans 6 40 6 6 52 376 434 Credit cards, unsecured loans and other retail lending 399 1,092 111 124 1,327 1,253 2,979 Wholesale loans 280 475 49 9 533 840 1,653 Total 685 1,607 166 139 1,912 2,469 5,066 Net exposure Home loans 9,621 721 47 81 849 723 11,193 Credit cards, unsecured loans and other retail lending 18,524 3,895 282 67 4,244 600 23,368 Wholesale loans 82,974 13,709 1,017 679 15,405 1,327 99,706 Total 111,119 18,325 1,346 827 20,498 2,650 134,267 Coverage ratio % % % % % % % Home loans 0.1 5.3 11.3 6.9 5.8 34.2 3.7 Credit cards, unsecured loans and other retail lending 2.1 21.9 28.2 64.9 23.8 67.6 11.3 Wholesale loans 0.3 3.3 4.6 1.3 3.3 38.8 1.6 Total 0.6 8.1 11.0 14.4 8.5 48.2 3.6 1 Other financial assets subject to impairment excluded in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income, accrued income and sundry debtors. These have a total gross exposure of £159.9bn (December 2020: £150.3bn) and impairment allowance of £102m (December 2020: £145m). This comprises £7m (December 2020: £7m) ECL on £159.8bn (December 2020: £146.3bn) Stage 1 assets, £1m(December 2020: £6m) on £34m (December 2020: £3.8bn) Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £94m (December 2020: £132m) on £94m (December 2020: £132m) Stage 3 other assets. Loan commitments and financial guarantee contracts have total ECL of £572m (December 2020:£769m). Movement in gross exposures and impairment allowance including provisions for loan commitments and financial guarantees The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. Explanation of the terms: 12-month ECL, lifetime ECL and credit-impaired are included in the Barclays Bank PLC Annual Report 2020 on page 169. Transfers between stages in the tables have been reflected as if they had taken place at the beginning of the year. The movements are measured over a 6-month period. Loans and advances at amortised cost Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL £m £m £m £m £m £m £m £m Home loans As at 1 January 2021 9,627 6 901 52 1,099 376 11,627 434 Transfers from Stage 1 to Stage 2 (282) — 282 — — — — — Transfers from Stage 2 to Stage 1 248 15 (248) (15) — — — — Transfers to Stage 3 (71) — (44) (4) 115 4 — — Transfers from Stage 3 14 — 35 2 (49) (2) — — Business activity in the year 826 — — — — — 826 — Changes to models used for calculation 1 — — — (4) — 38 — 34 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (484) (14) (48) 9 (55) (64) (587) (69) Final repayments (303) — (71) (1) (83) (1) (457) (2) Disposals — — — — — — — — Write-offs 2 — — — — (10) (10) (10) (10) As at 30 June 2021 3 9,575 7 807 39 1,017 341 11,399 387 Credit cards, unsecured loans and other retail lending As at 1 January 2021 18,923 399 5,571 1,327 1,853 1,253 26,347 2,979 Transfers from Stage 1 to Stage 2 (539) (31) 539 31 — — — — Transfers from Stage 2 to Stage 1 2,508 546 (2,508) (546) — — — — Transfers to Stage 3 (130) (7) (280) (127) 410 134 — — Transfers from Stage 3 14 18 20 6 (34) (24) — — Business activity in the year 2,330 30 20 4 20 4 2,370 38 Changes to models used for calculation 1 — (3) — (27) — — — (30) Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (752) (316) (463) 119 (84) 174 (1,299) (23) Final repayments (1,158) (27) (49) (6) (61) (5) (1,268) (38) Disposals 4 — — — — (19) (11) (19) (11) Write-offs 2 — — — — (468) (468) (468) (468) As at 30 June 2021 3 21,196 609 2,850 781 1,617 1,057 25,663 2,447 1 Changes to models used for calculation include a £34m movement in Home Loans, £30m in Credit cards, unsecured loans and other retail lending and £36m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses. 2 In H121, gross write-offs amounted to £606m (H120: £643m) and post write-off recoveries amounted to £15m (H120: £1m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £591m (H120: £642m). 3 Other financial assets subject to impairment excluded in the tables above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £159.9bn (December 2020: £150.3bn) and impairment allowance of £102m (December 2020: £145m). This comprises £7m ECL (December 2020: £7m) on £159.8bn Stage 1 assets (December 2020: £146.3bn), £1m (December 2020: £6m) on £34m Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2020: £3.8bn) and £94m (December 2020: £132m) on £94m Stage 3 other assets (December 2020: £132m). 4 The £19m of disposals reported within Credit cards, unsecured loans and other retail lending portfolio relate to debt sales undertaken during the year. The £101m of disposals reported within Wholesale loans include the sale of Barclays Asset Finance and debt sales. Loans and advances at amortised cost Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL £m £m £m £m £m £m £m £m Wholesale loans As at 1 January 2021 83,254 280 15,938 533 2,167 840 101,359 1,653 Transfers from Stage 1 to Stage 2 (3,956) (10) 3,956 10 — — — — Transfers from Stage 2 to Stage 1 5,093 104 (5,093) (104) — — — — Transfers to Stage 3 (98) (1) (105) (11) 203 12 — — Transfers from Stage 3 395 1 272 8 (667) (9) — — Business activity in the year 17,980 32 1,124 29 78 16 19,182 77 Changes to models used for calculation 1 — (7) — (29) — — — (36) Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 1,001 (167) 152 (14) (76) (4) 1,077 (185) Final repayments (17,539) (38) (2,885) (91) (187) (32) (20,611) (161) Disposals 2 (43) (1) (8) — (50) (28) (101) (29) Write-offs 3 — — — — (128) (128) (128) (128) As at 30 June 2021 4 86,087 193 13,351 331 1,340 667 100,778 1,191 Reconciliation of ECL movement to impairment charge/(release) for the period £m Home loans (37) Credit cards, unsecured loans and other retail lending (53) Wholesale loans (305) ECL movement excluding assets derecognised due to disposals and write-offs (395) Recoveries and reimbursements 5 201 Exchange and other adjustments 6 105 Impairment charge on loan commitments and other financial guarantees (185) Impairment charge on other financial assets 4 (14) Income statement release for the period (288) 1 Changes to models used for calculation include a £34m movement in Home Loans, £30m in Credit cards, unsecured loans and other retail lending and £36m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses 2 The £19m of disposals reported within Credit cards, unsecured loans and other retail lending portfolio relate to debt sales undertaken during the year. The £101m disposal reported within Wholesale loans include sale of Barclays Asset Finance and debt sales. 3 In H121, gross write-offs amounted to £606m (H120: £643m) and post write-off recoveries amounted to £15m (H120: £1m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £591m (H120: £642m). 4 Other financial assets subject to impairment excluded from the tables above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £159.9bn (December 2020: £150.3bn) and impairment allowance of £102m (December 2020: £145m). This comprises £7m ECL (December 2020: £7m) on £159.8bn Stage 1 assets (December 2020: £146.3bn), £1m (December 2020: £6m) on £34m Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2020: £3.8bn) and £94m (December 2020: £132m) on £94m Stage 3 other assets (December 2020: £132m). 5 Recoveries and reimbursements includes a net loss in relation to reimbursements from guarantee contracts held with third parties of £216m and post write off recoveries of £15m. 6 Exchange and other adjustments includes foreign exchange and interest and fees in suspense. Loan commitments and financial guarantees Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL £m £m £m £m £m £m £m £m Home loans As at 1 January 2021 125 — 2 — 4 — 131 — Net transfers between stages — — — — — — — — Business activity in the year 6 — 1 — — — 7 — Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (6) — — — — — (6) — Limit management and final repayments (88) — — — (3) — (91) — As at 30 June 2021 37 — 3 — 1 — 41 — Credit cards, unsecured loans and other retail lending As at 1 January 2021 68,211 34 6,244 33 30 23 74,485 90 Net transfers between stages 3,555 8 (3,786) (3) 231 (5) — — Business activity in the year 3,135 1 23 — 1 1 3,159 2 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 2,142 (9) 213 1 (232) 3 2,123 (5) Limit management and final repayments (4,476) — (353) — (3) (2) (4,832) (2) As at 30 June 2021 72,567 34 2,341 31 27 20 74,935 85 Wholesale loans As at 1 January 2021 160,404 205 39,426 446 2,031 28 201,861 679 Net transfers between stages 96 115 1,087 (111) (1,183) (4) — — Business activity in the year 39,001 28 2,916 89 12 9 41,929 126 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 1,912 (146) 688 (61) (28) 2 2,572 (205) Limit management and final repayments (32,861) (25) (4,843) (83) (455) (5) (38,159) (113) As at 30 June 2021 168,552 177 39,274 280 377 30 208,203 487 Management adjustments to models for impairment Management adjustments to impairment models are made in the ordinary course of business in order to reflect changes in policy or correct model performance issues identified through model monitoring. These adjustments remain in place until they are incorporated into future model development and are then retired. In addition, they may also be made in response to circumstances or uncertainty at the period end and this is particularly true of the ongoing COVID-19 pandemic. Total management adjustments to impairment allowance are presented by product below. Overview of management adjustments to models for impairment allowance 1 As at 30.06.21 As at 31.12.20 Management adjustments to impairment allowances Proportion of total impairment allowances Management adjustments to impairment allowances Proportion of total impairment allowances £m % £m % Home loans 22 5.7 54 12.4 Credit cards, unsecured loans and other retail lending 550 21.7 960 31.3 Wholesale loans 479 28.5 (78) (3.3) Total 1,051 22.9 936 16.0 Management adjustments to models for impairment allowance 1 Impairment allowance pre management adjustments 2 Economic uncertainty adjustments Other adjustments Total impairment allowance As at 30.06.2021 £m £m £m £m Home loans 365 22 — 387 Credit cards, unsecured loans and other retail lending 1,982 778 (228) 2,532 Wholesale loans 1,199 615 (136) 1,678 Total 3,546 1,415 (364) 4,597 As at 31.12.20 Home loans 380 21 33 434 Credit cards, unsecured loans and other retail lending 2,109 986 (26) 3,069 Wholesale loans 2,410 379 (457) 2,332 Total 4,899 1,386 (450) 5,835 1 Positive values reflect an increase in impairment allowance. 2 Includes £2.6bn (December 2020: £3.9bn) of modelled ECL, £0.7bn (December 2020: £0.8bn) of individually assessed impairments and £0.2bn (December 2020: £0.2bn) ECL from non-modelled exposures. Economic uncertainty adjustments The COVID-19 pandemic has impacted the global economy since early 2020 and macroeconomic forecasts indicate longer-term impacts that result in higher unemployment levels and customer and client stress. However, to date, little real credit deterioration has occurred, largely as a result of government and other support measures. Observed 30-day arrears rates have reduced in US cards to 1.6% (December 2020: 2.5%; December 2019: 2.7%) due to payment holidays granted to customers impacted by COVID-19 which reduced the delinquency entrance rate and overall flow through delinquency. However, uncertainty remains as government and other support measures taper down as to whether these schemes have either averted or delayed credit losses. In order to address this uncertainty, adjustments to the modelled provisions were made in 2020. COVID-19 related economic uncertainty adjustments of £1.4bn (December 2020: £1.4bn) continue to be recognised, specifically to address whether support measures have averted or delayed credit losses. However, within this, the approach has been refined and uncertainty is now captured in two distinct ways: firstly, the identification of specific customers and clients who may be more vulnerable to the withdrawal of relief and secondly, macroeconomic and risk parameter uncertainties which are applied at a portfolio level. A summary of the adjustments is provided below: • A £0.8bn adjustment has been applied for customers and clients considered potentially vulnerable to the withdrawal of government and other support schemes. In US consumer card portfolios, the populations identified are those who have higher potential risk indicators. In wholesale portfolios these include those corporate sectors deemed more vulnerable to the economic impacts of COVID-19. This adjustment is split between credit cards and unsecured loans, £0.6bn, and wholesale loans, £0.2bn. • Expert judgement has been used to adjust the probability of default at portfolio level to pre-COVID-19 levels to reflect the impact of temporary support measures on underlying customer and client behaviour. This adjustment, of £0.2bn, has remained at a similar level to December 2020 (£0.1bn). • Macroeconomic variables which may be temporarily influenced by support measures have been adjusted at a portfolio level enabling the model to consume the economic stress. This adjustment has been reduced to £0.5bn from £1.0bn at December 2020 as management judgement has been refined towards potentially vulnerable customers and clients as the pandemic has evolved. Other adjustments Credit cards, unsecured loans and other retail lending: Primarily relates to a net release in ECL of £0.2bn in Barclaycard US to more accurately reflect Loss Given Default in Stage 3. Wholesale loans: Represents the net adjustments of £136m in the Investment Bank for model inaccuracies informed by back-testing. An adjustment to offset modelled ECL output in the Investment Bank to limit excessive ECL sensitivity to the macroeconomic variable for Federal Tax Receipts in place at December 2020 is materially reduced due to the Q221 scenario refresh. Measurement uncertainty The Barclays Bank Group uses a five-scenario model to calculate ECL. An external consensus forecast is assembled from key sources, including HM Treasury (short and medium-term forecasts), Bloomberg (based on median of economic forecasts) and the Urban Land Institute (for US House Prices), which forms the Baseline scenario. In addition, two adverse scenarios (Downside 1 and Downside 2) and two favourable scenarios (Upside 1 and Upside 2) are derived, with associated probability weightings. The adverse scenarios are calibrated to a broadly similar severity to Barclays’ internal stress tests and stress scenarios provided by regulators whilst also considering IFRS 9 specific sensitivities and non-linearity. Downside 2 is benchmarked to the Bank of England’s stress scenarios and to the most severe scenario from Moody’s inventory, but is not designed to be the same. The favourable scenarios are calibrated to reflect upside risks to the Baseline scenario to the extent that is broadly consistent with recent favourable benchmark scenarios. All scenarios are regenerated at a minimum semi-annually. The scenarios include eight economic variables (GDP, unemployment, House Price Index (HPI) and base rates, in both the UK and US markets), and expanded variables using statistical models based on historical correlations. The upside and downside shocks are designed to evolve over a five Macroeconomic indicators were refreshed in Q221, with key drivers for the baseline scenario more optimistic than Q420, resulting in a net ECL provision release. In the Baseline scenario, UK GDP returns to the pre-pandemic level by mid-2022 with peak UK unemployment of just over 6% in Q421. In the Upside 2 scenario, effective fiscal stimulus measures, including public investments in infrastructure and skills, provide a boost to demand and confidence, which in turn leads to economic activity in almost all advanced economies returning to the pre-COVID-19 pandemic levels by the end of 2021. Unemployment levels decline back below 5% by H222 in the UK, and below 4% by early 2022 in the US. In the Downside 2 scenario supply and distribution issues slow the vaccination process and the emergence of new virus variants that are not susceptible to the existing vaccines fuels the outbreak again resulting in full national lockdowns in Q321. This leads to significant falls in GDP in Q321 and UK and US unemployment reaching c.10% and 12% respectively. Although the macroeconomic outlook has improved, the Barclays Bank Group’s view on uncertainty remains unchanged, believing potential credit deterioration could be seen once government support is removed, particularly in vulnerable areas of the portfolio. In response, economic uncertainty PMAs remained relatively stable at c.£1.4bn. For further details see page 13. Limited defaults have been observed to date in response to the COVID-19 pandemic, partly as a result of government and bank support measures. However, such support measures are scheduled to taper down from Q321 bringing with it uncertainty. Despite improvement in macroeconomic variables in the period, unemployment remains at elevated levels but portfolios are yet to respond, and may not do so until support measures fall away. The methodology for estimating probability weights for each of the scenarios involves a comparison of the distribution of key historical UK and US macroeconomic variables against the forecast paths of the five scenarios. The range of forecast paths generated in the calculation of the weights at 30 June 2021 is slightly narrower than 31 December 2020 due to lower levels of uncertainty. The Upside 2 and Downside 2 scenarios are therefore nearer the tails of the distribution than previously resulting in lower weights. See page 16 for probability weightings used H121. The tables below show: (i) the key consensus macroeconomic variables used in the scenarios (3-year annual paths); (ii) the probability weights applied to each scenario; and (iii) the macroeconomic variables by scenario using ‘specific bases’, i.e. the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios and the lowest unemployment for upside scenarios. The 5-year average table provides additional transparency. Baseline average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.2021 % % % UK GDP 1 4.9 5.6 2.3 UK unemployment 2 5.8 5.7 5.1 UK HPI 3 (0.5) 0.3 3.1 UK bank rate 0.1 0.2 0.4 US GDP 1 5.7 3.9 1.6 US unemployment 4 5.6 4.5 4.4 US HPI 5 3.9 3.5 3.5 US federal funds rate 0.3 0.3 0.7 As at 31.12.20 UK GDP 1 6.3 3.3 2.6 UK unemployment 2 6.7 6.4 5.8 UK HPI 3 2.4 2.3 5.0 UK bank rate — (0.1) — US GDP 1 3.9 3.1 2.9 US unemployment 4 6.9 5.7 5.6 US HPI 5 2.8 4.7 4.7 US federal funds rate 0.3 0.3 0.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Downside 2 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 (1.7) 2.0 5.2 UK unemployment 2 7.3 8.2 6.6 UK HPI 3 (5.8) (5.8) 0.2 UK bank rate 0.1 — — US GDP 1 1.5 1.4 2.0 US unemployment 4 8.7 11.0 9.3 US HPI 5 (4.9) (3.0) 1.1 US federal funds rate 0.3 0.3 0.3 As at 31.12.20 UK GDP 1 (3.9) 6.5 2.6 UK unemployment 2 8.0 9.3 7.8 UK HPI 3 (13.6) (10.8) 0.5 UK bank rate (0.2) (0.2) (0.1) US GDP 1 (2.4) 3.6 2.1 US unemployment 4 13.4 11.9 10.1 US HPI 5 (17.2) (0.7) 0.6 US federal funds rate 0.3 0.3 0.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Downside 1 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 0.6 4.4 4.2 UK unemployment 2 6.4 6.6 5.6 UK HPI 3 (3.1) (2.7) 1.7 UK bank rate 0.1 0.1 0.2 US GDP 1 3.4 2.5 1.6 US unemployment 4 7.4 7.9 6.1 US HPI 5 (0.5) 0.2 2.3 US federal funds rate 0.3 0.3 0.3 As at 31.12.20 UK GDP 1 0.1 6.6 3.2 UK unemployment 2 7.3 8.0 6.9 UK HPI 3 (6.7) (3.5) 1.7 UK bank rate (0.1) (0.1) — US GDP 1 0.4 3.6 2.3 US unemployment 4 11.0 8.9 6.9 US HPI 5 (5.9) 1.8 2.6 US federal funds rate 0.3 0.3 0.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Upside 2 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 6.8 9.4 4.0 UK unemployment 2 5.5 4.9 4.4 UK HPI 3 4.6 9.9 11.3 UK bank rate 0.1 0.4 0.6 US GDP 1 6.5 8.2 3.4 US unemployment 4 5.3 3.8 3.8 US HPI 5 6.5 8.0 7.3 US federal funds rate 0.3 0.3 1.1 As at 31.12.20 UK GDP 1 12.2 5.3 3.9 UK unemployment 2 6.2 5.5 4.8 UK HPI 3 6.6 10.4 10.8 UK bank rate 0.1 0.3 0.3 US GDP 1 7.1 4.6 4.0 US unemployment 4 5.5 4.3 4.1 US HPI 5 8.8 9.1 8.9 US federal funds rate 0.3 0.4 0.6 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Upside 1 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 5.9 7.3 3.0 UK unemployment 2 5.6 5.2 4.7 UK HPI 3 1.5 4.5 7.4 UK bank rate 0.1 0.2 0.6 US GDP 1 6.1 5.8 2.4 US unemployment 4 5.5 4.2 4.2 US HPI 5 6.2 6.8 5.7 US federal funds rate 0.3 0.3 0.9 As at 31.12.20 UK GDP 1 9.3 3.9 3.4 UK unemployment 2 6.4 6.0 5.2 UK HPI 3 4.6 6.1 6.1 UK bank rate 0.1 0.1 0.3 US GDP 1 5.5 4.0 3.7 US unemployment 4 6.0 4.8 4.6 US HPI 5 6.8 6.7 6.3 US federal funds rate 0.3 0.3 0.5 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Scenario probability weighting Upside 2 Upside 1 Baseline Downside 1 Downside 2 % % % % % As at 30.06.21 Scenario probability weighting 19.6 24.5 26.4 16.9 12.6 As at 31.12.20 Scenario probability weighting 20.2 24.2 24.7 15.5 15.4 Specific bases show the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest points relative to the start point in the 20 quarter period. Macroeconomic variables (specific bases) 1 Upside 2 Upside 1 Baseline Downside 1 Downside 2 As at 30.06.2021 % % % % % UK GDP 2 25.9 20.2 3.3 (4.2) (8.1) UK unemployment 3 4.1 4.3 5.1 7.5 9.8 UK HPI 4 48.2 25.5 1.6 (5.8) (11.8) UK bank rate 3 0.1 0.1 0.4 0.3 0.1 US GDP 2 23.7 18.3 2.8 (0.2) (3.2) US unemployment 3 3.8 4.2 4.7 8.9 12.0 US HPI 4 41.2 32.6 3.6 (1.3) (7.9) US federal funds rate 3 0.3 0.3 0.8 1.5 0.8 As at 31.12.20 UK GDP 2 14.2 8.8 0.7 (22.1) (22.1) UK unemployment 3 4.0 4.0 5.7 8.4 10.1 UK HPI 4 48.2 30.8 3.6 (4.5) (18.3) UK bank rate 3 0.1 0.1 — 0.6 0.6 US GDP 2 15.7 12.8 1.6 (10.6) (10.6) US unemployment 3 3.8 3.8 6.4 13.0 13.7 US HPI 4 42.2 30.9 3.8 (3.7) (15.9) US federal funds rate 3 0.1 0.1 0.3 1.3 1.3 1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20 quarter period starts from Q121 (2020: Q120). 2 Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year yearly average Compound Annual Growth Rate (CAGR) in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios. 3 Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter 20 quarter period in Downside scenarios.. 4 Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios. Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly average and quarterly CAGRs respectively. Macroeconomic variables (5-year averages) 1 Upside 2 Upside 1 Baseline Downside 1 Downside 2 As at 30.06.2021 % % % % % UK GDP 2 5.2 4.2 3.3 2.6 1.8 UK unemployment 3 4.6 4.8 5.1 5.7 6.5 UK HPI 4 8.2 4.7 1.6 — (1.6) UK bank rate 3 0.7 0.6 0.4 0.2 — US GDP 2 4.6 3.7 2.8 2.0 1.4 US unemployment 3 4.1 4.4 4.7 6.3 8.5 US HPI 4 7.1 5.8 3.6 1.6 (0.4) US federal funds rate 3 1.1 0.9 0.8 0.6 0.3 As at 31.12.20 UK GDP 2 2.5 1.6 0.7 0.1 (0.9) UK unemployment 3 5.0 5.3 5.7 6.5 7.2 UK HPI 4 8.2 5.5 3.6 (0.2) (3.6) UK bank rate 3 0.3 0.2 — — (0.1) US GDP 2 2.9 2.4 1.6 0.8 0.1 US unemployment 3 5.3 5.7 6.4 8.3 10.4 US HPI 4 7.3 5.5 3.8 0.8 (3.0) US federal funds rate 3 0.5 0.5 0.3 0.3 0.3 1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. . 2 5-year yearly average CAGR, starting 2020 (2020: 2019). 3 5-year average. Period based on 20 quarters from Q121 (2020: Q120). 4 5-year quarter end CAGR, starting Q420 (2020: Q419). |
Segmental reporting (Tables)
Segmental reporting (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of operating segments [abstract] | |
Analysis of results by business | Analysis of results by business Corporate and Investment Bank Consumer, Cards and Payments Head Office Barclays Bank Group Half year ended 30.06.21 £m £m £m £m Total income 6,632 1,649 (92) 8,189 Credit impairment releases 260 22 6 288 Net operating income/(expenses) 6,892 1,671 (86) 8,477 Operating expenses (3,617) (1,126) (316) (5,059) Litigation and conduct (2) (82) (3) (87) Total operating expenses (3,619) (1,208) (319) (5,146) Other net income 1 3 — — 3 Profit/(loss) before tax 3,276 463 (405) 3,334 As at 30.06.21 £bn £bn £bn £bn Total assets 991.3 62.7 10.3 1,064.3 Corporate and Investment Bank Consumer, Cards and Payments Head Office Barclays Bank Group Half year ended 30.06.20 £m £m £m £m Total income 6,973 1,742 (78) 8,637 Credit impairment charges (1,320) (1,299) (55) (2,674) Net operating income/(expenses) 5,653 443 (133) 5,963 Operating expenses (3,458) (1,053) (37) (4,548) Litigation and conduct (4) (8) (7) (19) Total operating expenses (3,462) (1,061) (44) (4,567) Other net income 1 12 115 — 127 Profit/(loss) before tax 2,203 (503) (177) 1,523 As at 31.12.20 £bn £bn £bn £bn Total assets 990.9 57.8 11.0 1,059.7 1 Other net income represents the share of post-tax results of associates and joint ventures and profit (or loss) on disposal of subsidiaries, associates and joint ventures. |
Split of income by geographic region | Split of income by geographic region 1 Half year ended 30.06.21 Half year ended 30.06.20 £m £m United Kingdom 2,698 2,835 Europe 1,213 1,240 Americas 3,676 3,872 Africa and Middle East 20 23 Asia 582 667 Total 8,189 8,637 1 The geographical analysis is based on the location of the office where the transactions are recorded. |
Net fee and commission income (
Net fee and commission income (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Fee and commission income (expense) [abstract] | |
Total fees in scope of IFRS 15 Revenues from Contracts with Customers | Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from Contracts with Customers: Corporate and Investment Bank Consumer, Cards and Payments Head Office Total Half year ended 30.06.21 £m £m £m £m Fee type Transactional 184 984 — 1,168 Advisory 399 61 — 460 Brokerage and execution 527 26 — 553 Underwriting and syndication 1,715 — — 1,715 Other 25 76 11 112 Total revenue from contracts with customers 2,850 1,147 11 4,008 Other non-contract fee income 59 3 — 62 Fee and commission income 2,909 1,150 11 4,070 Fee and commission expense (369) (496) (5) (870) Net fee and commission income 2,540 654 6 3,200 Corporate and Investment Bank Consumer, Cards and Payments Head Office Total Half year ended 30.06.20 £m £m £m £m Fee type Transactional 177 968 — 1,145 Advisory 260 46 — 306 Brokerage and execution 654 31 — 685 Underwriting and syndication 1,468 — — 1,468 Other 35 100 19 154 Total revenue from contracts with customers 2,594 1,145 19 3,758 Other non-contract fee income 57 3 — 60 Fee and commission income 2,651 1,148 19 3,818 Fee and commission expense (441) (497) (1) (939) Net fee and commission income 2,210 651 18 2,879 |
Tax (Tables)
Tax (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Major components of tax expense (income) [abstract] | |
Disclosure of deferred taxes | As at 30.06.21 As at 31.12.20 Deferred tax assets and liabilities £m £m USA 1,908 2,049 Other territories 454 503 Deferred tax assets 2,362 2,552 Deferred tax liabilities – UK (29) (225) Analysis of deferred tax assets Temporary differences 1,591 1,841 Tax losses 771 711 Deferred tax assets 2,362 2,552 |
Dividends on ordinary shares (T
Dividends on ordinary shares (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Dividends on ordinary shares [Abstract] | |
Dividends on ordinary shares | Half year ended 30.06.21 Half year ended 30.06.20 Dividends paid during the period £m £m Ordinary shares 694 263 Preference shares 13 28 Total 707 291 |
Fair value of financial instr_2
Fair value of financial instruments (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of fair value measurement of assets [abstract] | |
Assets and liabilities held at fair value disaggregated by valuation technique (fair value hierarchy) | The following table shows the Barclays Bank Group’s assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification: Valuation technique using Quoted market prices Observable inputs Significant unobservable inputs (Level 1) (Level 2) (Level 3) Total As at 30.06.21 £m £m £m £m Trading portfolio assets 73,307 71,285 2,552 147,144 Financial assets at fair value through the income statement 1,089 186,032 4,007 191,128 Derivative financial instruments 11,643 240,830 3,656 256,129 Financial assets at fair value through other comprehensive income 14,495 35,646 43 50,184 Investment property — — 8 8 Total assets 100,534 533,793 10,266 644,593 Trading portfolio liabilities (30,063) (26,057) (17) (56,137) Financial liabilities designated at fair value (142) (263,482) (296) (263,920) Derivative financial instruments (11,227) (230,157) (5,599) (246,983) Total liabilities (41,432) (519,696) (5,912) (567,040) As at 31.12.20 Trading portfolio assets 60,619 65,182 1,863 127,664 Financial assets at fair value through the income statement 4,439 162,930 4,392 171,761 Derivative financial instruments 9,154 289,071 4,468 302,693 Financial assets at fair value through other comprehensive income 12,150 39,599 153 51,902 Investment property — — 10 10 Total assets 86,362 556,782 10,886 654,030 Trading portfolio liabilities (23,331) (22,780) (28) (46,139) Financial liabilities designated at fair value (159) (249,126) (341) (249,626) Derivative financial instruments (8,762) (285,579) (6,239) (300,580) Total liabilities (32,252) (557,485) (6,608) (596,345) The following table shows the Barclays Bank Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type: As at 30.06.21 As at 31.12.20 Assets Liabilities Assets Liabilities £m £m £m £m Interest rate derivatives 916 (1,269) 1,613 (1,615) Foreign exchange derivatives 151 (129) 144 (143) Credit derivatives 100 (364) 196 (351) Equity derivatives 2,489 (3,837) 2,497 (4,112) Commodity derivatives — — 18 (18) Corporate debt 981 (38) 698 (3) Reverse repurchase and repurchase agreements — (161) — (174) Non-asset backed loans 3,467 — 3,093 — Asset backed securities 562 — 767 (24) Equity cash products 401 — 542 — Private equity investments 98 — 84 — Other 1 1,101 (114) 1,234 (168) Total 10,266 (5,912) 10,886 (6,608) 1 Other includes commercial real estate loans, fund and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property. |
Analysis of movements in Level 3 assets and liabilities | The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The table shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the period. Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as Level 3 if an unobservable input is deemed significant. Level 3 movement analysis Purchases Sales Issues Settle- ments Total gains and losses in the period recognised in the income statement Total gains or losses recognised in OCI Transfers As at 30.06.21 As at 01.01.21 Trading income Other income In Out £m £m £m £m £m £m £m £m £m £m £m Corporate debt 151 305 (87) — — 25 — — 40 (11) 423 Non-asset backed loans 709 620 (131) — (84) 13 — — 124 (106) 1,145 Asset backed securities 686 112 (294) — — (10) — — 43 (48) 489 Equity cash products 214 13 (17) — — 32 — — 29 (9) 262 Other 103 21 — — (51) (1) — — 162 (1) 233 Trading portfolio assets 1,863 1,071 (529) — (135) 59 — — 398 (175) 2,552 Non-asset backed loans 2,280 696 (299) — (388) 10 — — 69 (47) 2,321 Equity cash products 320 166 (194) — — (171) 18 — — — 139 Private equity investments 88 22 (7) — (7) (1) 3 — — — 98 Other 1,704 2,296 (2,389) — (160) (19) 1 — 16 — 1,449 Financial assets at fair value through the income statement 4,392 3,180 (2,889) — (555) (181) 22 — 85 (47) 4,007 Non-asset backed loans 106 — — — — — — — — (106) — Asset backed securities 47 — — — (5) — — 1 — — 43 Financial assets at fair value through other comprehensive income 153 — — — (5) — — 1 — (106) 43 Investment property 10 — (2) — — — — — — — 8 Trading portfolio liabilities (28) (3) 14 — — (7) — — — 7 (17) Financial liabilities (341) — — — 98 7 — — (78) 18 (296) Interest rate derivatives (2) 9 — — 33 (121) 4 — 21 (296) (352) Foreign exchange derivatives 1 — — — 58 (6) — — 3 (34) 22 Credit derivatives (155) (118) 2 — (5) 12 (1) — 1 (1) (265) Equity derivatives (1,615) (315) (1) — (32) (221) — — 28 808 (1,348) Net derivative financial instruments 1 (1,771) (424) 1 — 54 (336) 3 — 53 477 (1,943) Total 4,278 3,824 (3,405) — (543) (458) 25 1 458 174 4,354 1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,656m and derivative financial liabilities were £5,599m. Level 3 movement analysis Total gains and losses in the period recognised in the income statement Total gains or losses recognised in OCI Transfers As at 30.06.20 As at 01.01.20 Purchases Sales Issues Settle-ments Trading income Other income In Out £m £m £m £m £m £m £m £m £m £m Corporate debt 120 25 — — — (26) — — 4 (17) 106 Non-asset backed loans 974 1,927 (740) — (4) (111) — — 97 (320) 1,823 Asset backed securities 656 249 (224) — (76) (12) — — 41 (11) 623 Equity cash products 392 2 (4) — — (67) — — 28 (4) 347 Other 122 47 — — — 2 — — 8 — 179 Trading portfolio assets 2,264 2,250 (968) — (80) (214) — — 178 (352) 3,078 Non-asset backed loans 1,964 1,050 (270) — (112) 110 — — — — 2,742 Equity cash products 835 14 — — — (22) (29) — — — 798 Private equity investments 113 1 (2) — — 2 4 — 20 (12) 126 Other 1,250 1,865 (2,017) — (13) (8) 55 — 24 — 1,156 Financial assets at fair value through the income statement 4,162 2,930 (2,289) — (125) 82 30 — 44 (12) 4,822 Non-asset backed loans 343 79 — — (157) — — (3) — — 262 Asset backed securities 86 — (1) — — 1 — (1) — — 85 Financial assets at fair value through other comprehensive income 429 79 (1) — (157) 1 — (4) — — 347 Investment property 13 — (1) — — — (2) — 2 (2) 10 Trading portfolio liabilities — — — — — — — — — — — Financial liabilities designated at fair value (343) — — (3) — (12) (1) — (22) 26 (355) Interest rate derivatives (206) 17 — — 10 268 1 — 300 (10) 380 Foreign exchange derivatives (7) — — — (12) 89 — — 5 (8) 67 Credit derivatives 198 (258) 11 — (376) 151 1 — 2 8 (263) Equity derivatives (820) (447) (1) — 17 (90) — — (5) (23) (1,369) Net derivative financial instruments 1 (835) (688) 10 — (361) 418 2 — 302 (33) (1,185) Total 5,690 4,571 (3,249) (3) (723) 275 29 (4) 504 (373) 6,717 1 Derivative financial instruments are presented on a net basis. On a gross basis, derivative financial assets were £7,747m and derivative financial liabilities were £8,932m. |
Unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | Unrealised gains and losses on Level 3 financial assets and liabilities The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets and liabilities held at the period end. Half year ended 30.06.21 Half year ended 30.06.20 Income statement Other compre-hensive income Total Income statement Other compre-hensive income Total Trading income Other income Trading income Other income £m £m £m £m £m £m £m £m Trading portfolio assets 35 — — 35 (177) — — (177) Financial assets at fair value through the income statement (67) 35 — (32) 126 (24) — 102 Financial assets at fair value through other comprehensive income — — — — — — (2) (2) Investment properties — — — — — (2) — (2) Trading portfolio liabilities (6) — — (6) — — — — Financial liabilities designated at fair value 7 — — 7 (16) (1) — (17) Net derivative financial instruments (367) — — (367) 248 — — 248 Total (398) 35 — (363) 181 (27) (2) 152 |
Sensitivity analysis of valuations using unobservable inputs | Sensitivity analysis of valuations using unobservable inputs As at 30.06.21 As at 31.12.20 Favourable changes Unfavourable changes Favourable changes Unfavourable changes Income statement Equity Income Statement Equity Income statement Equity Income Statement Equity £m £m £m £m £m £m £m £m Interest rate derivatives 52 — (83) — 82 — (123) — Foreign exchange derivatives 6 — (10) — 6 — (11) — Credit derivatives 53 — (44) — 55 — (44) — Equity derivatives 185 — (193) — 174 — (179) — Commodity derivatives 2 — (2) — 2 — (2) — Corporate debt 22 — (16) — 16 — (14) — Non-asset backed loans 129 — (172) — 104 3 (190) (3) Equity cash products 122 — (111) — 158 — (141) — Private equity investments 17 — (18) — 15 — (15) — Other 1 18 — (18) — 21 — (21) — Total 606 — (667) — 633 3 (740) (3) 1 Other includes commercial real estate loans, fund and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property. |
Fair value adjustments | Fair value adjustments Key balance sheet valuation adjustments are quantified below: As at 30.06.21 As at 31.12.20 £m £m Exit price adjustments derived from market bid-offer spreads (492) (483) Uncollateralised derivative funding (80) (115) Derivative credit valuation adjustments (210) (268) Derivative debit valuation adjustments 91 113 |
Comparison of carrying amounts and fair values for assets and liabilities not held at fair value | The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Barclays Bank Group’s balance sheet: As at 30.06.21 As at 31.12.20 Carrying amount Fair value Carrying amount Fair value Financial assets £m £m £m £m Loans and advances at amortised cost 133,815 134,228 134,267 134,537 Reverse repurchase agreements and other similar secured lending 3,048 3,048 8,981 8,981 Financial liabilities Deposits at amortised cost (249,732) (249,757) (244,696) (244,738) Repurchase agreements and other similar secured borrowing (11,067) (11,067) (10,443) (10,443) Debt securities in issue (42,931) (42,925) (29,423) (29,486) Subordinated liabilities (29,045) (30,515) (32,005) (33,356) |
Subordinated Liabilities (Table
Subordinated Liabilities (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Subordinated liabilities [abstract] | |
Subordinated liabilities | Half year ended 30.06.21 Year ended 31.12.20 £m £m Opening balance 32,005 33,425 Issuances 5,075 3,856 Redemptions (6,599) (5,954) Other (1,436) 678 Closing balance 29,045 32,005 |
Provisions (Tables)
Provisions (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Provisions [abstract] | |
Provisions | As at 30.06.21 As at 31.12.20 £m £m Customer redress 51 44 Legal, competition and regulatory matters 207 222 Redundancy and restructuring 22 44 Undrawn contractually committed facilities and guarantees 572 769 Onerous contracts 4 6 Sundry provisions 95 123 Total 951 1,208 |
Other reserves (Tables)
Other reserves (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of reserves within equity [abstract] | |
Other reserves | As at 30.06.21 As at 31.12.20 £m £m Currency translation reserve 2,184 2,736 Fair value through other comprehensive income reserve (68) 244 Cash flow hedging reserve 358 1,181 Own credit reserve (1,001) (954) Other reserves (24) (24) Total 1,449 3,183 |
Contingent liabilities and co_2
Contingent liabilities and commitments (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of contingent liabilities [abstract] | |
Disclosure of contingent liabilities and commitments | As at 30.06.21 As at 31.12.20 Contingent liabilities £m £m Guarantees and letters of credit pledged as collateral security 13,805 15,138 Performance guarantees, acceptances and endorsements 6,601 5,794 Total 20,406 20,932 Commitments Documentary credits and other short-term trade related transactions 1,017 1,086 Standby facilities, credit lines and other commitments 282,742 263,936 Total 283,759 265,022 |
Related party transactions (Tab
Related party transactions (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of transactions between related parties [abstract] | |
Disclosure of transactions between related parties | Half year ended 30.06.21 Half year ended 30.06.20 Parent Fellow subsidiaries Parent Fellow subsidiaries £m £m £m £m Total income (304) 10 (346) 31 Operating expenses (31) (1,560) (34) (1,443) As at 30.06.21 As at 31.12.20 Parent Fellow subsidiaries Parent Fellow subsidiaries £m £m £m £m Total assets 6,311 1,672 6,803 1,917 Total liabilities 28,201 3,779 25,819 3,954 |
Barclays Bank PLC parent cond_2
Barclays Bank PLC parent condensed balance sheet (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Condensed Financial Information Disclosure [Abstract] | |
Barclays Bank PLC condensed balance sheet | As at 30.06.21 As at 31.12.20 Assets £m £m Cash and balances at central banks 139,089 133,386 Cash collateral and settlement balances 85,357 87,723 Loans and advances at amortised cost 191,048 191,538 Reverse repurchase agreements and other similar secured lending 5,745 11,535 Trading portfolio assets 95,985 84,089 Financial assets at fair value through the income statement 241,198 203,073 Derivative financial instruments 247,767 297,129 Financial assets at fair value through other comprehensive income 48,618 50,308 Investment in associates and joint ventures 12 13 Investment in subsidiaries 19,168 17,780 Goodwill and intangible assets 109 112 Property, plant and equipment 149 425 Current tax assets 566 545 Deferred tax assets 1,122 1,171 Retirement benefit assets 2,652 1,812 Other assets 1,652 913 Total assets 1,080,237 1,081,552 Liabilities Deposits at amortised cost 271,293 272,190 Cash collateral and settlement balances 69,758 68,862 Repurchase agreements and other similar secured borrowing 18,849 27,722 Debt securities in issue 30,404 17,221 Subordinated liabilities 28,813 31,852 Trading portfolio liabilities 54,033 48,093 Financial liabilities designated at fair value 310,115 267,137 Derivative financial instruments 238,875 292,538 Current tax liabilities 390 336 Deferred tax liabilities 29 225 Retirement benefit liabilities 113 104 Other liabilities 5,701 3,145 Provisions 776 984 Total liabilities 1,029,149 1,030,409 Equity Called up share capital and share premium 2,348 2,348 Other equity instruments 13,328 13,328 Other reserves (541) 776 Retained earnings 35,953 34,691 Total equity 51,088 51,143 Total liabilities and equity 1,080,237 1,081,552 |
Credit Risk (Tables)
Credit Risk (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of credit risk exposure [abstract] | |
Disclosure of provision matrix | The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification. Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure, as expected credit loss (ECL) is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision. Stage 2 As at 30.06.21 Stage 1 Not past due <=30 days past due >30 days past due Total Stage 3 Total 1 Gross exposure £m £m £m £m £m £m £m Home loans 9,575 643 21 143 807 1,017 11,399 Credit cards, unsecured loans and other retail lending 21,196 2,541 177 132 2,850 1,617 25,663 Wholesale loans 86,087 12,454 524 373 13,351 1,340 100,778 Total 116,858 15,638 722 648 17,008 3,974 137,840 Impairment allowance Home loans 7 37 1 1 39 341 387 Credit cards, unsecured loans and other retail lending 609 677 38 66 781 1,057 2,447 Wholesale loans 193 316 5 10 331 667 1,191 Total 809 1,030 44 77 1,151 2,065 4,025 Net exposure Home loans 9,568 606 20 142 768 676 11,012 Credit cards, unsecured loans and other retail lending 20,587 1,864 139 66 2,069 560 23,216 Wholesale loans 85,894 12,138 519 363 13,020 673 99,587 Total 116,049 14,608 678 571 15,857 1,909 133,815 Coverage ratio % % % % % % % Home loans 0.1 5.8 4.8 0.7 4.8 33.5 3.4 Credit cards, unsecured loans and other retail lending 2.9 26.6 21.5 50.0 27.4 65.4 9.5 Wholesale loans 0.2 2.5 1.0 2.7 2.5 49.8 1.2 Total 0.7 6.6 6.1 11.9 6.8 52.0 2.9 As at 31.12.20 Gross exposure £m £m £m £m £m £m £m Home loans 9,627 761 53 87 901 1,099 11,627 Credit cards, unsecured loans and other retail lending 18,923 4,987 393 191 5,571 1,853 26,347 Wholesale loans 83,254 14,184 1,066 688 15,938 2,167 101,359 Total 111,804 19,932 1,512 966 22,410 5,119 139,333 Impairment allowance Home loans 6 40 6 6 52 376 434 Credit cards, unsecured loans and other retail lending 399 1,092 111 124 1,327 1,253 2,979 Wholesale loans 280 475 49 9 533 840 1,653 Total 685 1,607 166 139 1,912 2,469 5,066 Net exposure Home loans 9,621 721 47 81 849 723 11,193 Credit cards, unsecured loans and other retail lending 18,524 3,895 282 67 4,244 600 23,368 Wholesale loans 82,974 13,709 1,017 679 15,405 1,327 99,706 Total 111,119 18,325 1,346 827 20,498 2,650 134,267 Coverage ratio % % % % % % % Home loans 0.1 5.3 11.3 6.9 5.8 34.2 3.7 Credit cards, unsecured loans and other retail lending 2.1 21.9 28.2 64.9 23.8 67.6 11.3 Wholesale loans 0.3 3.3 4.6 1.3 3.3 38.8 1.6 Total 0.6 8.1 11.0 14.4 8.5 48.2 3.6 1 Other financial assets subject to impairment excluded in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income, accrued income and sundry debtors. These have a total gross exposure of £159.9bn (December 2020: £150.3bn) and impairment allowance of £102m (December 2020: £145m). This comprises £7m (December 2020: £7m) ECL on £159.8bn (December 2020: £146.3bn) Stage 1 assets, £1m(December 2020: £6m) on £34m (December 2020: £3.8bn) Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £94m (December 2020: £132m) on £94m (December 2020: £132m) Stage 3 other assets. Loan commitments and financial guarantee contracts have total ECL of £572m (December 2020:£769m). |
Disclosure of credit risk | The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. Explanation of the terms: 12-month ECL, lifetime ECL and credit-impaired are included in the Barclays Bank PLC Annual Report 2020 on page 169. Transfers between stages in the tables have been reflected as if they had taken place at the beginning of the year. The movements are measured over a 6-month period. Loans and advances at amortised cost Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL £m £m £m £m £m £m £m £m Home loans As at 1 January 2021 9,627 6 901 52 1,099 376 11,627 434 Transfers from Stage 1 to Stage 2 (282) — 282 — — — — — Transfers from Stage 2 to Stage 1 248 15 (248) (15) — — — — Transfers to Stage 3 (71) — (44) (4) 115 4 — — Transfers from Stage 3 14 — 35 2 (49) (2) — — Business activity in the year 826 — — — — — 826 — Changes to models used for calculation 1 — — — (4) — 38 — 34 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (484) (14) (48) 9 (55) (64) (587) (69) Final repayments (303) — (71) (1) (83) (1) (457) (2) Disposals — — — — — — — — Write-offs 2 — — — — (10) (10) (10) (10) As at 30 June 2021 3 9,575 7 807 39 1,017 341 11,399 387 Credit cards, unsecured loans and other retail lending As at 1 January 2021 18,923 399 5,571 1,327 1,853 1,253 26,347 2,979 Transfers from Stage 1 to Stage 2 (539) (31) 539 31 — — — — Transfers from Stage 2 to Stage 1 2,508 546 (2,508) (546) — — — — Transfers to Stage 3 (130) (7) (280) (127) 410 134 — — Transfers from Stage 3 14 18 20 6 (34) (24) — — Business activity in the year 2,330 30 20 4 20 4 2,370 38 Changes to models used for calculation 1 — (3) — (27) — — — (30) Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (752) (316) (463) 119 (84) 174 (1,299) (23) Final repayments (1,158) (27) (49) (6) (61) (5) (1,268) (38) Disposals 4 — — — — (19) (11) (19) (11) Write-offs 2 — — — — (468) (468) (468) (468) As at 30 June 2021 3 21,196 609 2,850 781 1,617 1,057 25,663 2,447 1 Changes to models used for calculation include a £34m movement in Home Loans, £30m in Credit cards, unsecured loans and other retail lending and £36m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses. 2 In H121, gross write-offs amounted to £606m (H120: £643m) and post write-off recoveries amounted to £15m (H120: £1m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £591m (H120: £642m). 3 Other financial assets subject to impairment excluded in the tables above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £159.9bn (December 2020: £150.3bn) and impairment allowance of £102m (December 2020: £145m). This comprises £7m ECL (December 2020: £7m) on £159.8bn Stage 1 assets (December 2020: £146.3bn), £1m (December 2020: £6m) on £34m Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2020: £3.8bn) and £94m (December 2020: £132m) on £94m Stage 3 other assets (December 2020: £132m). 4 The £19m of disposals reported within Credit cards, unsecured loans and other retail lending portfolio relate to debt sales undertaken during the year. The £101m of disposals reported within Wholesale loans include the sale of Barclays Asset Finance and debt sales. Loans and advances at amortised cost Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL £m £m £m £m £m £m £m £m Wholesale loans As at 1 January 2021 83,254 280 15,938 533 2,167 840 101,359 1,653 Transfers from Stage 1 to Stage 2 (3,956) (10) 3,956 10 — — — — Transfers from Stage 2 to Stage 1 5,093 104 (5,093) (104) — — — — Transfers to Stage 3 (98) (1) (105) (11) 203 12 — — Transfers from Stage 3 395 1 272 8 (667) (9) — — Business activity in the year 17,980 32 1,124 29 78 16 19,182 77 Changes to models used for calculation 1 — (7) — (29) — — — (36) Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 1,001 (167) 152 (14) (76) (4) 1,077 (185) Final repayments (17,539) (38) (2,885) (91) (187) (32) (20,611) (161) Disposals 2 (43) (1) (8) — (50) (28) (101) (29) Write-offs 3 — — — — (128) (128) (128) (128) As at 30 June 2021 4 86,087 193 13,351 331 1,340 667 100,778 1,191 Reconciliation of ECL movement to impairment charge/(release) for the period £m Home loans (37) Credit cards, unsecured loans and other retail lending (53) Wholesale loans (305) ECL movement excluding assets derecognised due to disposals and write-offs (395) Recoveries and reimbursements 5 201 Exchange and other adjustments 6 105 Impairment charge on loan commitments and other financial guarantees (185) Impairment charge on other financial assets 4 (14) Income statement release for the period (288) 1 Changes to models used for calculation include a £34m movement in Home Loans, £30m in Credit cards, unsecured loans and other retail lending and £36m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses 2 The £19m of disposals reported within Credit cards, unsecured loans and other retail lending portfolio relate to debt sales undertaken during the year. The £101m disposal reported within Wholesale loans include sale of Barclays Asset Finance and debt sales. 3 In H121, gross write-offs amounted to £606m (H120: £643m) and post write-off recoveries amounted to £15m (H120: £1m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £591m (H120: £642m). 4 Other financial assets subject to impairment excluded from the tables above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £159.9bn (December 2020: £150.3bn) and impairment allowance of £102m (December 2020: £145m). This comprises £7m ECL (December 2020: £7m) on £159.8bn Stage 1 assets (December 2020: £146.3bn), £1m (December 2020: £6m) on £34m Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2020: £3.8bn) and £94m (December 2020: £132m) on £94m Stage 3 other assets (December 2020: £132m). 5 Recoveries and reimbursements includes a net loss in relation to reimbursements from guarantee contracts held with third parties of £216m and post write off recoveries of £15m. 6 Exchange and other adjustments includes foreign exchange and interest and fees in suspense. Loan commitments and financial guarantees Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL £m £m £m £m £m £m £m £m Home loans As at 1 January 2021 125 — 2 — 4 — 131 — Net transfers between stages — — — — — — — — Business activity in the year 6 — 1 — — — 7 — Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (6) — — — — — (6) — Limit management and final repayments (88) — — — (3) — (91) — As at 30 June 2021 37 — 3 — 1 — 41 — Credit cards, unsecured loans and other retail lending As at 1 January 2021 68,211 34 6,244 33 30 23 74,485 90 Net transfers between stages 3,555 8 (3,786) (3) 231 (5) — — Business activity in the year 3,135 1 23 — 1 1 3,159 2 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 2,142 (9) 213 1 (232) 3 2,123 (5) Limit management and final repayments (4,476) — (353) — (3) (2) (4,832) (2) As at 30 June 2021 72,567 34 2,341 31 27 20 74,935 85 Wholesale loans As at 1 January 2021 160,404 205 39,426 446 2,031 28 201,861 679 Net transfers between stages 96 115 1,087 (111) (1,183) (4) — — Business activity in the year 39,001 28 2,916 89 12 9 41,929 126 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 1,912 (146) 688 (61) (28) 2 2,572 (205) Limit management and final repayments (32,861) (25) (4,843) (83) (455) (5) (38,159) (113) As at 30 June 2021 168,552 177 39,274 280 377 30 208,203 487 |
Drivers of loan impairment charge | As at 30.06.21 As at 31.12.20 Management adjustments to impairment allowances Proportion of total impairment allowances Management adjustments to impairment allowances Proportion of total impairment allowances £m % £m % Home loans 22 5.7 54 12.4 Credit cards, unsecured loans and other retail lending 550 21.7 960 31.3 Wholesale loans 479 28.5 (78) (3.3) Total 1,051 22.9 936 16.0 Management adjustments to models for impairment allowance 1 Impairment allowance pre management adjustments 2 Economic uncertainty adjustments Other adjustments Total impairment allowance As at 30.06.2021 £m £m £m £m Home loans 365 22 — 387 Credit cards, unsecured loans and other retail lending 1,982 778 (228) 2,532 Wholesale loans 1,199 615 (136) 1,678 Total 3,546 1,415 (364) 4,597 As at 31.12.20 Home loans 380 21 33 434 Credit cards, unsecured loans and other retail lending 2,109 986 (26) 3,069 Wholesale loans 2,410 379 (457) 2,332 Total 4,899 1,386 (450) 5,835 1 Positive values reflect an increase in impairment allowance. 2 Includes £2.6bn (December 2020: £3.9bn) of modelled ECL, £0.7bn (December 2020: £0.8bn) of individually assessed impairments and £0.2bn (December 2020: £0.2bn) ECL from non-modelled exposures. |
Macroeconomic variables used in the calculation of ECL and the respective scenario probability weighting | Baseline average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.2021 % % % UK GDP 1 4.9 5.6 2.3 UK unemployment 2 5.8 5.7 5.1 UK HPI 3 (0.5) 0.3 3.1 UK bank rate 0.1 0.2 0.4 US GDP 1 5.7 3.9 1.6 US unemployment 4 5.6 4.5 4.4 US HPI 5 3.9 3.5 3.5 US federal funds rate 0.3 0.3 0.7 As at 31.12.20 UK GDP 1 6.3 3.3 2.6 UK unemployment 2 6.7 6.4 5.8 UK HPI 3 2.4 2.3 5.0 UK bank rate — (0.1) — US GDP 1 3.9 3.1 2.9 US unemployment 4 6.9 5.7 5.6 US HPI 5 2.8 4.7 4.7 US federal funds rate 0.3 0.3 0.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Downside 2 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 (1.7) 2.0 5.2 UK unemployment 2 7.3 8.2 6.6 UK HPI 3 (5.8) (5.8) 0.2 UK bank rate 0.1 — — US GDP 1 1.5 1.4 2.0 US unemployment 4 8.7 11.0 9.3 US HPI 5 (4.9) (3.0) 1.1 US federal funds rate 0.3 0.3 0.3 As at 31.12.20 UK GDP 1 (3.9) 6.5 2.6 UK unemployment 2 8.0 9.3 7.8 UK HPI 3 (13.6) (10.8) 0.5 UK bank rate (0.2) (0.2) (0.1) US GDP 1 (2.4) 3.6 2.1 US unemployment 4 13.4 11.9 10.1 US HPI 5 (17.2) (0.7) 0.6 US federal funds rate 0.3 0.3 0.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Downside 1 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 0.6 4.4 4.2 UK unemployment 2 6.4 6.6 5.6 UK HPI 3 (3.1) (2.7) 1.7 UK bank rate 0.1 0.1 0.2 US GDP 1 3.4 2.5 1.6 US unemployment 4 7.4 7.9 6.1 US HPI 5 (0.5) 0.2 2.3 US federal funds rate 0.3 0.3 0.3 As at 31.12.20 UK GDP 1 0.1 6.6 3.2 UK unemployment 2 7.3 8.0 6.9 UK HPI 3 (6.7) (3.5) 1.7 UK bank rate (0.1) (0.1) — US GDP 1 0.4 3.6 2.3 US unemployment 4 11.0 8.9 6.9 US HPI 5 (5.9) 1.8 2.6 US federal funds rate 0.3 0.3 0.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Upside 2 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 6.8 9.4 4.0 UK unemployment 2 5.5 4.9 4.4 UK HPI 3 4.6 9.9 11.3 UK bank rate 0.1 0.4 0.6 US GDP 1 6.5 8.2 3.4 US unemployment 4 5.3 3.8 3.8 US HPI 5 6.5 8.0 7.3 US federal funds rate 0.3 0.3 1.1 As at 31.12.20 UK GDP 1 12.2 5.3 3.9 UK unemployment 2 6.2 5.5 4.8 UK HPI 3 6.6 10.4 10.8 UK bank rate 0.1 0.3 0.3 US GDP 1 7.1 4.6 4.0 US unemployment 4 5.5 4.3 4.1 US HPI 5 8.8 9.1 8.9 US federal funds rate 0.3 0.4 0.6 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Upside 1 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 5.9 7.3 3.0 UK unemployment 2 5.6 5.2 4.7 UK HPI 3 1.5 4.5 7.4 UK bank rate 0.1 0.2 0.6 US GDP 1 6.1 5.8 2.4 US unemployment 4 5.5 4.2 4.2 US HPI 5 6.2 6.8 5.7 US federal funds rate 0.3 0.3 0.9 As at 31.12.20 UK GDP 1 9.3 3.9 3.4 UK unemployment 2 6.4 6.0 5.2 UK HPI 3 4.6 6.1 6.1 UK bank rate 0.1 0.1 0.3 US GDP 1 5.5 4.0 3.7 US unemployment 4 6.0 4.8 4.6 US HPI 5 6.8 6.7 6.3 US federal funds rate 0.3 0.3 0.5 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Scenario probability weighting Upside 2 Upside 1 Baseline Downside 1 Downside 2 % % % % % As at 30.06.21 Scenario probability weighting 19.6 24.5 26.4 16.9 12.6 As at 31.12.20 Scenario probability weighting 20.2 24.2 24.7 15.5 15.4 Specific bases show the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest points relative to the start point in the 20 quarter period. Macroeconomic variables (specific bases) 1 Upside 2 Upside 1 Baseline Downside 1 Downside 2 As at 30.06.2021 % % % % % UK GDP 2 25.9 20.2 3.3 (4.2) (8.1) UK unemployment 3 4.1 4.3 5.1 7.5 9.8 UK HPI 4 48.2 25.5 1.6 (5.8) (11.8) UK bank rate 3 0.1 0.1 0.4 0.3 0.1 US GDP 2 23.7 18.3 2.8 (0.2) (3.2) US unemployment 3 3.8 4.2 4.7 8.9 12.0 US HPI 4 41.2 32.6 3.6 (1.3) (7.9) US federal funds rate 3 0.3 0.3 0.8 1.5 0.8 As at 31.12.20 UK GDP 2 14.2 8.8 0.7 (22.1) (22.1) UK unemployment 3 4.0 4.0 5.7 8.4 10.1 UK HPI 4 48.2 30.8 3.6 (4.5) (18.3) UK bank rate 3 0.1 0.1 — 0.6 0.6 US GDP 2 15.7 12.8 1.6 (10.6) (10.6) US unemployment 3 3.8 3.8 6.4 13.0 13.7 US HPI 4 42.2 30.9 3.8 (3.7) (15.9) US federal funds rate 3 0.1 0.1 0.3 1.3 1.3 1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20 quarter period starts from Q121 (2020: Q120). 2 Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year yearly average Compound Annual Growth Rate (CAGR) in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios. 3 Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter 20 quarter period in Downside scenarios.. 4 Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios. Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly average and quarterly CAGRs respectively. Macroeconomic variables (5-year averages) 1 Upside 2 Upside 1 Baseline Downside 1 Downside 2 As at 30.06.2021 % % % % % UK GDP 2 5.2 4.2 3.3 2.6 1.8 UK unemployment 3 4.6 4.8 5.1 5.7 6.5 UK HPI 4 8.2 4.7 1.6 — (1.6) UK bank rate 3 0.7 0.6 0.4 0.2 — US GDP 2 4.6 3.7 2.8 2.0 1.4 US unemployment 3 4.1 4.4 4.7 6.3 8.5 US HPI 4 7.1 5.8 3.6 1.6 (0.4) US federal funds rate 3 1.1 0.9 0.8 0.6 0.3 As at 31.12.20 UK GDP 2 2.5 1.6 0.7 0.1 (0.9) UK unemployment 3 5.0 5.3 5.7 6.5 7.2 UK HPI 4 8.2 5.5 3.6 (0.2) (3.6) UK bank rate 3 0.3 0.2 — — (0.1) US GDP 2 2.9 2.4 1.6 0.8 0.1 US unemployment 3 5.3 5.7 6.4 8.3 10.4 US HPI 4 7.3 5.5 3.8 0.8 (3.0) US federal funds rate 3 0.5 0.5 0.3 0.3 0.3 1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. . 2 5-year yearly average CAGR, starting 2020 (2020: 2019). 3 5-year average. Period based on 20 quarters from Q121 (2020: Q120). 4 5-year quarter end CAGR, starting Q420 (2020: Q419). |
Segmental reporting - Analysis
Segmental reporting - Analysis of results by business (Details) - GBP (£) £ in Millions | 6 Months Ended | |||
Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | ||
Disclosure of operating segments [line items] | ||||
Total income | £ 8,189 | £ 8,637 | ||
Credit impairment releases | 288 | (2,674) | ||
Net operating income | 8,477 | 5,963 | ||
Operating expenses | (5,059) | (4,548) | ||
Litigation and conduct | (87) | (19) | ||
Operating expenses | (5,146) | (4,567) | ||
Other net income | 3 | 127 | ||
Profit before tax | 3,334 | 1,523 | [1] | |
Total assets | 1,064,337 | £ 1,059,731 | ||
Operating segments | Corporate and Investment Bank | ||||
Disclosure of operating segments [line items] | ||||
Total income | 6,632 | 6,973 | ||
Credit impairment releases | 260 | (1,320) | ||
Net operating income | 6,892 | 5,653 | ||
Operating expenses | (3,617) | (3,458) | ||
Litigation and conduct | (2) | (4) | ||
Operating expenses | (3,619) | (3,462) | ||
Other net income | 3 | 12 | ||
Profit before tax | 3,276 | 2,203 | ||
Total assets | 991,300 | 990,900 | ||
Operating segments | Consumer, Cards and Payments | ||||
Disclosure of operating segments [line items] | ||||
Total income | 1,649 | 1,742 | ||
Credit impairment releases | 22 | (1,299) | ||
Net operating income | 1,671 | 443 | ||
Operating expenses | (1,126) | (1,053) | ||
Litigation and conduct | (82) | (8) | ||
Operating expenses | (1,208) | (1,061) | ||
Other net income | 0 | 115 | ||
Profit before tax | 463 | (503) | ||
Total assets | 62,700 | 57,800 | ||
Head Office | ||||
Disclosure of operating segments [line items] | ||||
Total income | (92) | (78) | ||
Credit impairment releases | 6 | (55) | ||
Net operating income | (86) | (133) | ||
Operating expenses | (316) | (37) | ||
Litigation and conduct | (3) | (7) | ||
Operating expenses | (319) | (44) | ||
Other net income | 0 | 0 | ||
Profit before tax | (405) | £ (177) | ||
Total assets | £ 10,300 | £ 11,000 | ||
[1] | H120 comparative figures have been restated to make the condensed cash flow statement more relevant following a review of the disclosure and the accounting policies applied that was undertaken in H220. Amendments, which were first applied in the Barclays Bank PLC Annual Report 2020, have been made to the classification of cash collateral reported within cash and cash equivalents and to the presentation of items within net cash flows from operating and investing activities. Footnotes 2 and 3 below quantify the impact of the changes to the respective cash flow categories in H120 and provide further detail. |
Segmental reporting - Split of
Segmental reporting - Split of income by geographic region (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Disclosure of operating segments [line items] | ||
Total income | £ 8,189 | £ 8,637 |
United Kingdom | ||
Disclosure of operating segments [line items] | ||
Total income | 2,698 | 2,835 |
Europe | ||
Disclosure of operating segments [line items] | ||
Total income | 1,213 | 1,240 |
Americas | ||
Disclosure of operating segments [line items] | ||
Total income | 3,676 | 3,872 |
Africa and Middle East | ||
Disclosure of operating segments [line items] | ||
Total income | 20 | 23 |
Asia | ||
Disclosure of operating segments [line items] | ||
Total income | £ 582 | £ 667 |
Net fee and commission income_2
Net fee and commission income (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | £ 4,008 | £ 3,758 |
Other non-contract fee income | 62 | 60 |
Fee and commission income | 4,070 | 3,818 |
Fee and commission expense | (870) | (939) |
Net fee and commission income | 3,200 | 2,879 |
Transactional | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 1,168 | 1,145 |
Advisory | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 460 | 306 |
Brokerage and execution | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 553 | 685 |
Underwriting and syndication | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 1,715 | 1,468 |
Other | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 112 | 154 |
Operating segments | Corporate and Investment Bank | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 2,850 | 2,594 |
Other non-contract fee income | 59 | 57 |
Fee and commission income | 2,909 | 2,651 |
Fee and commission expense | (369) | (441) |
Net fee and commission income | 2,540 | 2,210 |
Operating segments | Corporate and Investment Bank | Transactional | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 184 | 177 |
Operating segments | Corporate and Investment Bank | Advisory | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 399 | 260 |
Operating segments | Corporate and Investment Bank | Brokerage and execution | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 527 | 654 |
Operating segments | Corporate and Investment Bank | Underwriting and syndication | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 1,715 | 1,468 |
Operating segments | Corporate and Investment Bank | Other | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 25 | 35 |
Operating segments | Consumer, Cards and Payments | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 1,147 | 1,145 |
Other non-contract fee income | 3 | 3 |
Fee and commission income | 1,150 | 1,148 |
Fee and commission expense | (496) | (497) |
Net fee and commission income | 654 | 651 |
Operating segments | Consumer, Cards and Payments | Transactional | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 984 | 968 |
Operating segments | Consumer, Cards and Payments | Advisory | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 61 | 46 |
Operating segments | Consumer, Cards and Payments | Brokerage and execution | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 26 | 31 |
Operating segments | Consumer, Cards and Payments | Underwriting and syndication | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 0 | 0 |
Operating segments | Consumer, Cards and Payments | Other | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 76 | 100 |
Head Office | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 11 | 19 |
Other non-contract fee income | 0 | 0 |
Fee and commission income | 11 | 19 |
Fee and commission expense | (5) | (1) |
Net fee and commission income | 6 | 18 |
Head Office | Transactional | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 0 | 0 |
Head Office | Advisory | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 0 | 0 |
Head Office | Brokerage and execution | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 0 | 0 |
Head Office | Underwriting and syndication | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 0 | 0 |
Head Office | Other | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | £ 11 | £ 19 |
Tax - Narrative (Details)
Tax - Narrative (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax charge | £ 611 | £ 230 |
Average effective tax rate | 18.30% | 15.10% |
Tax expense (income) excluding effect of tax rate change | £ 748 | |
Average effective tax rate excluding effect of tax rate change | 22.40% | |
UNITED KINGDOM | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Increase (decrease) relating to tax rate changes or imposition of new taxes, deferred tax liability (asset) | £ 28 | |
Deferred tax expense (income) relating to tax rate changes or imposition of new taxes | 137 | |
Deferred tax expense (income) relating to tax rate changes or imposition of new taxes, other comprehensive income | £ 165 |
Tax - Deferred tax assets and l
Tax - Deferred tax assets and liabilities (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Net deferred tax assets and liabilities [abstract] | ||
Deferred tax assets | £ 2,362 | £ 2,552 |
Deferred tax liabilities | (29) | (225) |
Temporary differences | ||
Net deferred tax assets and liabilities [abstract] | ||
Deferred tax assets | 1,591 | 1,841 |
Tax losses | ||
Net deferred tax assets and liabilities [abstract] | ||
Deferred tax assets | 771 | 711 |
USA | ||
Net deferred tax assets and liabilities [abstract] | ||
Deferred tax assets | 1,908 | 2,049 |
Other territories | ||
Net deferred tax assets and liabilities [abstract] | ||
Deferred tax assets | 454 | 503 |
Deferred tax liabilities – UK | ||
Net deferred tax assets and liabilities [abstract] | ||
Deferred tax liabilities | £ (29) | £ (225) |
Dividends on ordinary shares (D
Dividends on ordinary shares (Details) - GBP (£) £ in Millions | Aug. 02, 2021 | Jun. 30, 2021 | Dec. 30, 2020 | Jun. 30, 2020 |
Disclosure of reserves within equity [line items] | ||||
Ordinary shares | £ 694 | £ 263 | ||
Preference shares | 13 | £ 14 | 28 | |
Total | £ 707 | £ 291 | ||
Ordinary shares | ||||
Disclosure of reserves within equity [line items] | ||||
Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners | £ 100 |
Fair value of financial instr_3
Fair value of financial instruments - Assets and liabilities held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of detailed information about financial instruments [line items] | ||
Trading portfolio assets | £ 147,144 | £ 127,664 |
Financial assets at fair value through the income statement | 191,128 | 171,761 |
Derivative financial instruments | 256,129 | 302,693 |
Financial assets at fair value through other comprehensive income | 50,184 | 51,902 |
Trading portfolio liabilities | (56,137) | (46,139) |
Financial liabilities designated at fair value | (263,920) | (249,626) |
Derivative financial liabilities | (246,983) | (300,580) |
At fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading portfolio assets | 147,144 | 127,664 |
Financial assets at fair value through the income statement | 191,128 | 171,761 |
Derivative financial instruments | 256,129 | 302,693 |
Financial assets at fair value through other comprehensive income | 50,184 | 51,902 |
Investment property | 8 | 10 |
Total assets | 644,593 | 654,030 |
Trading portfolio liabilities | (56,137) | (46,139) |
Financial liabilities designated at fair value | (263,920) | (249,626) |
Derivative financial liabilities | (246,983) | (300,580) |
Total liabilities | (567,040) | (596,345) |
Quoted market prices (Level 1) | At fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading portfolio assets | 73,307 | 60,619 |
Financial assets at fair value through the income statement | 1,089 | 4,439 |
Derivative financial instruments | 11,643 | 9,154 |
Financial assets at fair value through other comprehensive income | 14,495 | 12,150 |
Investment property | 0 | 0 |
Total assets | 100,534 | 86,362 |
Trading portfolio liabilities | (30,063) | (23,331) |
Financial liabilities designated at fair value | (142) | (159) |
Derivative financial liabilities | (11,227) | (8,762) |
Total liabilities | (41,432) | (32,252) |
Observable inputs (Level 2) | At fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading portfolio assets | 71,285 | 65,182 |
Financial assets at fair value through the income statement | 186,032 | 162,930 |
Derivative financial instruments | 240,830 | 289,071 |
Financial assets at fair value through other comprehensive income | 35,646 | 39,599 |
Investment property | 0 | 0 |
Total assets | 533,793 | 556,782 |
Trading portfolio liabilities | (26,057) | (22,780) |
Financial liabilities designated at fair value | (263,482) | (249,126) |
Derivative financial liabilities | (230,157) | (285,579) |
Total liabilities | (519,696) | (557,485) |
Significant unobservable inputs (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Total assets | 10,266 | 10,886 |
Total liabilities | (5,912) | (6,608) |
Significant unobservable inputs (Level 3) | At fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading portfolio assets | 2,552 | 1,863 |
Financial assets at fair value through the income statement | 4,007 | 4,392 |
Derivative financial instruments | 3,656 | 4,468 |
Financial assets at fair value through other comprehensive income | 43 | 153 |
Investment property | 8 | 10 |
Total assets | 10,266 | 10,886 |
Trading portfolio liabilities | (17) | (28) |
Financial liabilities designated at fair value | (296) | (341) |
Derivative financial liabilities | (5,599) | (6,239) |
Total liabilities | £ (5,912) | £ (6,608) |
Fair value of financial instr_4
Fair value of financial instruments - Level 3 assets and liabilities held at fair value disaggregated by product type (Details) - Significant unobservable inputs (Level 3) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of detailed information about financial instruments [line items] | ||
Assets | £ 10,266 | £ 10,886 |
Liabilities | (5,912) | (6,608) |
Asset backed securities | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 562 | 767 |
Liabilities | 0 | (24) |
Corporate debt | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 981 | 698 |
Liabilities | (38) | (3) |
Reverse repurchase and repurchase agreements | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 0 | 0 |
Liabilities | (161) | (174) |
Non-asset backed loans | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 3,467 | 3,093 |
Liabilities | 0 | 0 |
Equity cash products | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 401 | 542 |
Liabilities | 0 | 0 |
Private equity investments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 98 | 84 |
Liabilities | 0 | 0 |
Other | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 1,101 | 1,234 |
Liabilities | (114) | (168) |
Interest rate derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 916 | 1,613 |
Liabilities | (1,269) | (1,615) |
Foreign exchange derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 151 | 144 |
Liabilities | (129) | (143) |
Credit derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 100 | 196 |
Liabilities | (364) | (351) |
Equity derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 2,489 | 2,497 |
Liabilities | (3,837) | (4,112) |
Commodity derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Assets | 0 | 18 |
Liabilities | £ 0 | £ (18) |
Fair value of financial instr_5
Fair value of financial instruments - Analysis of movements in Level 3 assets and liabilities (Details) - GBP (£) £ in Millions | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | |
Net assets (liabilities) [abstract] | |||
Derivative financial assets | £ 256,129 | £ 302,693 | |
Derivative financial instruments | 246,983 | £ 300,580 | |
Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 10,886 | ||
Ending balance, financial assets | 10,266 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | (6,608) | ||
Ending balance, financial liabilities | (5,912) | ||
Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, Assets (liabilities) net | 4,278 | £ 5,690 | |
Purchases, fair value measurement, assets (liabilities) net | 3,824 | 4,571 | |
Sales, fair value measurement, assets (liabilities) net | (3,405) | (3,249) | |
Issues, fair value measurement, assets (liabilities) net | 0 | (3) | |
Settlements, fair value measurement, assets (liabilities) net | (543) | (723) | |
Total gains or losses recognised in OCI, assets (liabilities) | 1 | (4) | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 458 | 504 | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 174 | (373) | |
Ending balance, Assets (liabilities) net | 4,354 | 6,717 | |
Derivative financial assets | 3,656 | 7,747 | |
Derivative financial instruments | 5,599 | 8,932 | |
Recurring fair value measurement | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (458) | 275 | |
Recurring fair value measurement | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 25 | 29 | |
Recurring fair value measurement | Investment property | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 10 | 13 | |
Purchases, fair value measurement, assets | 0 | 0 | |
Sales, fair value measurement, assets | (2) | (1) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 2 | |
Transfers out of Level 3 of fair value hierarchy, assets | 0 | (2) | |
Ending balance, financial assets | 8 | 10 | |
Recurring fair value measurement | Investment property | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Recurring fair value measurement | Investment property | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | (2) | |
Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, Assets (liabilities) net | (1,771) | (835) | |
Purchases, fair value measurement, assets (liabilities) net | (424) | (688) | |
Sales, fair value measurement, assets (liabilities) net | 1 | 10 | |
Issues, fair value measurement, assets (liabilities) net | 0 | 0 | |
Settlements, fair value measurement, assets (liabilities) net | 54 | (361) | |
Total gains or losses recognised in OCI, assets (liabilities) | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 53 | 302 | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 477 | (33) | |
Ending balance, Assets (liabilities) net | (1,943) | (1,185) | |
Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (336) | 418 | |
Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 3 | 2 | |
Trading portfolio liabilities | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial liabilities | |||
Beginning balance, financial liabilities | (28) | 0 | |
Purchases, fair value measurement, liabilities | (3) | 0 | |
Sales, fair value measurement, liabilities | 14 | 0 | |
Issues, fair value measurement, liabilities | 0 | 0 | |
Settlements, fair value measurement, liabilities | 0 | 0 | |
Total gains or losses recognised in OCI, liabilities | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, liabilities | 0 | 0 | |
Transfers out of Level 3 of fair value hierarchy, liabilities | 7 | 0 | |
Ending balance, financial liabilities | (17) | 0 | |
Trading portfolio liabilities | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial liabilities at fair value through profit or loss, category trading | |||
Financial liabilities | |||
Total gains and losses in the period recognised in the income statement, liabilities | (7) | 0 | |
Trading portfolio liabilities | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial liabilities at fair value through profit or loss, category other income | |||
Financial liabilities | |||
Total gains and losses in the period recognised in the income statement, liabilities | 0 | 0 | |
Financial liabilities designated at fair value | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial liabilities | |||
Beginning balance, financial liabilities | (341) | (343) | |
Purchases, fair value measurement, liabilities | 0 | 0 | |
Sales, fair value measurement, liabilities | 0 | 0 | |
Issues, fair value measurement, liabilities | 0 | (3) | |
Settlements, fair value measurement, liabilities | 98 | 0 | |
Total gains or losses recognised in OCI, liabilities | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, liabilities | (78) | (22) | |
Transfers out of Level 3 of fair value hierarchy, liabilities | 18 | 26 | |
Ending balance, financial liabilities | (296) | (355) | |
Financial liabilities designated at fair value | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial liabilities at fair value through profit or loss, category trading | |||
Financial liabilities | |||
Total gains and losses in the period recognised in the income statement, liabilities | 7 | (12) | |
Financial liabilities designated at fair value | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial liabilities at fair value through profit or loss, category other income | |||
Financial liabilities | |||
Total gains and losses in the period recognised in the income statement, liabilities | 0 | (1) | |
Asset backed securities | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 767 | ||
Ending balance, financial assets | 562 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | (24) | ||
Ending balance, financial liabilities | 0 | ||
Interest rate derivatives | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 1,613 | ||
Ending balance, financial assets | 916 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | (1,615) | ||
Ending balance, financial liabilities | (1,269) | ||
Interest rate derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, Assets (liabilities) net | (2) | (206) | |
Purchases, fair value measurement, assets (liabilities) net | 9 | 17 | |
Sales, fair value measurement, assets (liabilities) net | 0 | 0 | |
Issues, fair value measurement, assets (liabilities) net | 0 | 0 | |
Settlements, fair value measurement, assets (liabilities) net | 33 | 10 | |
Total gains or losses recognised in OCI, assets (liabilities) | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 21 | 300 | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | (296) | (10) | |
Ending balance, Assets (liabilities) net | (352) | 380 | |
Interest rate derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (121) | 268 | |
Interest rate derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 4 | 1 | |
Foreign exchange derivatives | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 144 | ||
Ending balance, financial assets | 151 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | (143) | ||
Ending balance, financial liabilities | (129) | ||
Foreign exchange derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, Assets (liabilities) net | 1 | (7) | |
Purchases, fair value measurement, assets (liabilities) net | 0 | 0 | |
Sales, fair value measurement, assets (liabilities) net | 0 | 0 | |
Issues, fair value measurement, assets (liabilities) net | 0 | 0 | |
Settlements, fair value measurement, assets (liabilities) net | 58 | (12) | |
Total gains or losses recognised in OCI, assets (liabilities) | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 3 | 5 | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | (34) | (8) | |
Ending balance, Assets (liabilities) net | 22 | 67 | |
Foreign exchange derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (6) | 89 | |
Foreign exchange derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |
Credit derivatives | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 196 | ||
Ending balance, financial assets | 100 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | (351) | ||
Ending balance, financial liabilities | (364) | ||
Credit derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, Assets (liabilities) net | (155) | 198 | |
Purchases, fair value measurement, assets (liabilities) net | (118) | (258) | |
Sales, fair value measurement, assets (liabilities) net | 2 | 11 | |
Issues, fair value measurement, assets (liabilities) net | 0 | 0 | |
Settlements, fair value measurement, assets (liabilities) net | (5) | (376) | |
Total gains or losses recognised in OCI, assets (liabilities) | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 1 | 2 | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | (1) | 8 | |
Ending balance, Assets (liabilities) net | (265) | (263) | |
Credit derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 12 | 151 | |
Credit derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (1) | 1 | |
Equity derivatives | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 2,497 | ||
Ending balance, financial assets | 2,489 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | (4,112) | ||
Ending balance, financial liabilities | (3,837) | ||
Equity derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, Assets (liabilities) net | (1,615) | (820) | |
Purchases, fair value measurement, assets (liabilities) net | (315) | (447) | |
Sales, fair value measurement, assets (liabilities) net | (1) | (1) | |
Issues, fair value measurement, assets (liabilities) net | 0 | 0 | |
Settlements, fair value measurement, assets (liabilities) net | (32) | 17 | |
Total gains or losses recognised in OCI, assets (liabilities) | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 28 | (5) | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 808 | (23) | |
Ending balance, Assets (liabilities) net | (1,348) | (1,369) | |
Equity derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (221) | (90) | |
Equity derivatives | Recurring fair value measurement | Net derivative financial instruments | Significant unobservable inputs (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |
Commodity derivatives | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 18 | ||
Ending balance, financial assets | 0 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | (18) | ||
Ending balance, financial liabilities | 0 | ||
Corporate debt | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 698 | ||
Ending balance, financial assets | 981 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | (3) | ||
Ending balance, financial liabilities | (38) | ||
Non-asset backed loans | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 3,093 | ||
Ending balance, financial assets | 3,467 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | 0 | ||
Ending balance, financial liabilities | 0 | ||
Equity cash products | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 542 | ||
Ending balance, financial assets | 401 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | 0 | ||
Ending balance, financial liabilities | 0 | ||
Private equity investments | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 84 | ||
Ending balance, financial assets | 98 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | 0 | ||
Ending balance, financial liabilities | 0 | ||
Other | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 1,234 | ||
Ending balance, financial assets | 1,101 | ||
Financial liabilities | |||
Beginning balance, financial liabilities | (168) | ||
Ending balance, financial liabilities | (114) | ||
Trading portfolio assets | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 1,863 | 2,264 | |
Purchases, fair value measurement, assets | 1,071 | 2,250 | |
Sales, fair value measurement, assets | (529) | (968) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (135) | (80) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 398 | 178 | |
Transfers out of Level 3 of fair value hierarchy, assets | (175) | (352) | |
Ending balance, financial assets | 2,552 | 3,078 | |
Trading portfolio assets | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 59 | (214) | |
Trading portfolio assets | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Trading portfolio assets | Asset backed securities | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 686 | 656 | |
Purchases, fair value measurement, assets | 112 | 249 | |
Sales, fair value measurement, assets | (294) | (224) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | (76) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 43 | 41 | |
Transfers out of Level 3 of fair value hierarchy, assets | (48) | (11) | |
Ending balance, financial assets | 489 | 623 | |
Trading portfolio assets | Asset backed securities | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | (10) | (12) | |
Trading portfolio assets | Asset backed securities | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Trading portfolio assets | Corporate debt | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 151 | 120 | |
Purchases, fair value measurement, assets | 305 | 25 | |
Sales, fair value measurement, assets | (87) | 0 | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 40 | 4 | |
Transfers out of Level 3 of fair value hierarchy, assets | (11) | (17) | |
Ending balance, financial assets | 423 | 106 | |
Trading portfolio assets | Corporate debt | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 25 | (26) | |
Trading portfolio assets | Corporate debt | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Trading portfolio assets | Non-asset backed loans | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 709 | 974 | |
Purchases, fair value measurement, assets | 620 | 1,927 | |
Sales, fair value measurement, assets | (131) | (740) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (84) | (4) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 124 | 97 | |
Transfers out of Level 3 of fair value hierarchy, assets | (106) | (320) | |
Ending balance, financial assets | 1,145 | 1,823 | |
Trading portfolio assets | Non-asset backed loans | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 13 | (111) | |
Trading portfolio assets | Non-asset backed loans | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Trading portfolio assets | Equity cash products | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 214 | 392 | |
Purchases, fair value measurement, assets | 13 | 2 | |
Sales, fair value measurement, assets | (17) | (4) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 29 | 28 | |
Transfers out of Level 3 of fair value hierarchy, assets | (9) | (4) | |
Ending balance, financial assets | 262 | 347 | |
Trading portfolio assets | Equity cash products | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 32 | (67) | |
Trading portfolio assets | Equity cash products | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Trading portfolio assets | Other | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 103 | 122 | |
Purchases, fair value measurement, assets | 21 | 47 | |
Sales, fair value measurement, assets | 0 | 0 | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (51) | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 162 | 8 | |
Transfers out of Level 3 of fair value hierarchy, assets | (1) | 0 | |
Ending balance, financial assets | 233 | 179 | |
Trading portfolio assets | Other | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | (1) | 2 | |
Trading portfolio assets | Other | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Financial assets at fair value through the income statement | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 4,392 | 4,162 | |
Purchases, fair value measurement, assets | 3,180 | 2,930 | |
Sales, fair value measurement, assets | (2,889) | (2,289) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (555) | (125) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 85 | 44 | |
Transfers out of Level 3 of fair value hierarchy, assets | (47) | (12) | |
Ending balance, financial assets | 4,007 | 4,822 | |
Financial assets at fair value through the income statement | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | (181) | 82 | |
Financial assets at fair value through the income statement | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 22 | 30 | |
Financial assets at fair value through the income statement | Non-asset backed loans | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 2,280 | 1,964 | |
Purchases, fair value measurement, assets | 696 | 1,050 | |
Sales, fair value measurement, assets | (299) | (270) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (388) | (112) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 69 | 0 | |
Transfers out of Level 3 of fair value hierarchy, assets | (47) | 0 | |
Ending balance, financial assets | 2,321 | 2,742 | |
Financial assets at fair value through the income statement | Non-asset backed loans | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 10 | 110 | |
Financial assets at fair value through the income statement | Non-asset backed loans | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Financial assets at fair value through the income statement | Equity cash products | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 320 | 835 | |
Purchases, fair value measurement, assets | 166 | 14 | |
Sales, fair value measurement, assets | (194) | 0 | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |
Transfers out of Level 3 of fair value hierarchy, assets | 0 | 0 | |
Ending balance, financial assets | 139 | 798 | |
Financial assets at fair value through the income statement | Equity cash products | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | (171) | (22) | |
Financial assets at fair value through the income statement | Equity cash products | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 18 | (29) | |
Financial assets at fair value through the income statement | Private equity investments | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 88 | 113 | |
Purchases, fair value measurement, assets | 22 | 1 | |
Sales, fair value measurement, assets | (7) | (2) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (7) | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 20 | |
Transfers out of Level 3 of fair value hierarchy, assets | 0 | (12) | |
Ending balance, financial assets | 98 | 126 | |
Financial assets at fair value through the income statement | Private equity investments | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | (1) | 2 | |
Financial assets at fair value through the income statement | Private equity investments | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 3 | 4 | |
Financial assets at fair value through the income statement | Other | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 1,704 | 1,250 | |
Purchases, fair value measurement, assets | 2,296 | 1,865 | |
Sales, fair value measurement, assets | (2,389) | (2,017) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (160) | (13) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 16 | 24 | |
Transfers out of Level 3 of fair value hierarchy, assets | 0 | 0 | |
Ending balance, financial assets | 1,449 | 1,156 | |
Financial assets at fair value through the income statement | Other | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | (19) | (8) | |
Financial assets at fair value through the income statement | Other | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 1 | 55 | |
Financial assets at fair value through other comprehensive income | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 153 | 429 | |
Purchases, fair value measurement, assets | 0 | 79 | |
Sales, fair value measurement, assets | 0 | (1) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (5) | (157) | |
Total gains or losses recognised in OCI, assets | 1 | (4) | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |
Transfers out of Level 3 of fair value hierarchy, assets | (106) | 0 | |
Ending balance, financial assets | 43 | 347 | |
Financial assets at fair value through other comprehensive income | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 1 | |
Financial assets at fair value through other comprehensive income | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Financial assets at fair value through other comprehensive income | Asset backed securities | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 47 | 86 | |
Purchases, fair value measurement, assets | 0 | 0 | |
Sales, fair value measurement, assets | 0 | (1) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (5) | 0 | |
Total gains or losses recognised in OCI, assets | 1 | (1) | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |
Transfers out of Level 3 of fair value hierarchy, assets | 0 | 0 | |
Ending balance, financial assets | 43 | 85 | |
Financial assets at fair value through other comprehensive income | Asset backed securities | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 1 | |
Financial assets at fair value through other comprehensive income | Asset backed securities | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Financial assets at fair value through other comprehensive income | Non-asset backed loans | Recurring fair value measurement | Significant unobservable inputs (Level 3) | |||
Financial assets | |||
Beginning balance, financial assets | 106 | 343 | |
Purchases, fair value measurement, assets | 0 | 79 | |
Sales, fair value measurement, assets | 0 | 0 | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | (157) | |
Total gains or losses recognised in OCI, assets | 0 | (3) | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |
Transfers out of Level 3 of fair value hierarchy, assets | (106) | 0 | |
Ending balance, financial assets | 0 | 262 | |
Financial assets at fair value through other comprehensive income | Non-asset backed loans | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Financial assets at fair value through other comprehensive income | Non-asset backed loans | Recurring fair value measurement | Significant unobservable inputs (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Financial assets | |||
Total gains and losses in the period recognised in the income statement, assets | £ 0 | £ 0 |
Fair value of financial instr_6
Fair value of financial instruments - Unrealised gains and losses recognised in the period on Level 3 assets and liabilities held at period end (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Disclosure of detailed information about financial instruments [line items] | ||
Net trading income | £ 3,467 | £ 4,225 |
Other income | 35 | 8 |
Other compre-hensive income | (1,631) | 3,723 |
Significant unobservable inputs (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Net trading income | (398) | 181 |
Other income | 35 | (27) |
Other compre-hensive income | 0 | (2) |
Total | (363) | 152 |
Significant unobservable inputs (Level 3) | Investment properties | ||
Disclosure of detailed information about financial instruments [line items] | ||
Net trading income | 0 | 0 |
Other income | 0 | (2) |
Other compre-hensive income | 0 | 0 |
Total | 0 | (2) |
Significant unobservable inputs (Level 3) | Net derivative financial instruments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Net trading income | (367) | 248 |
Other income | 0 | 0 |
Other compre-hensive income | 0 | 0 |
Total | (367) | 248 |
Trading portfolio liabilities | Significant unobservable inputs (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Net trading income | (6) | 0 |
Other income | 0 | 0 |
Other compre-hensive income | 0 | 0 |
Total | (6) | 0 |
Financial liabilities designated at fair value | Significant unobservable inputs (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Net trading income | 7 | (16) |
Other income | 0 | (1) |
Other compre-hensive income | 0 | 0 |
Total | 7 | (17) |
Trading portfolio assets | Significant unobservable inputs (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Net trading income | 35 | (177) |
Other income | 0 | 0 |
Other compre-hensive income | 0 | 0 |
Total | 35 | (177) |
Financial assets at fair value through the income statement | Significant unobservable inputs (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Net trading income | (67) | 126 |
Other income | 35 | (24) |
Other compre-hensive income | 0 | 0 |
Total | (32) | 102 |
Financial assets at fair value through other comprehensive income | Significant unobservable inputs (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Net trading income | 0 | 0 |
Other income | 0 | 0 |
Other compre-hensive income | 0 | (2) |
Total | £ 0 | £ (2) |
Fair value of financial instr_7
Fair value of financial instruments - Sensitivity analysis of valuations using unobservable inputs (Details) - Recurring fair value measurement - Significant unobservable inputs (Level 3) - GBP (£) | Jun. 30, 2021 | Dec. 31, 2020 |
Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | £ 606,000,000 | £ 633,000,000 |
Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 3,000,000 |
Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (667,000,000) | (740,000,000) |
Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | (3,000,000) |
Corporate debt | Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 22,000,000 | 16,000,000 |
Corporate debt | Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Corporate debt | Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (16,000,000) | (14,000,000) |
Corporate debt | Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Non-asset backed loans | Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 129,000,000 | 104,000,000 |
Non-asset backed loans | Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 3,000,000 |
Non-asset backed loans | Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (172,000,000) | (190,000,000) |
Non-asset backed loans | Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | (3,000,000) |
Equity cash products | Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 122,000,000 | 158,000,000 |
Equity cash products | Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Equity cash products | Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (111,000,000) | (141,000,000) |
Equity cash products | Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Private equity investments | Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 17,000,000 | 15,000,000 |
Private equity investments | Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Private equity investments | Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (18,000,000) | (15,000,000) |
Private equity investments | Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Other | Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 18,000,000 | 21,000,000 |
Other | Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Other | Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (18,000,000) | (21,000,000) |
Other | Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Interest rate derivatives | Favourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 52,000,000 | 82,000,000 |
Interest rate derivatives | Favourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Interest rate derivatives | Unfavourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (83,000,000) | (123,000,000) |
Interest rate derivatives | Unfavourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Foreign exchange derivatives | Favourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 6,000,000 | 6,000,000 |
Foreign exchange derivatives | Favourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Foreign exchange derivatives | Unfavourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (10,000,000) | (11,000,000) |
Foreign exchange derivatives | Unfavourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Credit derivatives | Favourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 53,000,000 | 55,000,000 |
Credit derivatives | Favourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Credit derivatives | Unfavourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (44,000,000) | (44,000,000) |
Credit derivatives | Unfavourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Equity derivatives | Favourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 185,000,000 | 174,000,000 |
Equity derivatives | Favourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Equity derivatives | Unfavourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (193,000,000) | (179,000,000) |
Equity derivatives | Unfavourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Commodity derivatives | Favourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 2,000,000 | 2,000,000 |
Commodity derivatives | Favourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Commodity derivatives | Unfavourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (2,000,000) | (2,000,000) |
Commodity derivatives | Unfavourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | £ 0 | £ 0 |
Fair value of financial instr_8
Fair value of financial instrument - Narrative (Details) - GBP (£) £ in Millions | 6 Months Ended | 12 Months Ended |
Jun. 30, 2021 | Dec. 31, 2020 | |
Disclosure of detailed information about financial instruments [line items] | ||
Deposits at amortised cost | £ 249,732 | £ 244,696 |
Brokered certificates of deposit | ||
Disclosure of detailed information about financial instruments [line items] | ||
Deposits at amortised cost | 1,241 | 1,494 |
Significant unobservable inputs (Level 3) | Favourable changes | ||
Disclosure of detailed information about financial instruments [line items] | ||
Increase in fair value measurement due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, assets (liabilities) | 606 | 636 |
Decrease in fair value measurement due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, assets (liabilities) | 667 | 743 |
Exit price adjustments derived from market bid-offer spreads | ||
Disclosure of detailed information about financial instruments [line items] | ||
Increase Decrease In Derivative Fair Value Adjustments | 9 | |
Fair value adjustments | 492 | 483 |
Uncollateralised derivative funding | ||
Disclosure of detailed information about financial instruments [line items] | ||
Increase Decrease In Derivative Fair Value Adjustments | (35) | |
Fair value adjustments | 80 | 115 |
Derivative credit valuation adjustments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Increase Decrease In Derivative Fair Value Adjustments | (58) | |
Fair value adjustments | 210 | 268 |
Derivative debit valuation adjustments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Increase Decrease In Derivative Fair Value Adjustments | (22) | |
Fair value adjustments | (91) | (113) |
Financial instruments at fair value, category | Significant unobservable inputs (Level 3) | Recurring fair value measurement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 114 | 103 |
Additions, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 32 | 26 |
Amortisation and releases, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 21 | 23 |
Financial instruments at amortised cost, category | Significant unobservable inputs (Level 3) | Recurring fair value measurement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 29 | 30 |
Additions, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 0 | 1 |
Amortisation and releases, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | £ 1 | £ 2 |
Fair value of financial instr_9
Fair value of financial instruments - Fair value adjustments (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Exit price adjustments derived from market bid-offer spreads | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | £ (492) | £ (483) |
Uncollateralised derivative funding | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | (80) | (115) |
Derivative credit valuation adjustments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | (210) | (268) |
Derivative debit valuation adjustments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | £ 91 | £ 113 |
Fair value of financial inst_10
Fair value of financial instruments - Comparison of carrying amounts and fair values for assets and liabilities not held at fair value (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Financial assets | |||
Loans and advances at amortised cost | £ 133,815 | £ 134,267 | |
Reverse repurchase agreements and other similar secured lending | 3,048 | 8,981 | |
Financial liabilities | |||
Deposits at amortised cost | (249,732) | (244,696) | |
Repurchase agreements and other similar secured borrowing | (11,067) | (10,443) | |
Debt securities in issue | (42,931) | (29,423) | |
Subordinated liabilities | (29,045) | (32,005) | £ (33,425) |
Fair value | |||
Financial assets | |||
Loans and advances at amortised cost | 134,228 | 134,537 | |
Reverse repurchase agreements and other similar secured lending | 3,048 | 8,981 | |
Financial liabilities | |||
Deposits at amortised cost | (249,757) | (244,738) | |
Repurchase agreements and other similar secured borrowing | (11,067) | (10,443) | |
Debt securities in issue | (42,925) | (29,486) | |
Subordinated liabilities | (30,515) | (33,356) | |
Gross exposure | |||
Financial assets | |||
Loans and advances at amortised cost | 133,815 | 134,267 | |
Reverse repurchase agreements and other similar secured lending | 3,048 | 8,981 | |
Financial liabilities | |||
Deposits at amortised cost | (249,732) | (244,696) | |
Repurchase agreements and other similar secured borrowing | (11,067) | (10,443) | |
Debt securities in issue | (42,931) | (29,423) | |
Subordinated liabilities | £ (29,045) | £ (32,005) |
Subordinated liabilities (Detai
Subordinated liabilities (Details) - GBP (£) £ in Millions | 6 Months Ended | 12 Months Ended |
Jun. 30, 2021 | Dec. 31, 2020 | |
Subordinated liabilities [abstract] | ||
Opening balance | £ 32,005 | £ 33,425 |
Issuances | 5,075 | 3,856 |
Redemptions | (6,599) | (5,954) |
Other | (1,436) | 678 |
Closing balance | £ 29,045 | £ 32,005 |
Subordinated liabilities - Narr
Subordinated liabilities - Narrative (Details) - GBP (£) £ in Millions | 6 Months Ended | 12 Months Ended |
Jun. 30, 2021 | Dec. 31, 2020 | |
Disclosure of detailed information about borrowings [line items] | ||
Issuances | £ 5,075 | £ 3,856 |
Redemption of subordinated debt | 6,599 | £ 5,954 |
Barclays Bank PLC loans issued intra-group Barclays PLC | Barclays PLC | ||
Disclosure of detailed information about borrowings [line items] | ||
Issuances | 4,920 | |
Redemption of subordinated debt | 2,065 | |
Barclays Bank PLC externally issued | ||
Disclosure of detailed information about borrowings [line items] | ||
Redemption of subordinated debt | 4,534 | |
USD Notes | Fixed interest rate | ||
Disclosure of detailed information about borrowings [line items] | ||
Redemption of subordinated debt | 73 | |
USD Notes | Floating interest rate | ||
Disclosure of detailed information about borrowings [line items] | ||
Issuances | 73 | |
ZAR Notes | Floating interest rate | ||
Disclosure of detailed information about borrowings [line items] | ||
Issuances | 82 | |
10% GBP Notes | Fixed interest rate | ||
Disclosure of detailed information about borrowings [line items] | ||
Redemption of subordinated debt | £ 1,961 | |
Interest rate | 10.00% | |
6% EUR Notes | Fixed interest rate | ||
Disclosure of detailed information about borrowings [line items] | ||
Redemption of subordinated debt | £ 1,339 | |
Interest rate | 6.00% | |
10.179% USD Notes | Fixed interest rate | ||
Disclosure of detailed information about borrowings [line items] | ||
Redemption of subordinated debt | £ 1,075 | |
Interest rate | 10.179% | |
EUR Notes | Floating interest rate | ||
Disclosure of detailed information about borrowings [line items] | ||
Redemption of subordinated debt | £ 86 |
Provisions - Total provisions (
Provisions - Total provisions (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of other provisions [line items] | ||
Provisions | £ 951 | £ 1,208 |
Customer redress | ||
Disclosure of other provisions [line items] | ||
Provisions | 51 | 44 |
Legal, competition and regulatory matters | ||
Disclosure of other provisions [line items] | ||
Provisions | 207 | 222 |
Redundancy and restructuring | ||
Disclosure of other provisions [line items] | ||
Provisions | 22 | 44 |
Undrawn contractually committed facilities and guarantees | ||
Disclosure of other provisions [line items] | ||
Provisions | 572 | 769 |
Onerous contracts | ||
Disclosure of other provisions [line items] | ||
Provisions | 4 | 6 |
Sundry provisions | ||
Disclosure of other provisions [line items] | ||
Provisions | £ 95 | £ 123 |
Retirement benefits - Narrative
Retirement benefits - Narrative (Details) - GBP (£) £ in Billions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of fair value of plan assets [line items] | ||
Surplus in plan | £ 2.4 | £ 1.6 |
Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | Pension defined benefit plans | United Kingdom | ||
Disclosure of fair value of plan assets [line items] | ||
Surplus in plan | £ 2.6 | £ 1.8 |
Retirement benefits - UKRF fund
Retirement benefits - UKRF funding valuations (Narrative) (Details) - GBP (£) £ in Millions | 1 Months Ended | 6 Months Ended | |||
Apr. 30, 2021 | Jun. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Sep. 30, 2019 | |
Disclosure of fair value of plan assets [line items] | |||||
Deficit in plan | £ (2,400) | £ (1,600) | |||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | |||||
Disclosure of fair value of plan assets [line items] | |||||
Deficit in plan | (2,600) | £ (1,800) | |||
Employer contributions | £ 350 | 1,000 | |||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | Deficit contributions valuation recovery plan 2019 | |||||
Disclosure of fair value of plan assets [line items] | |||||
Deficit in plan | £ 2,300 | ||||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | Deficit contributions valuation recovery plan 2020 | |||||
Disclosure of fair value of plan assets [line items] | |||||
Deficit in plan | £ 900 | ||||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | 2021 | Barclays Bank PLC | |||||
Disclosure of fair value of plan assets [line items] | |||||
Employer contributions | 700 | ||||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | 2022 | Barclays Bank PLC | |||||
Disclosure of fair value of plan assets [line items] | |||||
Employer contributions | 294 | ||||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | 2023 | Barclays Bank PLC | |||||
Disclosure of fair value of plan assets [line items] | |||||
Employer contributions | 286 | ||||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | Later than one month and not later than three months | |||||
Disclosure of fair value of plan assets [line items] | |||||
Estimate of contributions expected to be paid to plan for next annual reporting period | £ 350 |
Called up share capital - Narra
Called up share capital - Narrative (Details) £ / shares in Units, £ in Millions | Jun. 30, 2021GBP (£)£ / sharesshares | Jun. 30, 2021€ / shares | Jun. 30, 2021$ / shares | Dec. 31, 2020GBP (£)£ / sharesshares |
Ordinary shares | ||||
Number of shares issued (in shares) | 2,342,000,000 | 2,342,000,000 | ||
Par value per share | £ / shares | £ 1 | £ 1 | ||
Preference share capital | ||||
Called up share capital | £ | £ 6 | £ 6 | ||
Sterling 1 Preference Shares | ||||
Number of shares issued (in shares) | 1,000 | 1,000 | ||
Par value per share | £ / shares | £ 1 | |||
Euro Preference Shares | ||||
Number of shares issued (in shares) | 31,856 | 31,856 | ||
Par value per share | € / shares | € 100 | |||
US Dollar Preference Shares $100 | ||||
Number of shares issued (in shares) | 58,133 | 58,133 | ||
Par value per share | $ / shares | $ 100 |
Other equity instruments (Detai
Other equity instruments (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2019 | |||
Equity | £ 53,696 | £ 53,710 | £ 56,694 | £ 50,615 | |||
Other equity instruments | |||||||
Equity | £ 8,621 | [1] | £ 8,621 | [1] | £ 8,323 | [1] | £ 8,323 |
[1] | Details of share capital, other equity instruments and other reserves are shown on pages 40 to 41. |
Other reserves (Details)
Other reserves (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of reserves within equity [line items] | ||
Other reserves | £ 1,449 | £ 3,183 |
Currency translation reserve | ||
Disclosure of reserves within equity [line items] | ||
Other reserves | 2,184 | 2,736 |
Fair value through other comprehensive income reserve | ||
Disclosure of reserves within equity [line items] | ||
Other reserves | (68) | 244 |
Cash flow hedging reserve | ||
Disclosure of reserves within equity [line items] | ||
Other reserves | 358 | 1,181 |
Own credit reserve | ||
Disclosure of reserves within equity [line items] | ||
Other reserves | (1,001) | (954) |
Other reserves | ||
Disclosure of reserves within equity [line items] | ||
Other reserves | £ (24) | £ (24) |
Other reserves - Narrative (Det
Other reserves - Narrative (Details) - GBP (£) £ in Millions | 6 Months Ended | |||
Jun. 30, 2021 | Dec. 30, 2020 | Jun. 30, 2020 | Dec. 31, 2020 | |
Disclosure of reserves within equity [line items] | ||||
Other reserves | £ 1,449 | £ 3,183 | ||
Other | (2) | £ (12) | £ 1 | |
Currency translation reserve | ||||
Disclosure of reserves within equity [line items] | ||||
Other reserves | 2,184 | 2,736 | ||
Movements | (552) | |||
Fair value through other comprehensive income reserve | ||||
Disclosure of reserves within equity [line items] | ||||
Other reserves | (68) | 244 | ||
Movements | 312 | |||
Changes in fair value | (303) | |||
Net gains transferred to net profits | 151 | |||
Reversal of impairment loss recognised in other comprehensive income | 5 | |||
Tax credit | (147) | |||
Cash flow hedging reserve | ||||
Disclosure of reserves within equity [line items] | ||||
Other reserves | 358 | 1,181 | ||
Movements | 823 | |||
Changes in fair value | (931) | |||
Net gains transferred to net profits | 143 | |||
Tax credit | (256) | |||
Own credit reserve | ||||
Disclosure of reserves within equity [line items] | ||||
Other reserves | (1,001) | (954) | ||
Movements | (47) | |||
Tax credit | (115) | |||
Loss on change in value of foreign currency basis spreads, before tax | 266 | |||
Other | 100 | |||
Other reserves | ||||
Disclosure of reserves within equity [line items] | ||||
Other reserves | £ (24) | £ (24) |
Contingent liabilities and co_3
Contingent liabilities and commitments (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Contingent liabilities | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | £ 20,406 | £ 20,932 |
Commitments | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | 283,759 | 265,022 |
Guarantees and letters of credit pledged as collateral security | Contingent liabilities | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | 13,805 | 15,138 |
Performance guarantees, acceptances and endorsements | Contingent liabilities | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | 6,601 | 5,794 |
Documentary credits and other short-term trade related transactions | Commitments | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | 1,017 | 1,086 |
Standby facilities, credit lines and other commitments | Commitments | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | £ 282,742 | £ 263,936 |
Legal, competition and regula_2
Legal, competition and regulatory matters (Details) € in Millions, £ in Millions, SFr in Millions, $ in Millions | 1 Months Ended | 5 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||||
Jun. 30, 2021USD ($) | Apr. 30, 2021USD ($) | Jun. 30, 2019settlement | May 31, 2019EUR (€)settlement | Jan. 31, 2017CHF (SFr) | May 31, 2021USD ($) | Jun. 30, 2021GBP (£)lawsuitssettlementdefendantplaintiff | Jun. 30, 2020GBP (£) | Dec. 31, 2020USD ($)pensionFunddefendant | Dec. 31, 2018GBP (£) | Dec. 31, 2018USD ($) | Dec. 31, 2016lawsuits | Dec. 31, 2015USD ($)settlement | Dec. 31, 2013GBP (£) | Dec. 31, 2012USD ($)lawsuits | Dec. 31, 2008USD ($)agreement | Dec. 31, 2007lawsuits | Aug. 31, 2020GBP (£) | |
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Losses on litigation settlements | £ | £ 87 | £ 19 | ||||||||||||||||
USD LIBOR Cases in MDL Court | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of settlements | settlement | 2 | |||||||||||||||||
Sterling LIBOR case in SDNY | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of lawsuits with damages sought | 2 | |||||||||||||||||
Foreign Exchange investigations | Fines settlement | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of settlements | settlement | 2 | 2 | ||||||||||||||||
Losses on litigation settlements | € | € 210 | |||||||||||||||||
Foreign Exchange investigations | Violation of NPA | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Losses on litigation settlements | SFr | SFr 27 | |||||||||||||||||
US residential and commercial mortgage-related activity and litigation | RMBS repurchase requests | Originated and sold to third parties by Acquired Subsidiary | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of lawsuits with damages sought | 2 | 4 | ||||||||||||||||
Number of settlements | settlement | 2 | |||||||||||||||||
Number of lawsuits dismissed | settlement | 1 | |||||||||||||||||
US residential and commercial mortgage-related activity and litigation | Legacy RMBS purchases | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Asset-backed debt instruments held | $ | $ 22 | |||||||||||||||||
Number of defendants | defendant | 6 | |||||||||||||||||
US residential and commercial mortgage-related activity and litigation | Legacy RMBS purchases | NEW MEXICO | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of retirement benefit funds | pensionFund | 2 | |||||||||||||||||
Civil actions in respect of VRDO | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of lawsuits with damages sought | 2 | |||||||||||||||||
Civil actions in respect of VRDO - SNDY | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of lawsuits with damages sought | 3 | |||||||||||||||||
Number of lawsuits consolidated | 2 | |||||||||||||||||
Government and agency securities civil actions and related matters | Barclays Capital Inc | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Losses on litigation settlements | $ | $ 87 | |||||||||||||||||
Civil actions in respect of the US Anti-Terrorism Act | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of lawsuits with damages sought | 6 | |||||||||||||||||
Number of plaintiffs | plaintiff | 4,000 | |||||||||||||||||
Number of lawsuits dismissed | 3 | |||||||||||||||||
Number of lawsuits subject to appeal | 1 | |||||||||||||||||
HMRC assessments concerning UK VAT | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Loss Contingency, Damages sought, claimed amounts, Value | £ | £ 181 | |||||||||||||||||
HMRC assessments concerning UK VAT | Barclays UK PLC | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Loss Contingency, Damages sought, claimed amounts, Value | £ | 128 | |||||||||||||||||
Civil actions in respect of the US Anti-Terrorism Act - SDNY | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of lawsuits with damages sought | 2 | |||||||||||||||||
Number of lawsuits dismissed | 1 | |||||||||||||||||
Supranational, Sovereign and Agency bonds civil actions | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of lawsuits dismissed | 1 | |||||||||||||||||
CFS remediation of ASL loans | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Expected reimbursement, other provisions | £ | £ 37 | |||||||||||||||||
LIBOR local authority civil action | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of defendants | defendant | 1 | |||||||||||||||||
Non-US forex civil actions | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of lawsuits with damages sought | 2 | |||||||||||||||||
Barclays Bank PLC | FCA Proceedings and other investigations | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of advisory service agreements | agreement | 2 | |||||||||||||||||
Loss contingency, financial penalty warning | £ | £ 50 | |||||||||||||||||
Barclays Bank PLC | USD LIBOR Cases in MDL Court | Lawsuits with damages sought | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Number of lawsuits with damages sought | 3 | |||||||||||||||||
Loss Contingency, Damages sought, claimed amounts, Value | $ | $ 100 | |||||||||||||||||
Barclays Bank PLC | USD LIBOR Cases in MDL Court | Exchange-based class claims | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Losses on litigation settlements | $ | $ 7.5 | $ 7.1 | ||||||||||||||||
Barclays Bank PLC | USD LIBOR Cases in MDL Court | Debt securities class claims | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Losses on litigation settlements | $ | $ 20 | |||||||||||||||||
Barclays Bank PLC | Foreign Exchange investigations | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Losses on litigation settlements | $ | $ 2,380 | |||||||||||||||||
Barclays Bank PLC | Consolidated FX Action | Barclays Capital Inc | Securities and Exchange Commission | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Losses on litigation settlements | $ | $ 384 | |||||||||||||||||
Barclays Bank PLC | US residential and commercial mortgage-related activity and litigation | RMBS repurchase requests | Originated and sold to third parties by Acquired Subsidiary | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Original unpaid principal balance at time of sale | $ | $ 2,100 | |||||||||||||||||
Barclays Bank PLC | Government and agency securities civil actions and related matters | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Losses on litigation settlements | $ | $ 5.7 | |||||||||||||||||
Barclays Bank PLC | BDC Finance LLC | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Litigation settlements approved, value | $ | $ 3.3 | $ 298 | ||||||||||||||||
Barclays Bank PLC | HMRC assessments concerning UK VAT | ||||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||||
Loss Contingency, Damages sought, claimed amounts, Value | £ | £ 53 |
Related party transactions - Am
Related party transactions - Amounts included in the Barclays Bank Group's financial statements with other Barclays Group companies (Details) - GBP (£) £ in Millions | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | |
Disclosure of transactions between related parties [line items] | |||
Total income | £ 8,189 | £ 8,637 | |
Operating expenses | (5,146) | (4,567) | |
Total assets | 1,064,337 | £ 1,059,731 | |
Total liabilities | 1,010,641 | 1,006,021 | |
Parent | |||
Disclosure of transactions between related parties [line items] | |||
Total income | (304) | (346) | |
Operating expenses | (31) | (34) | |
Total assets | 6,311 | 6,803 | |
Total liabilities | 28,201 | 25,819 | |
Fellow subsidiaries | |||
Disclosure of transactions between related parties [line items] | |||
Total income | 10 | 31 | |
Operating expenses | (1,560) | £ (1,443) | |
Total assets | 1,672 | 1,917 | |
Total liabilities | £ 3,779 | £ 3,954 |
Barclays Bank PLC parent cond_3
Barclays Bank PLC parent condensed balance sheet (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2019 |
Assets | ||||
Cash and balances at central banks | £ 163,804 | £ 155,902 | ||
Cash collateral and settlement balances | 108,536 | 97,616 | ||
Loans and advances at amortised cost | 133,815 | 134,267 | ||
Reverse repurchase agreements and other similar secured lending | 3,048 | 8,981 | ||
Trading portfolio assets | 147,144 | 127,664 | ||
Financial assets at fair value through the income statement | 191,128 | 171,761 | ||
Derivative financial instruments | 256,129 | 302,693 | ||
Financial assets at fair value through other comprehensive income | 50,184 | 51,902 | ||
Investments in associates and joint ventures | 22 | 24 | ||
Goodwill and intangible assets | 1,453 | 1,154 | ||
Property, plant and equipment | 1,193 | 1,537 | ||
Current tax assets | 500 | 424 | ||
Deferred tax assets | 2,362 | 2,552 | ||
Retirement benefit assets | 2,701 | 1,814 | ||
Other assets | 2,318 | 1,440 | ||
Total assets | 1,064,337 | 1,059,731 | ||
Liabilities | ||||
Deposits at amortised cost | 249,732 | 244,696 | ||
Cash collateral and settlement balances | 100,957 | 85,549 | ||
Repurchase agreements and other similar secured borrowing | 11,067 | 10,443 | ||
Debt securities in issue | 42,931 | 29,423 | ||
Subordinated liabilities | 29,045 | 32,005 | £ 33,425 | |
Trading portfolio liabilities | 56,137 | 46,139 | ||
Financial liabilities designated at fair value | 263,920 | 249,626 | ||
Derivative financial instruments | 246,983 | 300,580 | ||
Current tax liabilities | 586 | 644 | ||
Deferred tax liabilities | 29 | 225 | ||
Retirement benefit liabilities | 275 | 232 | ||
Other liabilities | 8,028 | 5,251 | ||
Provisions | 951 | 1,208 | ||
Total liabilities | 1,010,641 | 1,006,021 | ||
Equity | ||||
Called up share capital and share premium | 2,348 | 2,348 | ||
Other equity instruments | 8,621 | 8,621 | ||
Other reserves | 1,449 | 3,183 | ||
Retained earnings | 41,278 | 39,558 | ||
Total equity | 53,696 | 53,710 | £ 56,694 | £ 50,615 |
Total liabilities and equity | 1,064,337 | 1,059,731 | ||
Barclays Bank PLC | ||||
Assets | ||||
Cash and balances at central banks | 139,089 | 133,386 | ||
Cash collateral and settlement balances | 85,357 | 87,723 | ||
Loans and advances at amortised cost | 191,048 | 191,538 | ||
Reverse repurchase agreements and other similar secured lending | 5,745 | 11,535 | ||
Trading portfolio assets | 95,985 | 84,089 | ||
Financial assets at fair value through the income statement | 241,198 | 203,073 | ||
Derivative financial instruments | 247,767 | 297,129 | ||
Financial assets at fair value through other comprehensive income | 48,618 | 50,308 | ||
Investments in associates and joint ventures | 12 | 13 | ||
Investment in subsidiaries | 19,168 | 17,780 | ||
Goodwill and intangible assets | 109 | 112 | ||
Property, plant and equipment | 149 | 425 | ||
Current tax assets | 566 | 545 | ||
Deferred tax assets | 1,122 | 1,171 | ||
Retirement benefit assets | 2,652 | 1,812 | ||
Other assets | 1,652 | 913 | ||
Total assets | 1,080,237 | 1,081,552 | ||
Liabilities | ||||
Deposits at amortised cost | 271,293 | 272,190 | ||
Cash collateral and settlement balances | 69,758 | 68,862 | ||
Repurchase agreements and other similar secured borrowing | 18,849 | 27,722 | ||
Debt securities in issue | 30,404 | 17,221 | ||
Subordinated liabilities | 28,813 | 31,852 | ||
Trading portfolio liabilities | 54,033 | 48,093 | ||
Financial liabilities designated at fair value | 310,115 | 267,137 | ||
Derivative financial instruments | 238,875 | 292,538 | ||
Current tax liabilities | 390 | 336 | ||
Deferred tax liabilities | 29 | 225 | ||
Retirement benefit liabilities | 113 | 104 | ||
Other liabilities | 5,701 | 3,145 | ||
Provisions | 776 | 984 | ||
Total liabilities | 1,029,149 | 1,030,409 | ||
Equity | ||||
Called up share capital and share premium | 2,348 | 2,348 | ||
Other equity instruments | 13,328 | 13,328 | ||
Other reserves | (541) | 776 | ||
Retained earnings | 35,953 | 34,691 | ||
Total equity | 51,088 | 51,143 | ||
Total liabilities and equity | £ 1,080,237 | £ 1,081,552 |
Credit Risk - Loans and advance
Credit Risk - Loans and advances at amortised cost by product (Details) £ in Millions | Dec. 31, 2021GBP (£) | Jun. 30, 2021GBP (£) | Dec. 31, 2020GBP (£) |
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Provisions | £ 951 | £ 1,208 | |
Provision for credit commitments | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Provisions | 572 | 769 | |
Loans and advances | Financial assets at amortised cost | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 133,815 | £ 134,267 | |
Coverage ratio | 0.029 | 0.036 | |
Loans and advances | Financial assets at amortised cost | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 137,840 | £ 139,333 | |
Loans and advances | Financial assets at amortised cost | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (4,025) | (5,066) | |
Loans and advances | Stage 1 | Financial assets at amortised cost | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 116,049 | £ 111,119 | |
Coverage ratio | 0.007 | 0.006 | |
Loans and advances | Stage 1 | Financial assets at amortised cost | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 116,858 | £ 111,804 | |
Loans and advances | Stage 1 | Financial assets at amortised cost | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (809) | (685) | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 15,857 | £ 20,498 | |
Coverage ratio | 0.068 | 0.085 | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 14,608 | £ 18,325 | |
Coverage ratio | 0.066 | 0.081 | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 678 | £ 1,346 | |
Coverage ratio | 0.061 | 0.110 | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 571 | £ 827 | |
Coverage ratio | 0.119 | 0.144 | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 17,008 | £ 22,410 | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 15,638 | 19,932 | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 722 | 1,512 | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 648 | 966 | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (1,151) | (1,912) | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (1,030) | (1,607) | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (44) | (166) | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (77) | (139) | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 1,909 | £ 2,650 | |
Coverage ratio | 0.520 | 0.482 | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 3,974 | £ 5,119 | |
Loans and advances | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (2,065) | (2,469) | |
Home loans | Financial assets at amortised cost | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 11,012 | £ 11,193 | |
Coverage ratio | 0.034 | 0.037 | |
Home loans | Financial assets at amortised cost | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 11,399 | £ 11,627 | |
Home loans | Financial assets at amortised cost | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (387) | (434) | |
Home loans | Stage 1 | Financial assets at amortised cost | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 9,568 | £ 9,621 | |
Coverage ratio | 0.001 | 0.001 | |
Home loans | Stage 1 | Financial assets at amortised cost | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 9,575 | £ 9,627 | |
Home loans | Stage 1 | Financial assets at amortised cost | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (7) | (6) | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 768 | £ 849 | |
Coverage ratio | 0.048 | 0.058 | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 606 | £ 721 | |
Coverage ratio | 0.058 | 0.053 | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 20 | £ 47 | |
Coverage ratio | 0.048 | 0.113 | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 142 | £ 81 | |
Coverage ratio | 0.007 | 0.069 | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 807 | £ 901 | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 643 | 761 | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 21 | 53 | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 143 | 87 | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (39) | (52) | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (37) | (40) | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (1) | (6) | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (1) | (6) | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 676 | £ 723 | |
Coverage ratio | 0.335 | 0.342 | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 1,017 | £ 1,099 | |
Home loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (341) | (376) | |
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 23,216 | £ 23,368 | |
Coverage ratio | 0.095 | 0.113 | |
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 25,663 | £ 26,347 | |
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (2,447) | (2,979) | |
Credit cards, unsecured loans and other retail lending | Stage 1 | Financial assets at amortised cost | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 20,587 | £ 18,524 | |
Coverage ratio | 0.029 | 0.021 | |
Credit cards, unsecured loans and other retail lending | Stage 1 | Financial assets at amortised cost | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 21,196 | £ 18,923 | |
Credit cards, unsecured loans and other retail lending | Stage 1 | Financial assets at amortised cost | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (609) | (399) | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 2,069 | £ 4,244 | |
Coverage ratio | 0.274 | 0.238 | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 1,864 | £ 3,895 | |
Coverage ratio | 0.266 | 0.219 | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 139 | £ 282 | |
Coverage ratio | 0.215 | 0.282 | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 66 | £ 67 | |
Coverage ratio | 0.500 | 0.649 | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 2,850 | £ 5,571 | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 2,541 | 4,987 | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 177 | 393 | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 132 | 191 | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (781) | (1,327) | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (677) | (1,092) | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (38) | (111) | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (66) | (124) | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 560 | £ 600 | |
Coverage ratio | 0.654 | 0.676 | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 1,617 | £ 1,853 | |
Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (1,057) | (1,253) | |
Wholesale loans | Financial assets at amortised cost | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 99,587 | £ 99,706 | |
Coverage ratio | 0.012 | 0.016 | |
Wholesale loans | Financial assets at amortised cost | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 100,778 | £ 101,359 | |
Wholesale loans | Financial assets at amortised cost | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (1,191) | (1,653) | |
Wholesale loans | Stage 1 | Financial assets at amortised cost | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 85,894 | £ 82,974 | |
Coverage ratio | 0.002 | 0.003 | |
Wholesale loans | Stage 1 | Financial assets at amortised cost | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 86,087 | £ 83,254 | |
Wholesale loans | Stage 1 | Financial assets at amortised cost | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (193) | (280) | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 13,020 | £ 15,405 | |
Coverage ratio | 0.025 | 0.033 | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 12,138 | £ 13,709 | |
Coverage ratio | 0.025 | 0.033 | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 519 | £ 1,017 | |
Coverage ratio | 0.010 | 0.046 | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 363 | £ 679 | |
Coverage ratio | 0.027 | 0.013 | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 13,351 | £ 15,938 | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 12,454 | 14,184 | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 524 | 1,066 | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Gross exposure | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 373 | 688 | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (331) | (533) | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | Not past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (316) | (475) | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | Not later than 30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (5) | (49) | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 2 | Impairment allowance | >30 days past due | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (10) | (9) | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 673 | £ 1,327 | |
Coverage ratio | 0.498 | 0.388 | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 1,340 | £ 2,167 | |
Wholesale loans | Lifetime expected credit losses | Financial assets at amortised cost | Stage 3 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (667) | (840) | |
Impairment charge on other financial assets | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 159,900 | 150,300 | |
Impairment charge on other financial assets | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (102) | (145) | |
Impairment charge on other financial assets | Stage 1 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 159,800 | 146,300 | |
Impairment charge on other financial assets | Stage 1 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (7) | (7) | |
Impairment charge on other financial assets | Lifetime expected credit losses | Stage 3 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ 132 | 94 | 132 |
Financial assets at fair value through other comprehensive income | Lifetime expected credit losses | Stage 2 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 34 | 3,800 | |
Financial assets at fair value through other comprehensive income | Lifetime expected credit losses | Stage 2 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | (1) | (6) | |
Other assets | Lifetime expected credit losses | Stage 3 | Gross exposure | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | 94 | 132 | |
Other assets | Lifetime expected credit losses | Stage 3 | Impairment allowance | |||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||
Financial assets | £ (94) | £ (132) |
Credit Risk - Movement in impai
Credit Risk - Movement in impairment allowance on loans and advances at amortised cost - incl ECL recon (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||
Income statement release for the period | £ (288) | £ 2,674 |
Loans and advances | ||
Loans and advances at amortised cost | ||
Opening balance | 5,835 | |
Ending balance | 4,597 | |
Home loans | ||
Loans and advances at amortised cost | ||
Opening balance | 434 | |
Ending balance | 387 | |
Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Opening balance | 3,069 | |
Ending balance | 2,532 | |
Wholesale loans | ||
Loans and advances at amortised cost | ||
Opening balance | 2,332 | |
Ending balance | 1,678 | |
Gross exposure | Home loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (6) | |
Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,123 | |
Gross exposure | Wholesale loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,572 | |
Impairment allowance | Home loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |
Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (5) | |
Impairment allowance | Wholesale loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (205) | |
Impairment allowance | Impairment charge on loan commitments and other financial guarantees | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||
Income statement release for the period | (185) | |
Impairment allowance | Impairment charge on other financial assets | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||
Income statement release for the period | (14) | |
Financial assets at amortised cost | Loans and advances | ||
Loans and advances at amortised cost | ||
Disposals | 0 | |
Write-offs | 606 | £ 643 |
Financial assets at amortised cost | Gross exposure | Home loans | ||
Loans and advances at amortised cost | ||
Opening balance | 11,627 | |
Business activity in the year | 826 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (587) | |
Final repayments | 457 | |
Disposals | 0 | |
Write-offs | 10 | |
Ending balance | 11,399 | |
Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Home loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Opening balance | 26,347 | |
Business activity in the year | 2,370 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (1,299) | |
Final repayments | 1,268 | |
Disposals | 19 | |
Write-offs | 468 | |
Ending balance | 25,663 | |
Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Wholesale loans | ||
Loans and advances at amortised cost | ||
Opening balance | 101,359 | |
Business activity in the year | 19,182 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1,077 | |
Final repayments | 20,611 | |
Disposals | 101 | |
Write-offs | 128 | |
Ending balance | 100,778 | |
Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Loans and advances | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||
ECL movement excluding assets derecognised due to disposals and write-offs | (395) | |
Recoveries and reimbursements | 201 | |
Exchange and other adjustments | 105 | |
Financial assets at amortised cost | Impairment allowance | Home loans | ||
Loans and advances at amortised cost | ||
Opening balance | 434 | |
Business activity in the year | 0 | |
Changes to models used for calculation | 34 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (69) | |
Final repayments | (2) | |
Disposals | 0 | |
Write-offs | (10) | |
Ending balance | 387 | |
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||
ECL movement excluding assets derecognised due to disposals and write-offs | (37) | |
Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Home loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Opening balance | 2,979 | |
Business activity in the year | 38 | |
Changes to models used for calculation | (30) | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (23) | |
Final repayments | (38) | |
Disposals | (11) | |
Write-offs | (468) | |
Ending balance | 2,447 | |
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||
ECL movement excluding assets derecognised due to disposals and write-offs | (53) | |
Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Wholesale loans | ||
Loans and advances at amortised cost | ||
Opening balance | 1,653 | |
Business activity in the year | 77 | |
Changes to models used for calculation | (36) | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (185) | |
Final repayments | (161) | |
Disposals | (29) | |
Write-offs | (128) | |
Ending balance | 1,191 | |
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||
ECL movement excluding assets derecognised due to disposals and write-offs | (305) | |
Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Stage 1 | Gross exposure | Home loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (6) | |
Stage 1 | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,142 | |
Stage 1 | Gross exposure | Wholesale loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1,912 | |
Stage 1 | Impairment allowance | Home loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |
Stage 1 | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (9) | |
Stage 1 | Impairment allowance | Wholesale loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (146) | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Home loans | ||
Loans and advances at amortised cost | ||
Opening balance | 9,627 | |
Business activity in the year | 826 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (484) | |
Final repayments | 303 | |
Disposals | 0 | |
Write-offs | 0 | |
Ending balance | 9,575 | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (282) | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 248 | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (71) | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 14 | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Opening balance | 18,923 | |
Business activity in the year | 2,330 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (752) | |
Final repayments | 1,158 | |
Disposals | 0 | |
Write-offs | 0 | |
Ending balance | 21,196 | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (539) | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 2,508 | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (130) | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 14 | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Wholesale loans | ||
Loans and advances at amortised cost | ||
Opening balance | 83,254 | |
Business activity in the year | 17,980 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1,001 | |
Final repayments | 17,539 | |
Disposals | 43 | |
Write-offs | 0 | |
Ending balance | 86,087 | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (3,956) | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 5,093 | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (98) | |
Stage 1 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 395 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Home loans | ||
Loans and advances at amortised cost | ||
Opening balance | 6 | |
Business activity in the year | 0 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (14) | |
Final repayments | 0 | |
Disposals | 0 | |
Write-offs | 0 | |
Ending balance | 7 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 15 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Opening balance | 399 | |
Business activity in the year | 30 | |
Changes to models used for calculation | (3) | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (316) | |
Final repayments | (27) | |
Disposals | 0 | |
Write-offs | 0 | |
Ending balance | 609 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (31) | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 546 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (7) | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 18 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | ||
Loans and advances at amortised cost | ||
Opening balance | 280 | |
Business activity in the year | 32 | |
Changes to models used for calculation | (7) | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (167) | |
Final repayments | (38) | |
Disposals | (1) | |
Write-offs | 0 | |
Ending balance | 193 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (10) | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 104 | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (1) | |
Stage 1 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 1 | |
Lifetime expected credit losses | Stage 2 | Gross exposure | Home loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |
Lifetime expected credit losses | Stage 2 | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 213 | |
Lifetime expected credit losses | Stage 2 | Gross exposure | Wholesale loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 688 | |
Lifetime expected credit losses | Stage 2 | Impairment allowance | Home loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |
Lifetime expected credit losses | Stage 2 | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1 | |
Lifetime expected credit losses | Stage 2 | Impairment allowance | Wholesale loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (61) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Home loans | ||
Loans and advances at amortised cost | ||
Opening balance | 901 | |
Business activity in the year | 0 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (48) | |
Final repayments | 71 | |
Disposals | 0 | |
Write-offs | 0 | |
Ending balance | 807 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 282 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (248) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (44) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 35 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Opening balance | 5,571 | |
Business activity in the year | 20 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (463) | |
Final repayments | 49 | |
Disposals | 0 | |
Write-offs | 0 | |
Ending balance | 2,850 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 539 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (2,508) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (280) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 20 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Wholesale loans | ||
Loans and advances at amortised cost | ||
Opening balance | 15,938 | |
Business activity in the year | 1,124 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 152 | |
Final repayments | 2,885 | |
Disposals | 8 | |
Write-offs | 0 | |
Ending balance | 13,351 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 3,956 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (5,093) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (105) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 272 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Home loans | ||
Loans and advances at amortised cost | ||
Opening balance | 52 | |
Business activity in the year | 0 | |
Changes to models used for calculation | (4) | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 9 | |
Final repayments | (1) | |
Disposals | 0 | |
Write-offs | 0 | |
Ending balance | 39 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (15) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (4) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 2 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Opening balance | 1,327 | |
Business activity in the year | 4 | |
Changes to models used for calculation | (27) | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 119 | |
Final repayments | (6) | |
Disposals | 0 | |
Write-offs | 0 | |
Ending balance | 781 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 31 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (546) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (127) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 6 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | ||
Loans and advances at amortised cost | ||
Opening balance | 533 | |
Business activity in the year | 29 | |
Changes to models used for calculation | (29) | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (14) | |
Final repayments | (91) | |
Disposals | 0 | |
Write-offs | 0 | |
Ending balance | 331 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 10 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (104) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (11) | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 8 | |
Lifetime expected credit losses | Stage 3 | Gross exposure | Home loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |
Lifetime expected credit losses | Stage 3 | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (232) | |
Lifetime expected credit losses | Stage 3 | Gross exposure | Wholesale loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (28) | |
Lifetime expected credit losses | Stage 3 | Impairment allowance | Home loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |
Lifetime expected credit losses | Stage 3 | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 3 | |
Lifetime expected credit losses | Stage 3 | Impairment allowance | Wholesale loans | ||
Loans and advances at amortised cost | ||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Home loans | ||
Loans and advances at amortised cost | ||
Opening balance | 1,099 | |
Business activity in the year | 0 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (55) | |
Final repayments | 83 | |
Disposals | 0 | |
Write-offs | 10 | |
Ending balance | 1,017 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 115 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Home loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (49) | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Opening balance | 1,853 | |
Business activity in the year | 20 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (84) | |
Final repayments | 61 | |
Disposals | 19 | |
Write-offs | 468 | |
Ending balance | 1,617 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 410 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (34) | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Wholesale loans | ||
Loans and advances at amortised cost | ||
Opening balance | 2,167 | |
Business activity in the year | 78 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (76) | |
Final repayments | 187 | |
Disposals | 50 | |
Write-offs | 128 | |
Ending balance | 1,340 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 203 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Gross exposure | Wholesale loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (667) | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Home loans | ||
Loans and advances at amortised cost | ||
Opening balance | 376 | |
Business activity in the year | 0 | |
Changes to models used for calculation | 38 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (64) | |
Final repayments | (1) | |
Write-offs | (10) | |
Ending balance | 341 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 4 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Home loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (2) | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Loans and advances at amortised cost | ||
Opening balance | 1,253 | |
Business activity in the year | 4 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 174 | |
Final repayments | (5) | |
Disposals | (11) | |
Write-offs | (468) | |
Ending balance | 1,057 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 134 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | (24) | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | ||
Loans and advances at amortised cost | ||
Opening balance | 840 | |
Business activity in the year | 16 | |
Changes to models used for calculation | 0 | |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (4) | |
Final repayments | (32) | |
Disposals | (28) | |
Write-offs | (128) | |
Ending balance | 667 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 0 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers to Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | 12 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost | Impairment allowance | Wholesale loans | Transfers from Stage 3 | ||
Loans and advances at amortised cost | ||
Increase (decrease) through transfers, financial assets | £ (9) |
Credit Risk - Movement in gross
Credit Risk - Movement in gross exposure for loans and advances at amortised cost - footnotes narrative (Details) - GBP (£) £ in Millions | 6 Months Ended | |||
Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Financial guarantee contracts | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Post write-off recoveries | £ 15 | |||
Net release in ECL | 216 | |||
Home loans | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 11,012 | £ 11,193 | ||
Home loans | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 9,568 | 9,621 | ||
Home loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 768 | 849 | ||
Home loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 676 | 723 | ||
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 23,216 | 23,368 | ||
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 20,587 | 18,524 | ||
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 2,069 | 4,244 | ||
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 560 | 600 | ||
Wholesale loans | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 99,587 | 99,706 | ||
Wholesale loans | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 85,894 | 82,974 | ||
Wholesale loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 13,020 | 15,405 | ||
Wholesale loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 673 | 1,327 | ||
Loans and advances | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Gross write-offs | 606 | £ 643 | ||
Post write-off recoveries | 15 | 1 | ||
Net write-offs | 591 | £ 642 | ||
Financial assets | 133,815 | 134,267 | ||
Decrease through derecognition, financial assets | 0 | |||
Loans and advances | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 116,049 | 111,119 | ||
Loans and advances | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 15,857 | 20,498 | ||
Loans and advances | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 1,909 | 2,650 | ||
Impairment allowance | Home loans | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |||
Impairment allowance | Home loans | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |||
Impairment allowance | Home loans | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |||
Impairment allowance | Home loans | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |||
Impairment allowance | Home loans | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | (34) | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (69) | |||
Gross write-offs | (10) | |||
Financial assets | (387) | (434) | ||
Decrease through derecognition, financial assets | 0 | |||
Impairment allowance | Home loans | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (14) | |||
Gross write-offs | 0 | |||
Financial assets | (7) | (6) | ||
Decrease through derecognition, financial assets | 0 | |||
Impairment allowance | Home loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 4 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 9 | |||
Gross write-offs | 0 | |||
Financial assets | (39) | (52) | ||
Decrease through derecognition, financial assets | 0 | |||
Impairment allowance | Home loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | (38) | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (64) | |||
Gross write-offs | (10) | |||
Financial assets | (341) | (376) | ||
Impairment allowance | Credit cards, unsecured loans and other retail lending | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (5) | |||
Impairment allowance | Credit cards, unsecured loans and other retail lending | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (9) | |||
Impairment allowance | Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1 | |||
Impairment allowance | Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 3 | |||
Impairment allowance | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 30 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (23) | |||
Gross write-offs | (468) | |||
Financial assets | (2,447) | (2,979) | ||
Decrease through derecognition, financial assets | (11) | |||
Impairment allowance | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 3 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (316) | |||
Gross write-offs | 0 | |||
Financial assets | (609) | (399) | ||
Decrease through derecognition, financial assets | 0 | |||
Impairment allowance | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 27 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 119 | |||
Gross write-offs | 0 | |||
Financial assets | (781) | (1,327) | ||
Decrease through derecognition, financial assets | 0 | |||
Impairment allowance | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 174 | |||
Gross write-offs | (468) | |||
Financial assets | (1,057) | (1,253) | ||
Decrease through derecognition, financial assets | (11) | |||
Impairment allowance | Wholesale loans | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (205) | |||
Impairment allowance | Wholesale loans | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (146) | |||
Impairment allowance | Wholesale loans | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (61) | |||
Impairment allowance | Wholesale loans | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2 | |||
Impairment allowance | Wholesale loans | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 36 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (185) | |||
Gross write-offs | (128) | |||
Financial assets | (1,191) | (1,653) | ||
Decrease through derecognition, financial assets | (29) | |||
Impairment allowance | Wholesale loans | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 7 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (167) | |||
Gross write-offs | 0 | |||
Financial assets | (193) | (280) | ||
Decrease through derecognition, financial assets | (1) | |||
Impairment allowance | Wholesale loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 29 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (14) | |||
Gross write-offs | 0 | |||
Financial assets | (331) | (533) | ||
Decrease through derecognition, financial assets | 0 | |||
Impairment allowance | Wholesale loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (4) | |||
Gross write-offs | (128) | |||
Financial assets | (667) | (840) | ||
Decrease through derecognition, financial assets | (28) | |||
Impairment allowance | Loans and advances | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | (4,025) | (5,066) | ||
Impairment allowance | Loans and advances | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | (809) | (685) | ||
Impairment allowance | Loans and advances | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | (1,151) | (1,912) | ||
Impairment allowance | Loans and advances | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | (2,065) | (2,469) | ||
Impairment allowance | Impairment charge on other financial assets | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | (102) | (145) | ||
Impairment allowance | Impairment charge on other financial assets | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | (7) | (7) | ||
Impairment allowance | Financial assets at fair value through other comprehensive income | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | (1) | (6) | ||
Impairment allowance | Other assets | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | (94) | (132) | ||
Gross exposure | Home loans | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (6) | |||
Gross exposure | Home loans | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (6) | |||
Gross exposure | Home loans | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |||
Gross exposure | Home loans | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |||
Gross exposure | Home loans | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (587) | |||
Gross write-offs | 10 | |||
Financial assets | 11,399 | 11,627 | ||
Decrease through derecognition, financial assets | 0 | |||
Gross exposure | Home loans | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (484) | |||
Gross write-offs | 0 | |||
Financial assets | 9,575 | 9,627 | ||
Decrease through derecognition, financial assets | 0 | |||
Gross exposure | Home loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (48) | |||
Gross write-offs | 0 | |||
Financial assets | 807 | 901 | ||
Decrease through derecognition, financial assets | 0 | |||
Gross exposure | Home loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (55) | |||
Gross write-offs | 10 | |||
Financial assets | 1,017 | 1,099 | ||
Decrease through derecognition, financial assets | 0 | |||
Gross exposure | Credit cards, unsecured loans and other retail lending | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,123 | |||
Gross exposure | Credit cards, unsecured loans and other retail lending | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,142 | |||
Gross exposure | Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 213 | |||
Gross exposure | Credit cards, unsecured loans and other retail lending | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (232) | |||
Gross exposure | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (1,299) | |||
Gross write-offs | 468 | |||
Financial assets | 25,663 | 26,347 | ||
Decrease through derecognition, financial assets | 19 | |||
Gross exposure | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (752) | |||
Gross write-offs | 0 | |||
Financial assets | 21,196 | 18,923 | ||
Decrease through derecognition, financial assets | 0 | |||
Gross exposure | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (463) | |||
Gross write-offs | 0 | |||
Financial assets | 2,850 | 5,571 | ||
Decrease through derecognition, financial assets | 0 | |||
Gross exposure | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (84) | |||
Gross write-offs | 468 | |||
Financial assets | 1,617 | 1,853 | ||
Decrease through derecognition, financial assets | 19 | |||
Gross exposure | Wholesale loans | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,572 | |||
Gross exposure | Wholesale loans | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1,912 | |||
Gross exposure | Wholesale loans | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 688 | |||
Gross exposure | Wholesale loans | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (28) | |||
Gross exposure | Wholesale loans | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1,077 | |||
Gross write-offs | 128 | |||
Financial assets | 100,778 | 101,359 | ||
Decrease through derecognition, financial assets | 101 | |||
Gross exposure | Wholesale loans | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1,001 | |||
Gross write-offs | 0 | |||
Financial assets | 86,087 | 83,254 | ||
Decrease through derecognition, financial assets | 43 | |||
Gross exposure | Wholesale loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 152 | |||
Gross write-offs | 0 | |||
Financial assets | 13,351 | 15,938 | ||
Decrease through derecognition, financial assets | 8 | |||
Gross exposure | Wholesale loans | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Increase (decrease) through changes in models or risk parameters, financial assets | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (76) | |||
Gross write-offs | 128 | |||
Financial assets | 1,340 | 2,167 | ||
Decrease through derecognition, financial assets | 50 | |||
Gross exposure | Loans and advances | Financial assets at amortised cost | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 137,840 | 139,333 | ||
Gross exposure | Loans and advances | Financial assets at amortised cost | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 116,858 | 111,804 | ||
Gross exposure | Loans and advances | Financial assets at amortised cost | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 17,008 | 22,410 | ||
Gross exposure | Loans and advances | Financial assets at amortised cost | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 3,974 | 5,119 | ||
Gross exposure | Impairment charge on other financial assets | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 159,900 | 150,300 | ||
Gross exposure | Impairment charge on other financial assets | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 159,800 | 146,300 | ||
Gross exposure | Impairment charge on other financial assets | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 94 | £ 132 | 132 | |
Gross exposure | Financial assets at fair value through other comprehensive income | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | 34 | 3,800 | ||
Gross exposure | Other assets | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Financial assets | £ 94 | £ 132 |
Credit Risk - Movement in gro_2
Credit Risk - Movement in gross exposure for loan commitment and financial guarantees (Details) £ in Millions | 6 Months Ended |
Jun. 30, 2021GBP (£) | |
Gross exposure | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | £ 131 |
Net transfers between stages | 0 |
Business activity in the year | 7 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (6) |
Limit management and final repayments | (91) |
Ending balance | 41 |
Gross exposure | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 74,485 |
Net transfers between stages | 0 |
Business activity in the year | 3,159 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,123 |
Limit management and final repayments | (4,832) |
Ending balance | 74,935 |
Gross exposure | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 201,861 |
Net transfers between stages | 0 |
Business activity in the year | 41,929 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,572 |
Limit management and final repayments | (38,159) |
Ending balance | 208,203 |
Impairment allowance | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 0 |
Net transfers between stages | 0 |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 |
Limit management and final repayments | 0 |
Ending balance | 0 |
Impairment allowance | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 90 |
Net transfers between stages | 0 |
Business activity in the year | 2 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (5) |
Limit management and final repayments | (2) |
Ending balance | 85 |
Impairment allowance | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 679 |
Net transfers between stages | 0 |
Business activity in the year | 126 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (205) |
Limit management and final repayments | (113) |
Ending balance | 487 |
Stage 1 | Gross exposure | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 125 |
Net transfers between stages | 0 |
Business activity in the year | 6 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (6) |
Limit management and final repayments | (88) |
Ending balance | 37 |
Stage 1 | Gross exposure | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 68,211 |
Net transfers between stages | 3,555 |
Business activity in the year | 3,135 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,142 |
Limit management and final repayments | (4,476) |
Ending balance | 72,567 |
Stage 1 | Gross exposure | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 160,404 |
Net transfers between stages | 96 |
Business activity in the year | 39,001 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1,912 |
Limit management and final repayments | (32,861) |
Ending balance | 168,552 |
Stage 1 | Impairment allowance | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 0 |
Net transfers between stages | 0 |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 |
Limit management and final repayments | 0 |
Ending balance | 0 |
Stage 1 | Impairment allowance | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 34 |
Net transfers between stages | 8 |
Business activity in the year | 1 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (9) |
Limit management and final repayments | 0 |
Ending balance | 34 |
Stage 1 | Impairment allowance | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 205 |
Net transfers between stages | 115 |
Business activity in the year | 28 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (146) |
Limit management and final repayments | (25) |
Ending balance | 177 |
Lifetime expected credit losses | Stage 2 | Gross exposure | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 2 |
Net transfers between stages | 0 |
Business activity in the year | 1 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 |
Limit management and final repayments | 0 |
Ending balance | 3 |
Lifetime expected credit losses | Stage 2 | Gross exposure | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 6,244 |
Net transfers between stages | (3,786) |
Business activity in the year | 23 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 213 |
Limit management and final repayments | (353) |
Ending balance | 2,341 |
Lifetime expected credit losses | Stage 2 | Gross exposure | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 39,426 |
Net transfers between stages | 1,087 |
Business activity in the year | 2,916 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 688 |
Limit management and final repayments | (4,843) |
Ending balance | 39,274 |
Lifetime expected credit losses | Stage 2 | Impairment allowance | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 0 |
Net transfers between stages | 0 |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 |
Limit management and final repayments | 0 |
Ending balance | 0 |
Lifetime expected credit losses | Stage 2 | Impairment allowance | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 33 |
Net transfers between stages | (3) |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1 |
Limit management and final repayments | 0 |
Ending balance | 31 |
Lifetime expected credit losses | Stage 2 | Impairment allowance | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 446 |
Net transfers between stages | (111) |
Business activity in the year | 89 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (61) |
Limit management and final repayments | (83) |
Ending balance | 280 |
Lifetime expected credit losses | Stage 3 | Gross exposure | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 4 |
Net transfers between stages | 0 |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 |
Limit management and final repayments | (3) |
Ending balance | 1 |
Lifetime expected credit losses | Stage 3 | Gross exposure | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 30 |
Net transfers between stages | 231 |
Business activity in the year | 1 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (232) |
Limit management and final repayments | (3) |
Ending balance | 27 |
Lifetime expected credit losses | Stage 3 | Gross exposure | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 2,031 |
Net transfers between stages | (1,183) |
Business activity in the year | 12 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (28) |
Limit management and final repayments | (455) |
Ending balance | 377 |
Lifetime expected credit losses | Stage 3 | Impairment allowance | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 0 |
Net transfers between stages | 0 |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 |
Limit management and final repayments | 0 |
Ending balance | 0 |
Lifetime expected credit losses | Stage 3 | Impairment allowance | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 23 |
Net transfers between stages | (5) |
Business activity in the year | 1 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 3 |
Limit management and final repayments | (2) |
Ending balance | 20 |
Lifetime expected credit losses | Stage 3 | Impairment allowance | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 28 |
Net transfers between stages | (4) |
Business activity in the year | 9 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2 |
Limit management and final repayments | (5) |
Ending balance | £ 30 |
Credit Risk - Management adjust
Credit Risk - Management adjustments to models for impairment charge (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of financial assets [line items] | ||
Management adjustments to impairment allowances | £ 1,051 | £ 936 |
Proportion of total impairment allowances | 22.90% | 16.00% |
Loans and advances | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | £ 4,597 | £ 5,835 |
Loans and advances | Impairment allowance pre management adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 3,546 | 4,899 |
Loans and advances | Economic uncertainty adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 1,415 | 1,386 |
Loans and advances | Other adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | (364) | (450) |
Loans and advances | Modelled ECL | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 2,600 | 3,900 |
Loans and advances | Individually assessed impairments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 700 | 800 |
Loans and advances | Non-modelled ECL | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 200 | 200 |
Home loans | ||
Disclosure of financial assets [line items] | ||
Management adjustments to impairment allowances | £ 22 | £ 54 |
Proportion of total impairment allowances | 5.70% | 12.40% |
Allowance account for credit losses of financial assets | £ 387 | £ 434 |
Home loans | Impairment allowance pre management adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 365 | 380 |
Home loans | Economic uncertainty adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 22 | 21 |
Home loans | Other adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 0 | 33 |
Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Management adjustments to impairment allowances | £ 550 | £ 960 |
Proportion of total impairment allowances | 21.70% | 31.30% |
Allowance account for credit losses of financial assets | £ 2,532 | £ 3,069 |
Credit cards, unsecured loans and other retail lending | Impairment allowance pre management adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 1,982 | 2,109 |
Credit cards, unsecured loans and other retail lending | Economic uncertainty adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 778 | 986 |
Credit cards, unsecured loans and other retail lending | Other adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | (228) | (26) |
Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Management adjustments to impairment allowances | £ 479 | £ (78) |
Proportion of total impairment allowances | 28.50% | (3.30%) |
Allowance account for credit losses of financial assets | £ 1,678 | £ 2,332 |
Wholesale loans | Impairment allowance pre management adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 1,199 | 2,410 |
Wholesale loans | Economic uncertainty adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 615 | 379 |
Wholesale loans | Other adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | £ (136) | £ (457) |
Credit Risk - Economic uncertai
Credit Risk - Economic uncertainty adjustments (Details) £ in Millions | 6 Months Ended | 12 Months Ended | |
Jun. 30, 2021GBP (£)method | Dec. 31, 2020GBP (£) | Dec. 31, 2019 | |
Covid-19 Related Uncertainty Adjustments | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | £ 1,400 | £ 1,400 | |
Number of methods for uncertainty | method | 2 | ||
Credit cards, unsecured loans and other retail lending | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | £ 2,532 | 3,069 | |
Credit cards, unsecured loans and other retail lending | Covid-19 Related Uncertainty Adjustments | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | 600 | ||
Credit cards, unsecured loans and other retail lending | Other adjustments | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | (228) | (26) | |
Credit cards, unsecured loans and other retail lending | Other adjustments | Americas | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | (200) | ||
Wholesale loans | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | 1,678 | 2,332 | |
Wholesale loans | Covid-19 Related Uncertainty Adjustments | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | 200 | ||
Wholesale loans | Other adjustments | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | (136) | (457) | |
Loans and advances | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | 4,597 | 5,835 | |
Loans and advances | Covid-19 Related Uncertainty Adjustments | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | 800 | ||
Loans and advances | Covid-19 Related Uncertainty Adjustments | Customers | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | 200 | 100 | |
Loans and advances | Covid-19 Related Uncertainty Adjustments | Specific bases | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | 500 | 1,000 | |
Loans and advances | Other adjustments | |||
Disclosure of financial assets [line items] | |||
Allowance account for credit losses of financial assets | £ (364) | £ (450) | |
Financial assets at amortised cost | |||
Disclosure of financial assets [line items] | |||
Arrears collection period | 30 days | ||
Financial assets at amortised cost | USA | Credit cards, unsecured loans and other retail lending | |||
Disclosure of financial assets [line items] | |||
Decrease in arrears collection rate | 1.60% | ||
Arrears collection rate | 2.50% | 2.70% |
Credit Risk - Measurement uncer
Credit Risk - Measurement uncertainty, Narrative (Details) £ in Millions | 6 Months Ended | |
Jun. 30, 2021GBP (£)economic_scenario | Dec. 31, 2020GBP (£) | |
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Stress horizon period | 5 years | |
Loans and advances | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Allowance account for credit losses of financial assets | £ | £ 4,597 | £ 5,835 |
Economic uncertainty adjustments | Loans and advances | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Allowance account for credit losses of financial assets | £ | £ 1,415 | £ 1,386 |
Credit risk | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Number of economic scenarios | economic_scenario | 5 | |
Number of economic variables to calculate ECL | economic_scenario | 8 | |
Stress horizon period | 5 years | |
Term at which scenario converges to steady state | 8 years | |
Period for ECL estimates | 3 years | |
UNITED KINGDOM | Downside 2 | Later than one month and not later than three months | Unemployment | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 10.00% | |
UNITED KINGDOM | Upside 2 | Later than one year | Unemployment | Maximum | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 5.00% | |
UNITED KINGDOM | Baseline | Later than three months and not later than six months | Unemployment | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 6.00% | |
USA | Downside 2 | Later than one month and not later than three months | Unemployment | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 12.00% | |
USA | Upside 2 | Later than one year | Unemployment | Maximum | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 4.00% |
Credit Risk - Measurement unc_2
Credit Risk - Measurement uncertainty - Average macroeconomic variables used in the calculation of ECL (Details) | Jun. 30, 2021 | Dec. 31, 2020 |
Baseline | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 26.40% | 24.70% |
Baseline | GDP | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.90% | 6.30% |
Baseline | GDP | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.60% | 3.30% |
Baseline | GDP | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.30% | 2.60% |
Baseline | GDP | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.70% | 3.90% |
Baseline | GDP | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.90% | 3.10% |
Baseline | GDP | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.60% | 2.90% |
Baseline | Unemployment | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.80% | 6.70% |
Baseline | Unemployment | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.70% | 6.40% |
Baseline | Unemployment | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.10% | 5.80% |
Baseline | Unemployment | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.60% | 6.90% |
Baseline | Unemployment | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.50% | 5.70% |
Baseline | Unemployment | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.40% | 5.60% |
Baseline | HPI | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (0.50%) | 2.40% |
Baseline | HPI | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 2.30% |
Baseline | HPI | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.10% | 5.00% |
Baseline | HPI | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.90% | 2.80% |
Baseline | HPI | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.50% | 4.70% |
Baseline | HPI | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.50% | 4.70% |
Baseline | UK bank rate | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.00% |
Baseline | UK bank rate | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | (0.10%) |
Baseline | UK bank rate | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.40% | 0.00% |
Baseline | US federal funds rate | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Baseline | US federal funds rate | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Baseline | US federal funds rate | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.70% | 0.30% |
Downside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 12.60% | 15.40% |
Downside 2 | GDP | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (1.70%) | (3.90%) |
Downside 2 | GDP | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.00% | 6.50% |
Downside 2 | GDP | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.20% | 2.60% |
Downside 2 | GDP | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.50% | (2.40%) |
Downside 2 | GDP | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.40% | 3.60% |
Downside 2 | GDP | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.00% | 2.10% |
Downside 2 | Unemployment | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.30% | 8.00% |
Downside 2 | Unemployment | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.20% | 9.30% |
Downside 2 | Unemployment | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.60% | 7.80% |
Downside 2 | Unemployment | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.70% | 13.40% |
Downside 2 | Unemployment | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 11.00% | 11.90% |
Downside 2 | Unemployment | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 9.30% | 10.10% |
Downside 2 | HPI | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (5.80%) | (13.60%) |
Downside 2 | HPI | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (5.80%) | (10.80%) |
Downside 2 | HPI | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | 0.50% |
Downside 2 | HPI | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (4.90%) | (17.20%) |
Downside 2 | HPI | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (3.00%) | (0.70%) |
Downside 2 | HPI | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.10% | 0.60% |
Downside 2 | UK bank rate | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | (0.20%) |
Downside 2 | UK bank rate | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.00% | (0.20%) |
Downside 2 | UK bank rate | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.00% | (0.10%) |
Downside 2 | US federal funds rate | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Downside 2 | US federal funds rate | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Downside 2 | US federal funds rate | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Downside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 16.90% | 15.50% |
Downside 1 | GDP | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.60% | 0.10% |
Downside 1 | GDP | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.40% | 6.60% |
Downside 1 | GDP | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.20% | 3.20% |
Downside 1 | GDP | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.40% | 0.40% |
Downside 1 | GDP | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.50% | 3.60% |
Downside 1 | GDP | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.60% | 2.30% |
Downside 1 | Unemployment | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.40% | 7.30% |
Downside 1 | Unemployment | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.60% | 8.00% |
Downside 1 | Unemployment | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.60% | 6.90% |
Downside 1 | Unemployment | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.40% | 11.00% |
Downside 1 | Unemployment | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.90% | 8.90% |
Downside 1 | Unemployment | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.10% | 6.90% |
Downside 1 | HPI | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (3.10%) | (6.70%) |
Downside 1 | HPI | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (2.70%) | (3.50%) |
Downside 1 | HPI | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.70% | 1.70% |
Downside 1 | HPI | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (0.50%) | (5.90%) |
Downside 1 | HPI | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | 1.80% |
Downside 1 | HPI | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.30% | 2.60% |
Downside 1 | UK bank rate | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | (0.10%) |
Downside 1 | UK bank rate | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | (0.10%) |
Downside 1 | UK bank rate | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | 0.00% |
Downside 1 | US federal funds rate | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Downside 1 | US federal funds rate | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Downside 1 | US federal funds rate | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Upside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 19.60% | 20.20% |
Upside 2 | GDP | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.80% | 12.20% |
Upside 2 | GDP | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 9.40% | 5.30% |
Upside 2 | GDP | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.00% | 3.90% |
Upside 2 | GDP | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.50% | 7.10% |
Upside 2 | GDP | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.20% | 4.60% |
Upside 2 | GDP | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.40% | 4.00% |
Upside 2 | Unemployment | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.50% | 6.20% |
Upside 2 | Unemployment | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.90% | 5.50% |
Upside 2 | Unemployment | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.40% | 4.80% |
Upside 2 | Unemployment | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.30% | 5.50% |
Upside 2 | Unemployment | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.80% | 4.30% |
Upside 2 | Unemployment | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.80% | 4.10% |
Upside 2 | HPI | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.60% | 6.60% |
Upside 2 | HPI | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 9.90% | 10.40% |
Upside 2 | HPI | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 11.30% | 10.80% |
Upside 2 | HPI | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.50% | 8.80% |
Upside 2 | HPI | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.00% | 9.10% |
Upside 2 | HPI | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.30% | 8.90% |
Upside 2 | UK bank rate | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.10% |
Upside 2 | UK bank rate | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.40% | 0.30% |
Upside 2 | UK bank rate | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.60% | 0.30% |
Upside 2 | US federal funds rate | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Upside 2 | US federal funds rate | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.40% |
Upside 2 | US federal funds rate | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.10% | 0.60% |
Upside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 24.50% | 24.20% |
Upside 1 | GDP | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.90% | 9.30% |
Upside 1 | GDP | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.30% | 3.90% |
Upside 1 | GDP | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.00% | 3.40% |
Upside 1 | GDP | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.10% | 5.50% |
Upside 1 | GDP | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.80% | 4.00% |
Upside 1 | GDP | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.40% | 3.70% |
Upside 1 | Unemployment | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.60% | 6.40% |
Upside 1 | Unemployment | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.20% | 6.00% |
Upside 1 | Unemployment | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.70% | 5.20% |
Upside 1 | Unemployment | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.50% | 6.00% |
Upside 1 | Unemployment | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.20% | 4.80% |
Upside 1 | Unemployment | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.20% | 4.60% |
Upside 1 | HPI | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.50% | 4.60% |
Upside 1 | HPI | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.50% | 6.10% |
Upside 1 | HPI | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.40% | 6.10% |
Upside 1 | HPI | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.20% | 6.80% |
Upside 1 | HPI | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.80% | 6.70% |
Upside 1 | HPI | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.70% | 6.30% |
Upside 1 | UK bank rate | UNITED KINGDOM | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.10% |
Upside 1 | UK bank rate | UNITED KINGDOM | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | 0.10% |
Upside 1 | UK bank rate | UNITED KINGDOM | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.60% | 0.30% |
Upside 1 | US federal funds rate | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Upside 1 | US federal funds rate | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Upside 1 | US federal funds rate | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.90% | 0.50% |
Credit Risk - Measurement unc_3
Credit Risk - Measurement uncertainty - Scenario probability weighting (Details) | Jun. 30, 2021 | Dec. 31, 2020 |
Upside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 19.60% | 20.20% |
Upside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 24.50% | 24.20% |
Baseline | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 26.40% | 24.70% |
Downside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 16.90% | 15.50% |
Downside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 12.60% | 15.40% |
Credit Risk - Measurement unc_4
Credit Risk - Measurement uncertainty - Macroeconomic variables (specific bases and 5-year averages) (Details) | Jun. 30, 2021 | Dec. 31, 2020 |
Upside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 19.60% | 20.20% |
Upside 2 | GDP | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 25.90% | 14.20% |
Upside 2 | GDP | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.20% | 2.50% |
Upside 2 | GDP | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 23.70% | 15.70% |
Upside 2 | GDP | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.60% | 2.90% |
Upside 2 | Unemployment | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.10% | 4.00% |
Upside 2 | Unemployment | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.60% | 5.00% |
Upside 2 | Unemployment | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.80% | 3.80% |
Upside 2 | Unemployment | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.10% | 5.30% |
Upside 2 | HPI | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 48.20% | 48.20% |
Upside 2 | HPI | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.20% | 8.20% |
Upside 2 | HPI | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 41.20% | 42.20% |
Upside 2 | HPI | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.10% | 7.30% |
Upside 2 | UK bank rate | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.10% |
Upside 2 | UK bank rate | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.70% | 0.30% |
Upside 2 | US federal funds rate | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.10% |
Upside 2 | US federal funds rate | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.10% | 0.50% |
Upside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 24.50% | 24.20% |
Upside 1 | GDP | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 20.20% | 8.80% |
Upside 1 | GDP | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.20% | 1.60% |
Upside 1 | GDP | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 18.30% | 12.80% |
Upside 1 | GDP | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.70% | 2.40% |
Upside 1 | Unemployment | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.30% | 4.00% |
Upside 1 | Unemployment | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.80% | 5.30% |
Upside 1 | Unemployment | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.20% | 3.80% |
Upside 1 | Unemployment | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.40% | 5.70% |
Upside 1 | HPI | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 25.50% | 30.80% |
Upside 1 | HPI | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.70% | 5.50% |
Upside 1 | HPI | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 32.60% | 30.90% |
Upside 1 | HPI | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.80% | 5.50% |
Upside 1 | UK bank rate | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.10% |
Upside 1 | UK bank rate | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.60% | 0.20% |
Upside 1 | US federal funds rate | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.10% |
Upside 1 | US federal funds rate | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.90% | 0.50% |
Baseline | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 26.40% | 24.70% |
Baseline | GDP | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.30% | 0.70% |
Baseline | GDP | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.30% | 0.70% |
Baseline | GDP | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.80% | 1.60% |
Baseline | GDP | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.80% | 1.60% |
Baseline | Unemployment | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.10% | 5.70% |
Baseline | Unemployment | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.10% | 5.70% |
Baseline | Unemployment | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.70% | 6.40% |
Baseline | Unemployment | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.70% | 6.40% |
Baseline | HPI | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.60% | 3.60% |
Baseline | HPI | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.60% | 3.60% |
Baseline | HPI | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.60% | 3.80% |
Baseline | HPI | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.60% | 3.80% |
Baseline | UK bank rate | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.40% | 0.00% |
Baseline | UK bank rate | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.40% | 0.00% |
Baseline | US federal funds rate | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.80% | 0.30% |
Baseline | US federal funds rate | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.80% | 0.30% |
Downside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 16.90% | 15.50% |
Downside 1 | GDP | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (4.20%) | (22.10%) |
Downside 1 | GDP | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.60% | 0.10% |
Downside 1 | GDP | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (0.20%) | (10.60%) |
Downside 1 | GDP | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.00% | 0.80% |
Downside 1 | Unemployment | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.50% | 8.40% |
Downside 1 | Unemployment | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.70% | 6.50% |
Downside 1 | Unemployment | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.90% | 13.00% |
Downside 1 | Unemployment | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.30% | 8.30% |
Downside 1 | HPI | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (5.80%) | (4.50%) |
Downside 1 | HPI | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.00% | (0.20%) |
Downside 1 | HPI | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (1.30%) | (3.70%) |
Downside 1 | HPI | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.60% | 0.80% |
Downside 1 | UK bank rate | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.60% |
Downside 1 | UK bank rate | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | 0.00% |
Downside 1 | US federal funds rate | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.50% | 1.30% |
Downside 1 | US federal funds rate | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.60% | 0.30% |
Downside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 12.60% | 15.40% |
Downside 2 | GDP | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (8.10%) | (22.10%) |
Downside 2 | GDP | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.80% | (0.90%) |
Downside 2 | GDP | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (3.20%) | (10.60%) |
Downside 2 | GDP | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.40% | 0.10% |
Downside 2 | Unemployment | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 9.80% | 10.10% |
Downside 2 | Unemployment | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.50% | 7.20% |
Downside 2 | Unemployment | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 12.00% | 13.70% |
Downside 2 | Unemployment | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.50% | 10.40% |
Downside 2 | HPI | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (11.80%) | (18.30%) |
Downside 2 | HPI | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (1.60%) | (3.60%) |
Downside 2 | HPI | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (7.90%) | (15.90%) |
Downside 2 | HPI | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (0.40%) | (3.00%) |
Downside 2 | UK bank rate | UNITED KINGDOM | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.60% |
Downside 2 | UK bank rate | UNITED KINGDOM | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.00% | (0.10%) |
Downside 2 | US federal funds rate | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.80% | 1.30% |
Downside 2 | US federal funds rate | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Uncategorized Items - _IXDS
Label | Element | Value | |
Expense from equity-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets | ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets | £ 126,000,000 | |
Other comprehensive income, net of tax, financial assets measured at fair value through other comprehensive income | ifrs-full_OtherComprehensiveIncomeNetOfTaxFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome | 246,000,000 | |
Increase (decrease) other equity instruments coupons paid | c070_IncreaseDecreaseOtherEquityInstrumentsCouponsPaid | (344,000,000) | |
Increase (decrease) through exercise of options, equity | ifrs-full_IncreaseDecreaseThroughExerciseOfOptions | (11,000,000) | |
Issue and/or exchange of other equity instruments | c070_IssueAndExchangeOfOtherEquityInstruments | 245,000,000 | |
Other reserves [member] | |||
Other comprehensive income, net of tax, financial assets measured at fair value through other comprehensive income | ifrs-full_OtherComprehensiveIncomeNetOfTaxFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome | 246,000,000 | [1] |
Comprehensive income | ifrs-full_ComprehensiveIncome | (3,136,000,000) | [1] |
Other comprehensive income, net of tax, exchange differences on translation | ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | (2,033,000,000) | [1] |
Other comprehensive income, net of tax, cash flow hedges | ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges | (272,000,000) | [1] |
Other comprehensive income, net of tax, change in fair value of financial liability attributable to change in credit risk of liability | ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiability | (1,077,000,000) | [1] |
Other equity interest [member] | |||
Profit (loss) | ifrs-full_ProfitLoss | 344,000,000 | [1] |
Comprehensive income | ifrs-full_ComprehensiveIncome | 344,000,000 | [1] |
Increase (decrease) other equity instruments coupons paid | c070_IncreaseDecreaseOtherEquityInstrumentsCouponsPaid | (344,000,000) | [1] |
Issue and/or exchange of other equity instruments | c070_IssueAndExchangeOfOtherEquityInstruments | 298,000,000 | [1] |
Retained earnings [member] | |||
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans | ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans | (753,000,000) | |
Expense from equity-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets | ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets | 126,000,000 | |
Other individually immaterial components of other comprehensive income, net of tax | ifrs-full_OtherIndividuallyImmaterialComponentsOfOtherComprehensiveIncomeNetOfTax | 9,000,000 | |
Profit (loss) | ifrs-full_ProfitLoss | 814,000,000 | |
Comprehensive income | ifrs-full_ComprehensiveIncome | 70,000,000 | |
Increase (decrease) through other changes, equity | ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity | (12,000,000) | |
Increase (decrease) through exercise of options, equity | ifrs-full_IncreaseDecreaseThroughExerciseOfOptions | (11,000,000) | |
Issue and/or exchange of other equity instruments | c070_IssueAndExchangeOfOtherEquityInstruments | (53,000,000) | |
Dividends paid, other shares | ifrs-full_DividendsPaidOtherShares | £ 14,000,000 | |
[1] | Details of share capital, other equity instruments and other reserves are shown on pages 40 to 41. |